Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,42296,-0.222930898766965,0.00511456914202239,-0.232955454285329,-0.212906343248601,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.155532890559197,0.0032479778356171,0.149166854001387,0.161898927117006,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,41843,-0.575623159265896,0.0121642409936605,-0.59946507161347,-0.551781246918321,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,-0.206698139322334,0.00509072740947427,-0.216675965044903,-0.196720313599764,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,42137,-0.245533539855248,0.00429761606171509,-0.253956867336209,-0.237110212374286,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,42262,-0.276516285834107,0.0062829306953927,-0.288830829997076,-0.264201741671137,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.128507035784356,0.0032128922792845,0.122209766916958,0.134804304651753,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,-0.152797982571315,0.00389908940652007,-0.160440197808094,-0.145155767334536,1.11253710506346e-308
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,42080,-0.15609624942307,0.00420590394610326,-0.164339821157432,-0.147852677688707,3.66993082528649e-287
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,0.109187648267803,0.00295906523385662,0.103387880409444,0.114987416126162,3.89763349195368e-284
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PYY,Peptide YY,39575,-0.347089886051231,0.0101263462656805,-0.366937524731965,-0.327242247370498,1.06599298351003e-244
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,39958,-0.295434767082529,0.0087274524462336,-0.312540573877147,-0.278328960287911,2.13800158148256e-239
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,42070,-0.292824338662516,0.00894827880327117,-0.310362965116928,-0.275285712208105,4.4508845552165e-226
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C9,Complement component C9,39990,0.192308348659475,0.0058666804596795,0.180809654958504,0.203807042360447,2.73727233617633e-225
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,42145,0.156077962031419,0.00490754991419782,0.146459164199592,0.165696759863247,3.89438200986499e-214
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,-0.0937242783512425,0.00296186431795663,-0.0995295324144375,-0.0879190242880475,4.6596273456691e-212
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,39990,0.0838715887876434,0.00264492886653947,0.078687528209226,0.0890556493660607,1.49082776685497e-211
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,-0.100597850391483,0.00330661507109315,-0.107078815930826,-0.0941168848521405,9.17542590705364e-197
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,42047,-0.219339058709012,0.00734615002792324,-0.233737512763742,-0.204940604654283,1.00978357570327e-189
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,0.387629364653248,0.0129871859841098,0.362174480124392,0.413084249182103,1.0718246684499e-189
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,-0.198520177602077,0.00666939522206937,-0.211592192237333,-0.185448162966821,1.53223137750399e-188
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,42123,-0.17017644019011,0.00578155010829176,-0.181508278402362,-0.158844601977858,1.24217199672765e-184
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,42145,-0.187403484924135,0.00640944870129155,-0.199966004378667,-0.174840965469604,2.71073928410781e-182
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,41913,-0.247094136302943,0.00847334745838553,-0.263701897321379,-0.230486375284507,2.81552984575254e-181
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,-0.0904750798937465,0.00310627025032924,-0.0965633695843918,-0.0843867902031012,6.63403910717342e-181
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,42199,0.0840761408151829,0.00291186271901975,0.0783688898859042,0.0897833917444616,5.66210092878009e-178
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,42296,-0.0864058886781063,0.00299304588837675,-0.0922722586193247,-0.0805395187368879,5.93129409198878e-178
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,42163,-0.246893484459865,0.00871849096291108,-0.263981726747171,-0.229805242172559,1.89914232064012e-171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,-0.140199716008924,0.00496638768391183,-0.149933835869391,-0.130465596148457,1.92607089749204e-170
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,39979,0.198672499315859,0.00707762568735765,0.184800352968638,0.21254464566308,1.07127774209001e-167
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,-0.233115344609688,0.00839309310176967,-0.249565807089157,-0.21666488213022,4.30239576933371e-165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,-0.143515730984984,0.00520001135915258,-0.153707753248923,-0.133323708721045,4.49152033865201e-163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,42089,-0.291256204092775,0.0105769752487756,-0.311987075580376,-0.270525332605175,1.89395783214788e-162
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,39958,-0.256077644194514,0.00933715287173934,-0.274378463823123,-0.237776824565905,2.12210994197508e-160
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,39649,-0.235485772924875,0.00858372280071157,-0.25230986961427,-0.218661676235481,2.35962371221324e-160
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,42145,-0.172562510377977,0.00648276229939355,-0.185268724484789,-0.159856296271166,3.28090991568529e-152
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,41225,-0.111520285611644,0.00426895874552544,-0.119887444752874,-0.103153126470415,1.48729774856509e-146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,-0.175605662558247,0.00673505906343069,-0.188806378322571,-0.162404946793922,3.4592126994956e-146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,-0.063154570398339,0.00243867593975985,-0.0679343752402683,-0.0583747655564097,2.21452457024287e-144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,-0.390260209346826,0.0150806817956238,-0.419818345666249,-0.360702073027404,4.14285673120283e-144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,42262,-0.0893552723819944,0.00348246537552154,-0.0961809045180166,-0.0825296402459722,7.54984668658122e-142
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0929484698432258,0.00362539142426931,-0.100054237034794,-0.0858427026516579,1.30236973359644e-141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,-0.143343740684624,0.00563034346629305,-0.154379213878558,-0.13230826749069,1.202142208016e-139
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.0884084711293838,0.003496203823131,-0.0952610306227205,-0.081555911636047,7.32877162183471e-138
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,41839,-0.137213104388689,0.00543879902275653,-0.147873150473292,-0.126553058304087,3.30425412058436e-137
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,-0.178654515860851,0.00709755638366863,-0.192565726372842,-0.164743305348861,1.16178881297559e-136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,42310,-0.133234964580486,0.00529759838985562,-0.143618257424603,-0.122851671736369,1.71182978277535e-136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,0.0789431971230414,0.00319398729627154,0.0726829820223492,0.0852034122237336,2.38461615851552e-131
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,-0.124137973026881,0.00506380612876181,-0.134063033039254,-0.114212913014508,7.41968905345573e-130
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FURIN,Furin,42181,-0.0833571055353285,0.00341821209997569,-0.0900568012512808,-0.0766574098193761,1.36911148219555e-128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,-0.132900949279561,0.00545410817587793,-0.143591001304282,-0.12221089725484,2.22605684173054e-128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,-0.219126002362261,0.0089837620834242,-0.236734176045773,-0.20151782867875,4.16167401559739e-128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,-0.0814770597385457,0.00335066582713549,-0.0880443647597312,-0.0749097547173601,3.12438491075272e-127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,42296,-0.0657498697829079,0.0027120288184791,-0.0710654462671269,-0.0604342932986889,3.6110114456174e-127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,-0.137021502655323,0.00565706444651827,-0.148109348970499,-0.125933656340147,7.23349026506633e-127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,-0.0819450512907694,0.00339581211878565,-0.0886008430435893,-0.0752892595379496,5.45205314528727e-126
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELN,Elastin,39958,-0.0871041935517883,0.0036037445552726,-0.0941675328801226,-0.080040854223454,6.66397914721525e-126
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,42137,-0.0987547504202566,0.00411104219526749,-0.106812393122981,-0.0906971077175323,6.64298686579358e-125
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,42070,-0.139914520335568,0.00582963890161275,-0.151340612582729,-0.128488428088407,1.11725879962928e-124
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,-0.0784460064395649,0.00328768157195458,-0.0848898623205959,-0.0720021505585339,2.60193231459491e-123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,-0.0765745590944831,0.00321587026840088,-0.0828776648205488,-0.0702714533684174,8.33818308683506e-123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,-0.20787028269731,0.00878361895408407,-0.225086175847315,-0.190654389547305,2.35032396719679e-121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,42193,-0.0806481219786249,0.00342159275251082,-0.0873544437735461,-0.0739418001837037,1.99089829067552e-120
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,-0.140731396101929,0.00597294103549193,-0.152438360531493,-0.129024431672365,2.61308914735912e-120
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MME,Neprilysin,42070,-0.190026209128975,0.00807030888896953,-0.205844014551356,-0.174208403706595,3.60414026605196e-120
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,-0.123961010854443,0.00525685896745947,-0.134264454430663,-0.113657567278222,5.45060733835829e-120
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,42267,0.0916708448467852,0.00391397634843952,0.0839994512038437,0.0993422384897266,5.61994528593678e-119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,-0.1387726554324,0.00595078141378824,-0.150436187003425,-0.127109123861375,5.54004866402203e-118
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,42310,-0.110458652720487,0.0047434927867667,-0.119755898582549,-0.101161406858424,1.15448676450259e-117
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,-0.136807135731424,0.00589313941013351,-0.148357688975286,-0.125256582487562,1.66358332165136e-116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,-0.203700353722442,0.00880819051462397,-0.220964407131104,-0.186436300313779,4.53322602901045e-116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,39468,0.101248495347062,0.00438875315606651,0.0926465391611716,0.109850451532952,5.22526607392753e-115
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,-0.0863851190229615,0.00376910672358752,-0.093772568201193,-0.0789976698447299,4.57013208468747e-114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,-0.0671123909366152,0.00293411406521785,-0.0728632545044422,-0.0613615273687882,1.15891175437573e-113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,-0.142347386436385,0.00622324649626521,-0.154544949569065,-0.130149823303705,1.33749026523253e-113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,-0.125498667042341,0.00550392552492065,-0.136286361071186,-0.114710973013497,5.88635386188232e-113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,42296,-0.0816198210468545,0.00358327280939861,-0.0886430357532757,-0.0745966063404332,9.31258205682531e-113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,-0.340769836019351,0.015020768325572,-0.370210541937472,-0.31132913010123,7.03866436068299e-112
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,42247,-0.281506487834538,0.0124605691787508,-0.305929203424889,-0.257083772244186,5.59522915066964e-111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,39990,0.108722819924794,0.0048857665908638,0.099146717406701,0.118298922442887,2.0166873730217e-107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.0796527448442886,0.00359688195157897,-0.0867026334693834,-0.0726028562191939,8.77344993424065e-107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.184483256231524,0.0083499014264198,-0.200849063027307,-0.168117449435741,2.7548871315082e-106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,-0.0847077835975972,0.00387001326821808,-0.0922930096033046,-0.0771225575918898,2.12384908838539e-104
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,42195,-0.0767223600533092,0.00352988785222349,-0.0836409402436672,-0.0698037798629511,5.371893057636e-103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,42224,-0.109442082872427,0.00506102654860395,-0.119361694907691,-0.0995224708371636,5.43398147779227e-102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,39736,-0.0622664738976462,0.00287728921482057,-0.0679059607586945,-0.0566269870365979,9.13674021684475e-102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,-0.187926672909408,0.00869891956085174,-0.204976555248677,-0.170876790570138,9.24905359709735e-102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,-0.0781190343905899,0.00361257854385129,-0.0851996883365384,-0.0710383804446414,1.17167652291792e-101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,-0.10930052054883,0.00506532118465761,-0.119228550070759,-0.099372491026901,3.35833683203136e-101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,42123,0.100049192021213,0.0046482500032964,0.090938622014752,0.109159762027674,4.56258027783769e-101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,42184,-0.0640751628684788,0.00297998914490498,-0.0699159415924925,-0.058234384144465,7.13176507328089e-101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,-0.0632100506216008,0.0029368474121812,-0.0689662715494759,-0.0574538296937256,9.59220262428068e-101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,42310,-0.0971726423033175,0.00452436954497563,-0.10604040661147,-0.0883048779951653,1.14049144547436e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,-0.112100497275645,0.00521288983780197,-0.122317761357737,-0.101883233193553,1.54231997539058e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,-0.204388387183631,0.00952483518216491,-0.223057064140674,-0.185719710226588,1.90468508389868e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,-0.188905968322101,0.00888166188893454,-0.206314025624413,-0.171497911019789,9.140241349575e-99
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,42185,-0.0933134737905836,0.00439634917588933,-0.101930318175327,-0.0846966294058405,2.19437774340965e-98
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,-0.159546544791757,0.00757771267158629,-0.174398861628066,-0.144694227955448,1.43025852704471e-96
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,-0.080938272537383,0.00385308400998676,-0.0884903171969571,-0.073386227877809,2.01365940079145e-96
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.0989897289701395,0.00474494150392973,-0.108289814317842,-0.0896896436224373,3.88793332013716e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,42205,-0.143842939303636,0.00691427068064187,-0.157394909837694,-0.130290968769577,1.18241720398495e-94
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,-0.0714072909882999,0.00343934636153927,-0.0781484098569169,-0.0646661721196829,2.69554184353324e-94
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,-0.166433895718117,0.00804548932755962,-0.182203054800134,-0.1506647366361,2.40034719786245e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MENT,Protein MENT,39736,0.0513511204161674,0.00248461291557097,0.0464812791016483,0.0562209617306865,3.74673153411532e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,-0.048260796049461,0.00234145273707225,-0.0528500434141226,-0.0436715486847994,5.6973315466623e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.0833325345717434,0.00404343715893358,-0.0912576714032532,-0.0754073977402336,5.7896236000715e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,-0.265063718536859,0.012871570270509,-0.290291996267057,-0.239835440806661,8.09995645479126e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,-0.180232457076607,0.00875436774649947,-0.197391017859746,-0.163073896293468,9.94461300699075e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,-0.120791488822604,0.00589075582640929,-0.132337370242366,-0.109245607402842,8.89062923057773e-92
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELE,E-selectin,42310,-0.10752721343061,0.00525354548749489,-0.1178241625861,-0.0972302642751204,9.79536380442547e-92
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.084652609508414,0.00413900006650083,-0.0927650496387556,-0.0765401693780724,1.32764357710652e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,-0.169031030353306,0.00833317109963724,-0.185364045708595,-0.152698014998017,3.92077632567581e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,42070,-0.0740726424942889,0.00366667535078365,-0.0812593261818249,-0.066885958806753,1.9919050917489e-89
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,-0.1624591802637,0.00804374470558701,-0.178224919886651,-0.14669344064075,2.29574015038736e-89
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,42216,-0.126304833749157,0.00625739580179411,-0.138569329520674,-0.114040337977641,2.67828644280435e-89
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,39930,-0.160427977418122,0.0079612380889124,-0.176032004072391,-0.144823950763854,9.35369660134197e-89
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,42239,-0.0422190762685671,0.00210101166662999,-0.0463370591351619,-0.0381010934019723,1.56362785646272e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,-0.138715624594187,0.00690103537019943,-0.152241653919778,-0.125189595268596,2.47718972045002e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,42070,-0.0818328810761098,0.00408239839354734,-0.0898343819274626,-0.073831380224757,4.25137401507877e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,39736,-0.134922084458658,0.00674595936720249,-0.148144164818374,-0.121700004098941,1.85595223836294e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGRN,Agrin,42185,-0.0744406594974026,0.00373691507519856,-0.0817650130447917,-0.0671163059500134,4.71916065184407e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,42296,-0.0635453888502389,0.00319028542556982,-0.0697983482843558,-0.0572924294161221,4.79094270912163e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,-0.0909987054536271,0.00458056960237789,-0.0999766218742877,-0.0820207890329664,1.42509609694375e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,-0.0665842908429591,0.00336205429125011,-0.0731739172538093,-0.0599946644321089,4.44899191411064e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,-0.17025173331362,0.00860339914304051,-0.187114395633979,-0.15338907099326,6.43924385332229e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,39638,-0.130242152117142,0.00659325618882289,-0.143164934247235,-0.11731936998705,2.19843882108323e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,42145,-0.0547181718717478,0.00278157242865888,-0.0601700538319192,-0.0492662899115764,5.76245933645351e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,42119,-0.107847988000649,0.00548585599377982,-0.118600265748457,-0.0970957102528403,7.34446039015308e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,-0.11198706954771,0.00570718593604272,-0.123173153982354,-0.100800985113066,1.60080104656214e-84
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.100063262631329,0.00510528599728766,-0.110069623186013,-0.0900569020766454,2.28643619710628e-84
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REN,Renin,42145,-0.165871674873086,0.00847221869326012,-0.182477223511876,-0.149266126234296,3.43838806821605e-84
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,-0.113052349442516,0.00580596890125838,-0.124432048488982,-0.101672650396049,2.7418802598329e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,42296,-0.0922392260538857,0.00474154375143077,-0.10153265180669,-0.0829458003010814,3.60020994917341e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.0671266697780769,0.00345710103664313,-0.0739025878098974,-0.0603507517462564,1.24756815028086e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,42145,-0.0713403046166708,0.00368269457998233,-0.0785583859934362,-0.0641222232399055,1.7381675740125e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,42262,0.073933690975314,0.0038302759518629,0.0664263501096627,0.0814410318409653,6.29347572713399e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,-0.0670390264704465,0.00348696075658106,-0.0738734695533453,-0.0602045833875476,2.66812273336634e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,-0.074120224206284,0.00386376680678953,-0.0816932071475915,-0.0665472412649765,6.18688712754576e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.067903242929383,0.00354114160432385,-0.0748438804738578,-0.0609626053849083,6.96911672621563e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,42258,-0.0531158875731587,0.00279524112305187,-0.0585945601743403,-0.047637214971977,1.72737719143132e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,-0.0820860901418166,0.00432096152777654,-0.0905551747362586,-0.0736170055473745,1.96031161545338e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,42250,-0.10000104799775,0.0052762403365183,-0.110342479057326,-0.0896596169381744,4.30414799178636e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OCLN,Occludin,39934,-0.0880675242439053,0.00464555666863756,-0.0971728153144349,-0.0789622331733757,6.34834463104879e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,39638,-0.106029400678456,0.00559623447364728,-0.116998020246804,-0.0950607811101069,8.33721629464044e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,0.0417980621161409,0.00221228594461264,0.0374619816647001,0.0461341425675817,1.29305337583398e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,0.0537163352424478,0.00284337687859114,0.0481433165604092,0.0592893539244865,2.09500660746995e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,-0.197023120616109,0.0104713039631233,-0.217546876383831,-0.176499364848387,5.94267781968579e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,-0.113478969520878,0.00602437853518216,-0.125286751449835,-0.101671187591921,6.26854978936417e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,42255,-0.0478262095203214,0.0025520365772414,-0.0528282012117146,-0.0428242178289283,2.16233069337532e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,-0.20891341863265,0.0111479876201698,-0.230763474368183,-0.187063362897117,2.24478859183814e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,39713,-0.0765591324560931,0.00410980675093358,-0.0846143536879229,-0.0685039112242633,2.7283716090851e-76
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,0.0722238178719588,0.00389175606294253,0.0645959759885914,0.0798516597553261,6.11626080956686e-76
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,-0.0998888258695897,0.00540541717100805,-0.110483443524765,-0.0892942082144139,2.5568659398575e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,-0.138837113642377,0.00753166266585902,-0.15359917246746,-0.124075054817293,5.93036556945989e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,-0.0683926188953107,0.0037185043388548,-0.0756808873994661,-0.0611043503911553,1.20229910129483e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,-0.132303630319975,0.00718491862445878,-0.146386070823915,-0.118221189816036,1.33890127725743e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,-0.0629556682840124,0.00344045692477049,-0.0696989638565625,-0.0562123727114622,6.95871791931535e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.080508628624962,0.00440586056202982,-0.0891441153265404,-0.0718731419233835,1.04061154362243e-73
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,0.0945553413909678,0.00519065932721662,0.0843816491096233,0.104729033672312,4.19074779448458e-73
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,-0.101527969914546,0.00559249611135212,-0.112489262292797,-0.0905666775362962,1.2669358080716e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,41992,-0.0611341938599729,0.00337164499971944,-0.067742618059423,-0.0545257696605228,1.31639255389568e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,42129,-0.0594834983251004,0.00328103554843084,-0.0659143280000249,-0.053052668650176,1.3459165158578e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,42199,-0.034531320294436,0.0019161890028608,-0.0382870507400432,-0.0307755898488288,9.12311771254864e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0761184553012068,0.00424212950166095,-0.0844330291244622,-0.0678038814779513,3.6577902443309e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,-0.0706076735881885,0.00393178024012217,-0.078313962858828,-0.0629013843175491,4.15058493736909e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,39645,-0.0522537010945293,0.00291397216626521,-0.0579650865404091,-0.0465423156486495,6.67199917239148e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,-0.0757222132765778,0.00423081653959493,-0.0840146136941838,-0.0674298128589717,8.04088121833624e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0541435816472088,0.00304270967126808,0.0481798706915234,0.0601072926028942,4.84103347283102e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,-0.0530280797530318,0.00298405070710893,-0.0588768191389653,-0.0471793403670983,7.31313174268886e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0575260017422204,0.00323793001115192,-0.0638723445640782,-0.0511796589203626,7.98479262505118e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,42262,-0.101253546319059,0.00570318912760831,-0.112431797009172,-0.0900752956289471,9.75502699537268e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,0.100078580838972,0.00564235779369682,0.089019559563326,0.111137602114618,1.3655653641182e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,42262,0.0307890196678496,0.00173810411222016,0.0273823356078981,0.0341957037278011,1.94582791874361e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,39979,0.0509720921802905,0.00287480057286649,0.0453374830574721,0.0566067013031088,2.07901438423629e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,0.0658860441390948,0.00373009246413011,0.0585750629093998,0.0731970253687898,4.78092829776215e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,-0.0546205988757435,0.00311650481151877,-0.0607289483063203,-0.0485122494451667,5.0548948582079e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.103056855370022,0.00587448945221269,-0.114570854696359,-0.0915428560436849,5.6603912860283e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,-0.0520589098608492,0.0029698779437545,-0.057879870630608,-0.0462379490910904,6.75399459618617e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,-0.0691093900897317,0.00397557444481637,-0.0769015160015718,-0.0613172641778917,5.87413739198734e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,-0.139432865382538,0.00803465197501283,-0.155180783253563,-0.123684947511513,9.69149851744578e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,-0.0571714096791337,0.00330021565523864,-0.0636398323634014,-0.0507029869948659,1.6260873230459e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,42129,-0.0560755274272099,0.00323756267052257,-0.0624211502614341,-0.0497299045929856,1.72146765511874e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,-0.0653325240515317,0.00379169240444185,-0.0727642411642377,-0.0579008069388257,8.02090539080042e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.0710334607436787,0.00413978505362578,-0.0791474394487853,-0.0629194820385722,3.75623100881373e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,-0.117228583690709,0.00687953775143941,-0.13071247768353,-0.103744689697888,1.9436069657655e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,42204,-0.122351624989655,0.00719650054219309,-0.136456766052354,-0.108246483926957,3.67357681617588e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,0.0702584356429374,0.0041356588479244,0.0621525443010056,0.0783643269848692,4.61469350215382e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,42296,-0.0751591988629278,0.00442716458485582,-0.0838364414492452,-0.0664819562766104,5.49466792170827e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,41697,-0.0713880109973463,0.00421081499808327,-0.0796412083935895,-0.0631348136011031,8.67422136362601e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PXN,Paxillin,41839,-0.0908949725800976,0.00536182419119542,-0.101404147994841,-0.0803857971653546,8.7101878613825e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,-0.0759292443189644,0.00448251023131191,-0.0847149643723357,-0.067143524265593,1.04094871223726e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,-0.0687364638517573,0.00406507328549597,-0.0767040074913294,-0.0607689202121852,1.7012458804274e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,42119,-0.129019604612719,0.00763031726285417,-0.143975026447913,-0.114064182777524,1.73828578735728e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,42262,-0.0462581779410606,0.00273883444967519,-0.051626293462424,-0.0408900624196972,2.3498653245546e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANG,Angiogenin,42152,-0.0579240846780389,0.00342991538598008,-0.0646467188345598,-0.0512014505215179,2.45104250324051e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,42137,-0.0499199217104281,0.00296173225515485,-0.0557249169305316,-0.0441149264903246,4.23837650923606e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,42119,0.0596925867922392,0.00354335672646857,0.0527476076083608,0.0666375659761176,4.89959202432809e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,42145,-0.111109693674424,0.00660700796673282,-0.12405942928922,-0.0981599580596276,7.94580658433581e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,-0.0892510141528859,0.00533730412119175,-0.0997121302304217,-0.0787898980753501,3.79460789008405e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,-0.0503497297388523,0.00301127617296348,-0.0562518310378607,-0.0444476284398439,3.9496897520276e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,-0.0748195266608952,0.00448176480107884,-0.0836037856710097,-0.0660352676507807,5.9565121822718e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,-0.102698922263359,0.00615422940424928,-0.114761211895687,-0.09063663263103,6.7138579580599e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,42217,-0.0995320589387181,0.00598373832368905,-0.111260186053149,-0.0878039318242876,1.6042754468331e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,-0.106474779178003,0.00640267526676718,-0.119024022700867,-0.0939255356551392,1.73942427941621e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,42310,-0.107565967037507,0.0064905201933972,-0.120287386616565,-0.0948445474584484,4.30327191330382e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,-0.0474637689343512,0.00286512174372264,-0.0530794075520475,-0.0418481303166548,4.89210858582953e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,-0.0922133869141862,0.00556702997364683,-0.103124765662534,-0.0813020081658384,5.03541529833413e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,-0.132770745235955,0.00800957657445433,-0.148469515321885,-0.117071975150024,5.35298152383427e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,-0.130825078820159,0.0079047740571798,-0.146318435972231,-0.115331721668087,6.23241672520442e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,-0.075666701509886,0.00456885627492898,-0.0846216598087468,-0.0667117432110252,7.06294094847502e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,-0.0806085333253466,0.00486914016148551,-0.0901520480418582,-0.071065018608835,7.93150997178827e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,-0.0844311511975776,0.0051111733961879,-0.0944490510541059,-0.0744132513410493,1.08368262231475e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,-0.0454780110993913,0.00275445149756299,-0.0508767360346147,-0.0400792861641678,1.58678092128747e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,-0.0618110925837878,0.0037497039236909,-0.069160512274222,-0.0544616728933537,1.8158249240602e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,-0.111835540162271,0.00678475772195441,-0.125133665297302,-0.0985374150272403,1.85551329925158e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,42296,-0.0585576346080173,0.00355336605859606,-0.0655222320828656,-0.051593037133169,1.9647631180555e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,-0.132253687320246,0.00802897759590002,-0.14799048340821,-0.116516891232282,2.99884135862014e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.0681066432624449,0.0041525241860442,-0.0762455906670915,-0.0599676958577983,7.08269720865047e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,-0.181131015124412,0.0110475421291554,-0.202784197697556,-0.159477832551267,7.8121235152039e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,39736,-0.0658977872646266,0.00403357196582692,-0.0738035883176473,-0.0579919862116058,2.61551229163228e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEP,Leptin,42145,-0.118947644135859,0.00728976274096106,-0.133235579108143,-0.104659709163575,2.74129267370882e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,42137,-0.0950765156328035,0.00582791013954036,-0.106499219506303,-0.0836538117593044,2.88258900245021e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,-0.0514964904606686,0.00315658623788798,-0.057683399486929,-0.0453095814344081,2.88334875819594e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,42137,0.0460940680056516,0.00282943759514474,0.0405483703191679,0.0516397656921353,4.17648841008732e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_E,,42119,-0.0500570211668268,0.0030728664917228,-0.0560798394906035,-0.0440342028430501,4.24343230021405e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,39937,-0.0552220863217794,0.00339843336865285,-0.061883015724339,-0.0485611569192199,1.03897481188734e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,42119,-0.0946840881229075,0.00585331347178558,-0.106156582527607,-0.0832115937182078,2.61828429432698e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.1147619374512,0.00710185815457489,-0.128681579434167,-0.100842295468233,3.42514634986729e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,42194,-0.0524734468377254,0.00324889016098545,-0.0588412715532569,-0.0461056221221939,3.86904226149837e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,-0.0588551935464251,0.00364451835392274,-0.0659984495201137,-0.0517119375727366,4.02684186307806e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,42129,-0.0512971800706196,0.00318653425924823,-0.0575427872187461,-0.0450515729224931,9.04211831343224e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,42070,-0.12980360707167,0.00806661873449725,-0.145614179791285,-0.113993034352055,1.01024842174826e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,-0.0861008031877314,0.00535473931317743,-0.0965960922415592,-0.0756055141339037,1.20163902246505e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,-0.0665204241913182,0.00413745720634406,-0.0746298403157525,-0.0584110080668838,1.57538986385975e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,39930,-0.188876316158567,0.0117484217022714,-0.211903222695018,-0.165849409622115,1.60449166492545e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,39736,-0.0783199241245166,0.00487307755257425,-0.0878711561275622,-0.0687686921214711,1.77399248501275e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,42084,-0.0547594964600361,0.00342706870057291,-0.061476551113159,-0.0480424418069132,6.00571292064891e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,42070,-0.109990602940275,0.00689885797210743,-0.123512364565606,-0.0964688413149446,1.04621102189922e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0475313710641404,0.00298144212454492,-0.0533749976282484,-0.0416877445000323,1.06384312281016e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,-0.114110627006313,0.00715943135887989,-0.128143112469717,-0.100078141542908,1.15116342865051e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GH1,Somatotropin,42129,0.296646763365994,0.0186230269925884,0.260145630460521,0.333147896271467,1.30240253202338e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,39958,-0.046603063977915,0.00293671216061538,-0.0523590198127212,-0.0408471081431089,4.14778491209309e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,-0.0518036979342921,0.00328984604473596,-0.0582517961819746,-0.0453555996866096,2.23273667779112e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,-0.0567666525658891,0.00360429242721025,-0.0638310657232212,-0.049702239408557,2.64909763615934e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,41827,-0.0976125631089675,0.00620740501888559,-0.109779076945983,-0.0854460492719518,3.2131575114459e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.0569409357215091,0.00362146878967638,-0.0640390145492749,-0.0498428568937434,3.23493058151496e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,-0.12012392915199,0.00764775742415175,-0.135113533703328,-0.105134324600653,4.18581421818563e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,-0.156412985229865,0.0099625654159355,-0.175939613445098,-0.136886357014631,4.62456147846422e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,-0.0382266963503256,0.00243437444461136,-0.0429980702617639,-0.0334553224388874,5.60893673666772e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFM,Afamin,39979,-0.0333527278113928,0.00212561492073425,-0.0375189330560319,-0.0291865225667537,6.56178170794411e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,-0.104810974173559,0.00669918789318442,-0.1179413824442,-0.0916805659029175,1.3297710498999e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,39959,0.0633910584484154,0.00405382425121347,0.055445562916037,0.0713365539807938,1.49901068537413e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POSTN,Periostin,39966,0.0622069159094529,0.00397852595190801,0.0544090050437132,0.0700048267751926,1.5369567059656e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,-0.182849419095257,0.01171063192899,-0.205802257676077,-0.159896580514437,1.78809614850324e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,-0.0734327956518598,0.0047013060718467,-0.0826473555526793,-0.0642182357510402,2.03722819332903e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,-0.0722733162387343,0.00464287572650574,-0.0813733526626855,-0.063173279814783,3.641661278472e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,-0.0893789388010792,0.00574649434354132,-0.10064206771442,-0.0781158098877383,4.35812576719051e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,-0.04530319386965,0.00291434922652731,-0.0510153183536435,-0.0395910693856565,5.0445808796019e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,-0.106833973294729,0.00690926885755984,-0.120376140255546,-0.0932918063339114,1.7753693997539e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,-0.0494234330255931,0.00319665391637083,-0.0556888747016799,-0.0431579913495062,1.80803317024865e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0597267809732601,0.00386671013811501,-0.0673055328439655,-0.0521480291025547,2.27451712727752e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,-0.105182726236917,0.00681339695085694,-0.118536984260597,-0.0918284682132377,2.59039963074177e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EZR,Ezrin,42249,-0.0392641145918772,0.00254486159102605,-0.0442520433102883,-0.0342761858734661,2.95001263693977e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,41900,-0.0863836970609015,0.00560482996466574,-0.0973691637916464,-0.0753982303301567,3.88979882077441e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,42274,0.08679244330931,0.00563789024376763,0.0757421784315254,0.0978427081870945,4.9608867101751e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.0449833313392648,0.00292407873103593,-0.0507145256520952,-0.0392521370264344,5.87763670713239e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,0.0914272554313574,0.00595385917060427,0.0797576914569731,0.103096819405742,1.13017596546672e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,42249,-0.0734976393958071,0.00479748548369898,-0.0829007109438571,-0.0640945678477571,1.53663717531492e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,39638,-0.101449300605094,0.00662488793421424,-0.114434080956153,-0.0884645202540336,2.14849265355869e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,42145,0.0611281659773418,0.00400567701357214,0.0532770390307404,0.0689792929239432,3.8100024776092e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,-0.201693224466229,0.0132321635951094,-0.227628265112643,-0.175758183819815,5.0035102202865e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.111327452716736,0.00730184760968464,-0.125639074031718,-0.0970158314017543,5.85774127854825e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0597950716849512,0.00392654735444858,-0.0674911044996704,-0.052099038870232,6.17649753129682e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.0570547912157488,0.0037479578641768,-0.0644007886295353,-0.0497087938019623,6.84807569871481e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,-0.0586626844800159,0.00385451553377174,-0.0662175349262085,-0.0511078340338233,7.02012241670794e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MLN,Promotilin,42119,-0.141907459055163,0.0093659296444423,-0.16026468115827,-0.123550236952056,1.95898907914616e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAST,Gastrin,39929,-0.209015554849806,0.0137873238901785,-0.236038709674556,-0.181992400025056,2.07645539961269e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,0.0310432554188365,0.00205125683837526,0.027022792015621,0.035063718822052,2.56082380210481e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,0.0507892260851165,0.00335861763621133,0.0442063355181423,0.0573721166520907,3.01905198522015e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,-0.0502093133043501,0.00332087194213023,-0.0567182223109253,-0.0437004042977748,3.17518488562493e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,42119,-0.0716633230171273,0.00474485612989181,-0.0809632410317152,-0.0623634050025394,4.01806410893824e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,39736,-0.0449887688837146,0.00298200377567169,-0.0508334962840311,-0.0391440414833981,6.29829636392107e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,42137,-0.0609271979168814,0.00404670302151089,-0.0688587358390427,-0.05299565999472,8.12547088183531e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.0914462215236109,0.0060933646065246,-0.103389216152399,-0.0795032268948227,1.68368160461751e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,42171,0.0613172167345424,0.00408996063735601,0.0533008938853246,0.0693335395837602,2.09229004821589e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,39929,-0.0610142998359383,0.00408587187918289,-0.0690226087191367,-0.0530059909527398,5.99642233548509e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,-0.105592714791266,0.00707760819305525,-0.119464826849654,-0.0917206027328774,6.18310243551778e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,41880,-0.0568451679417269,0.00381237604075276,-0.0643174249816023,-0.0493729109018515,7.10727528810393e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,41830,-0.0772027868983132,0.00518539130884862,-0.0873661538636565,-0.0670394199329699,9.88479066784218e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,39959,-0.0456731929403812,0.00306938572128654,-0.0516891889541028,-0.0396571969266596,1.29755010560372e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,42158,0.0299291003716808,0.00201490770336971,0.0259798812730762,0.0338783194702855,1.60968952833494e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,42231,-0.058219427503117,0.0039307525716639,-0.0659237025435782,-0.0505151524626557,2.99039112987748e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,-0.13056680855569,0.00881443286437761,-0.14784309696987,-0.11329052014151,3.47826947842035e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,-0.0921726837033311,0.00627350861034241,-0.104468760579602,-0.07987660682706,1.71125354625949e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,42137,-0.0357297601320147,0.0024382476834132,-0.0405087255915046,-0.0309507946725248,2.97901460756881e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,0.0514301806848959,0.00351019218866094,0.0445502039951205,0.0583101573746713,3.0429173993165e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,-0.134040535829255,0.00916047689174137,-0.151995070537068,-0.116086001121442,4.89651100262476e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,-0.0605451586616165,0.00414883863288408,-0.0686768823820693,-0.0524134349411637,7.15423585057163e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,-0.0794906533416409,0.00544416834350927,-0.0901612232949191,-0.0688200833883628,7.6995681172221e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,42185,-0.058528497177483,0.00401734964725379,-0.0664025024861004,-0.0506544918688656,1.01361794860303e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,39358,-0.0371523759645011,0.00254962823062008,-0.0421496472965165,-0.0321551046324857,1.20789671320345e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,-0.0565739816758179,0.00388787486797199,-0.064194216417043,-0.0489537469345928,1.30815665128118e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,39657,-0.128684677049413,0.00885977955101184,-0.146049844969396,-0.11131950912943,2.30802267093907e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,-0.0535798135210622,0.00369508389023371,-0.0608221779459203,-0.0463374490962042,2.75745637548567e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,42016,-0.0597067355094801,0.00412400947915765,-0.0677897940886291,-0.0516236769303311,3.79056327095623e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.0442043595295679,0.00305469756340641,-0.0501915667538445,-0.0382171523052913,4.15360936055299e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,-0.0734007259741146,0.00508670132082902,-0.0833706605629394,-0.0634307913852897,8.71071598355609e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,39958,-0.138728789405096,0.00961496438558799,-0.157574119600848,-0.119883459209344,8.87756527895155e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,-0.172683647254738,0.0119800667445289,-0.196164578074014,-0.149202716435461,9.37605011324886e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,-0.0870346608388341,0.00604147227410412,-0.0988759464960781,-0.07519337518159,1.21786118867228e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,42145,-0.056604365812077,0.00393565070811579,-0.0643182411999839,-0.0488904904241701,1.46818829433228e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,39958,-0.101918461874209,0.00709250828116536,-0.115819778105293,-0.0880171456431248,2.03977593481746e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,42123,-0.041134155688282,0.00287262877061311,-0.0467645080786837,-0.0355038032978803,3.60344836364484e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,-0.0755344340803608,0.00527699782978743,-0.0858773498267442,-0.0651915183339775,3.85164874539808e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,-0.0440287460000258,0.00307923434561608,-0.0500640453174333,-0.0379934466826183,4.91387263482948e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,-0.0673672298513374,0.00470921015028863,-0.0765972817459031,-0.0581371779567717,5.09395978413664e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,39958,-0.0487988821224815,0.00342224174839647,-0.0555064759493386,-0.0420912882956244,9.72494855704534e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.0626956807890532,0.00439680555097639,-0.0713134196689669,-0.0540779419091394,9.74202376731041e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,-0.0471517757725263,0.00331404205299032,-0.0536472981963873,-0.0406562533486652,1.55308817689296e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,-0.0774445539750701,0.00546006122258097,-0.0881462739713288,-0.0667428339788114,2.42177748548698e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,42181,-0.080709733636877,0.00569248239899566,-0.0918669991389085,-0.0695524681348455,2.62673676407864e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,42249,-0.0555749683205107,0.00392101492835363,-0.0632601575800838,-0.0478897790609376,2.79498463432466e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,42296,-0.0555703390682711,0.00392410602796043,-0.0632615868830736,-0.0478790912534687,3.31523648271024e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,42211,-0.0905932545518038,0.00640256929525191,-0.103142290370498,-0.07804421873311,3.92711042243603e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,-0.0873076052566771,0.00617929993234608,-0.0994190331240754,-0.0751961773892788,5.256708447524e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,42262,-0.0699054513203501,0.00494845923999633,-0.0796044314307429,-0.0602064712099573,5.38990434817214e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,-0.0630970744417031,0.00447186170348417,-0.0718619233805321,-0.0543322255028741,6.81568241338578e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,41843,-0.0707734570158351,0.00502826089779608,-0.0806288483755154,-0.0609180656561548,1.13296082124406e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,39966,-0.0384365964075971,0.00273412142590198,-0.043795474402365,-0.0330777184128293,1.61980106071966e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,-0.090161918539241,0.00641461131668446,-0.102734556719943,-0.0775892803585395,1.7261460286643e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFI,Complement factor I,39979,-0.0287043728204667,0.00204562830685088,-0.0327138043018945,-0.024694941339039,2.32310909124111e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,-0.119172002335545,0.0084995394889583,-0.135831099733903,-0.102512904937186,2.7748619703919e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,39934,-0.0624056227335613,0.00445198495348464,-0.0711315132423912,-0.0536797322247314,2.85241937643932e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,39958,-0.0686552316169084,0.00489798954703032,-0.0782552911290878,-0.0590551721047289,2.86555046219304e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,39638,-0.0879406029886868,0.00627518670528969,-0.100239968931055,-0.075641237046319,3.06059584906365e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,0.0951181174613625,0.00679386680819282,0.0818021385173046,0.10843409640542,3.15067557925948e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,42262,-0.0548863722484618,0.00392104658358021,-0.062571623552279,-0.0472011209446446,3.24323593551048e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,-0.0995319023090495,0.00713624937006617,-0.113518951074379,-0.0855448535437198,6.53190400523737e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,-0.0374396792690685,0.00268554355604589,-0.0427033446389184,-0.0321760138992185,8.1674173967925e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,42181,-0.0623801566928025,0.00448420341096016,-0.0711691953782844,-0.0535911180073206,1.08146444589209e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,39954,0.0520167748908471,0.00374295352999285,0.0446805859720611,0.0593529638096331,1.49519892171966e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,42249,-0.0330896392440629,0.00238536897046372,-0.0377649624261717,-0.028414316061954,1.84827576096566e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,42143,-0.0524009434943963,0.00378634294268866,-0.0598221756620661,-0.0449797113267265,2.90147312065683e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,42119,-0.0861010699848687,0.00623036675861885,-0.0983125888317617,-0.0738895511379758,3.8147526077997e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0956714013734162,0.00692684279749028,-0.109248013256497,-0.0820947894903352,4.25021135362751e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,41839,-0.0966780725657184,0.0070065528966858,-0.110410916243223,-0.0829452288882142,5.18161443782071e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,42070,-0.0778015080574465,0.00564958382837074,-0.0888746923610532,-0.0667283237538398,7.41119894222861e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,-0.0479581904521076,0.00349677143905293,-0.0548118624726513,-0.0411045184315638,1.5880226922031e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0389408287979722,0.00283956603610195,0.0333752793672124,0.0445063782287321,1.61714671247821e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,-0.10299140562647,0.00751022778252335,-0.117711452080216,-0.0882713591727245,1.8406222914568e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0451275838036208,0.00329302150130751,-0.0515819059461835,-0.038673261661058,1.849458436356e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,-0.0418986642460422,0.0030582498466666,-0.0478928339455087,-0.0359044945465756,1.94312691475564e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.0397270040837008,0.00290133047374367,-0.0454136118122384,-0.0340403963551632,2.14617532667431e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.089804356325599,0.00655499791618755,-0.102652152241327,-0.0769565604098714,2.20574943788445e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0612405943906817,0.00447377898246762,-0.0700092011963182,-0.0524719875850451,2.26804512309713e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,41961,-0.0685293432414672,0.00501726552780845,-0.0783631836759718,-0.0586955028069626,3.43897945795191e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,42096,-0.0629136969214223,0.00461065387727715,-0.0719505785208855,-0.0538768153219591,4.09732778626953e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,42310,-0.0926209280758768,0.00678983486265374,-0.105929004406678,-0.0793128517450755,4.2923117188273e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,-0.0417180812756833,0.00305605755003569,-0.0477079540737533,-0.0357282084776133,4.34385602644847e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,-0.0428571353723304,0.00314040714454983,-0.049012333375648,-0.0367019373690127,4.51312954335574e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0653747227936177,0.00479691091786101,-0.0747766681926253,-0.0559727773946102,5.09380768983273e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,39638,-0.0740890811201699,0.00545815591263745,-0.0847870667089393,-0.0633910955314004,1.23182036248056e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,-0.0384622424961409,0.00283659558296116,-0.0440219698387448,-0.0329025151535371,1.30172599435762e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,42262,-0.0557054231706465,0.00410921862206408,-0.0637594916698921,-0.0476513546714009,1.35223103332193e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,-0.0562273128630571,0.00414794637413391,-0.0643572877563596,-0.0480973379697546,1.37070046342273e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,-0.1301216792542,0.00961026957393059,-0.148957807619103,-0.111285550889296,1.69073180868226e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,-0.042834354862229,0.00317541466420648,-0.0490581676040737,-0.0366105421203843,3.75123199754367e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD248,Endosialin,39966,0.0575337952686373,0.00426814122391848,0.0491682384697571,0.0658993520675176,4.25127985103507e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,0.0626399256998426,0.00466164484159384,0.0535031018103187,0.0717767495893665,6.68834687831657e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.0611879863732578,0.00455537318984875,-0.0701165178253613,-0.0522594549211542,7.16537177168366e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,-0.118075932579693,0.0087945251041034,-0.135313201783735,-0.10083866337565,7.78490416575465e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,42119,-0.0486471078148158,0.00362528889037927,-0.0557526740399592,-0.0415415415896725,8.55552999771727e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,-0.0385733812933863,0.0028874621811659,-0.0442328071684714,-0.0329139554183011,1.8911683447768e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0606522956482553,0.00454246885309352,-0.0695555346003186,-0.051749056696192,2.07139032067697e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0600701733658095,0.00450043680627503,-0.0688910295061086,-0.0512493172255105,2.21215023638996e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,-0.0793558721153438,0.005949785197907,-0.0910174511032415,-0.0676942931274461,2.50073654274655e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,41881,-0.0725727862257568,0.00544397630771302,-0.0832429797888743,-0.0619025926626393,2.77922711263461e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,41839,-0.0884221463273869,0.00663643730847717,-0.101429563452002,-0.0754147292027717,3.0587221149568e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.0531315639302862,0.00398891880971453,-0.0609498447973267,-0.0453132830632458,3.62447469269048e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0864865355513479,0.00650169652461426,-0.0992298607395918,-0.0737432103631039,4.01893240314328e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,-0.0347483084766585,0.00261287657384989,-0.0398695465614043,-0.0296270703919127,4.67198901802459e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,-0.0689695285792432,0.0051914582888107,-0.0791447868253122,-0.0587942703331742,5.02663718438852e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,-0.0477803416153023,0.00359917342424717,-0.0548347215268268,-0.0407259617037779,5.70709710729034e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,-0.0866155533447924,0.00653860569419659,-0.0994312205054177,-0.0737998861841671,9.29663044101929e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,-0.118493275663286,0.00895762134204391,-0.136050213493692,-0.10093633783288,1.20733033354436e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,-0.058638960453155,0.00443650831906381,-0.06733451675852,-0.0499434041477899,1.22037506933044e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,42016,-0.121918855548627,0.00923287556593036,-0.14001529165785,-0.103822419439403,1.45169435191402e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,42310,0.0221330860618277,0.00167641299475248,0.0188473165921129,0.0254188555315426,1.47657738418042e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,39966,-0.15820178991812,0.0119822218757101,-0.181686944794511,-0.134716635041728,1.64538212705176e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,-0.0829229022211413,0.00628726914608224,-0.0952459497474625,-0.0705998546948201,1.77902093494368e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,42145,-0.0946370609130901,0.00717554159339626,-0.108701122436147,-0.0805729993900334,1.78128485876354e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,42262,-0.0884975582421768,0.00671313558615741,-0.101655303991045,-0.0753398124933083,1.92007390735003e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,-0.134875479437562,0.0102344740136258,-0.154935048504269,-0.114815910370855,2.31078865051527e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,42103,0.0864713427510313,0.00657150435607458,0.0735911942131252,0.0993514912889375,2.65251468960088e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,-0.0384323483787695,0.00292354250348962,-0.0441624916856091,-0.0327022050719298,3.12967431392972e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,-0.0306221181363415,0.00233153212620131,-0.0351919211036961,-0.026052315168987,4.10934268047759e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,-0.0579023499544096,0.00441492088866882,-0.0665555948962005,-0.0492491050126187,4.71025364827831e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,-0.0537355882064806,0.00410446435747945,-0.0617803383471403,-0.0456908380658208,6.29409329805517e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSN,Gelsolin,39943,0.0262208106850702,0.00200163034383002,0.0222976152111633,0.030144006158977,6.33005072474573e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORT1,Sortilin,42129,-0.0524517209822997,0.00400892079431814,-0.0603092057391632,-0.0445942362254361,7.02081536280428e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,-0.151890513174487,0.0116151803693539,-0.174656266698421,-0.129124759650554,8.52455956081346e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,42272,-0.0391312341422928,0.00299862080792774,-0.0450085309258312,-0.0332539373587544,1.08553971766115e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,41991,-0.0710717852401068,0.00544614824453511,-0.0817462357993956,-0.060397334680818,1.09516182059311e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,-0.123151844627773,0.00944034748031382,-0.141654925689188,-0.104648763566358,1.16315713200119e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,39736,-0.162690458840956,0.0124647814043192,-0.187121430393422,-0.13825948728849,1.18854865095821e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,-0.0789286079396558,0.00605473405693586,-0.0907958866912501,-0.0670613291880615,1.30247049733468e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,-0.0690938623025851,0.00530964587048625,-0.0795007682087382,-0.058686956396432,1.7588487006179e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,42134,0.0534679398999545,0.00410983921718395,0.0454126550342739,0.061523224765635,1.83169086692855e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,-0.149383933217104,0.0114961908928215,-0.171916467367034,-0.126851399067174,2.47841134044957e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,-0.116747712581485,0.00899231403217497,-0.134372648084548,-0.0991227770784217,2.6076303214743e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,41992,-0.0627578144766791,0.00483910312731308,-0.0722424566062128,-0.0532731723471455,3.12007207077635e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,-0.0272491365859743,0.00210282721882167,-0.0313706779348648,-0.0231275952370839,3.55964788562133e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,42166,-0.0794816973958686,0.00614210257539109,-0.0915202184436351,-0.067443176348102,4.46813504948112e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,39736,-0.0725784729457327,0.00560890478498462,-0.0835719263243025,-0.0615850195671628,5.0369041338279e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,-0.0856536155267115,0.0066202165620331,-0.0986292399882963,-0.0726779910651266,5.17491527529614e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,-0.0715650767807682,0.00554078180933461,-0.0824250091270641,-0.0607051444344724,6.19135720505609e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.04887745892457,0.00378693778786523,-0.0562998569887858,-0.0414550608603541,6.88776441523335e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.0369322713586518,0.00286215743264054,-0.0425420999266272,-0.0313224427906763,7.16409578316534e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.0510198118460703,0.00395525993690726,-0.0587721213224085,-0.043267502369732,7.66045573411485e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTR,Transthyretin,39862,-0.0337935053001979,0.00261911465778178,-0.0389269700294502,-0.0286600405709456,8.05687150623242e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,-0.0381665224961071,0.00296029171752536,-0.0439686942624568,-0.0323643507297574,8.26584226885131e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,-0.0910851658182755,0.00714370858328603,-0.105086834641516,-0.0770834969950349,5.67085895062241e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,-0.101531460866519,0.00796902566900329,-0.117150751177766,-0.0859121705552729,5.68914332183856e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,41831,-0.0531851165054846,0.0041776676260523,-0.0613733450525471,-0.0449968879584221,6.56206445650972e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,-0.107112336849044,0.00841172217806162,-0.123599312318045,-0.0906253613800434,6.8777329523925e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,-0.130690322667776,0.0102735060717432,-0.150826394568393,-0.11055425076716,7.3552897460427e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,-0.0852898138904531,0.006705151244094,-0.0984319103288773,-0.0721477174520288,7.51657850829831e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,39919,-0.135266003299785,0.0106356678047594,-0.156111912197114,-0.114420094402457,8.36937402222702e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0511612388208781,0.00403253010756885,-0.059064997831713,-0.0432574798100431,1.12121541029127e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.0575878347787117,0.00454325228968527,-0.0664926092664948,-0.0486830602909286,1.30193434919204e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,42016,-0.0888328080404203,0.00701049419711585,-0.102573376666767,-0.0750922394140732,1.38000866976517e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,39966,-0.0375283755790811,0.00296562150707458,-0.0433409937329473,-0.0317157574252149,1.86087198391931e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,39906,-0.0435363936235517,0.00344366006578638,-0.050285967352493,-0.0367868198946104,2.16961249164405e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,-0.104423620464842,0.00828836536304958,-0.120668816576419,-0.0881784243532648,3.74754798123661e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,-0.0510798003846913,0.00405753641799777,-0.0590325717639669,-0.0431270290054156,3.87468824619089e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,-0.10768149549507,0.00856767653104864,-0.124474141495926,-0.0908888494942151,4.98872560628943e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,-0.0611142800420068,0.00486626283536237,-0.070652155199317,-0.0515764048846966,6.22989496638183e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.036164428369696,0.00288168788246766,-0.0418125366193326,-0.0305163201200594,6.31050727289417e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,42296,-0.0647464785320841,0.00516575552366458,-0.0748713593584666,-0.0546215977057015,7.67079562434119e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,42232,-0.0550523566652471,0.00439442984119239,-0.0636654391539841,-0.04643927417651,8.28690364838687e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,41843,-0.0847569954604832,0.00676774886749191,-0.0980217832407674,-0.0714922076801991,8.83700061106028e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,41843,-0.0990174789183273,0.00791229065054664,-0.114525568593399,-0.0835093892432559,9.91849288016666e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,-0.0497870840382801,0.00397863221695327,-0.0575852031835085,-0.0419889648930517,9.92012325678569e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,39979,-0.0400262300070938,0.00321153861408572,-0.0463208456907018,-0.0337316143234858,2.01631110713537e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,42230,-0.0903120896374771,0.00726201426487425,-0.104545637596631,-0.0760785416783236,2.58273315603529e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,-0.0757866769943553,0.00609628475032038,-0.0877353951049832,-0.0638379588837273,2.99045755478582e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,-0.0672856657227826,0.00541246230964636,-0.0778940918496895,-0.0566772395958758,3.03497746930625e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,-0.0339660353312179,0.00273595693396046,-0.0393285109217804,-0.0286035597406554,3.39132028934888e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,-0.0804568268634286,0.00648268024413463,-0.0931628801419325,-0.0677507735849247,3.56294309307026e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,39930,-0.125269826988535,0.0100949540122204,-0.145055936852487,-0.105483717124583,3.94154580855068e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,39657,-0.125049533749554,0.0100895996455124,-0.144825149054759,-0.10527391844435,4.81689275289207e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,42249,-0.074485410336839,0.00601402110208906,-0.0862728916969336,-0.0626979289767445,4.84226047692633e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,-0.0307953323378719,0.00248887948311103,-0.0356735361247695,-0.0259171285509743,6.12673502830504e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,-0.0260396152970848,0.00210692123035874,-0.030169180908588,-0.0219100496855817,6.72166555827715e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,39736,-0.0405596979937541,0.00327988544124345,-0.0469882734585913,-0.034131122528917,6.74599936783582e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,39929,-0.0506435193023109,0.0040989235375411,-0.0586774094358915,-0.0426096291687304,7.64079490351917e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,39802,-0.030543349854423,0.00247349206594403,-0.0353913943036733,-0.0256953054051727,8.3794406313538e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,39966,-0.053003822782438,0.00429457169166318,-0.0614211832980978,-0.0445864622667781,8.97631922541092e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,42310,-0.073922262215812,0.00599527617520273,-0.0856730035192093,-0.0621715209124146,9.53106004831084e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,-0.0949801659551671,0.00770823987224378,-0.110088316104765,-0.0798720158055693,1.06949223773365e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,-0.0917401040588886,0.00744894598107771,-0.106340038181801,-0.0771401699359763,1.14920767130201e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,-0.037780443203323,0.00307082946090317,-0.0437992689466932,-0.0317616174599528,1.33083483248722e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,-0.109462300503435,0.00891286589586959,-0.12693151765934,-0.0919930833475308,1.73849386592733e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.0494452986253357,0.00403377851679806,-0.0573515045182599,-0.0415390927324115,2.32352756104624e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,42166,-0.039622248888887,0.00323381224871035,-0.0459605208963592,-0.0332839768814147,2.47402151021966e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,42069,-0.0570398820218401,0.00465660868653364,-0.066166835047446,-0.0479129289962341,2.58195535816935e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,42152,-0.0520010140479062,0.00425178210859189,-0.0603345069807463,-0.043667521115066,3.23952383712998e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,-0.109306055137414,0.00893802968710141,-0.126824593324133,-0.0917875169506957,3.31457091740596e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,0.0400714888189269,0.00327700735315765,0.0336485544067379,0.0464944232311159,3.33274804373901e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.053996445258573,0.00441560184738576,-0.0626510248794491,-0.045341865637697,3.39082734795781e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0658922413927139,0.00539958760590478,-0.0764754331002873,-0.0553090496851405,4.50871015745254e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,42084,-0.102968378040951,0.00845249312317568,-0.119535264562375,-0.0864014915195263,5.84506456680689e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,42077,-0.0295070173647745,0.00242515805779633,-0.0342603271580553,-0.0247537075714937,7.00903779615045e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,-0.0414977328745698,0.00341035777546905,-0.0481820341144891,-0.0348134316346505,7.01712888026647e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,39638,-0.0502119509390492,0.00412927428835923,-0.0583053285442333,-0.0421185733338651,8.34803678366948e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,-0.128376246011903,0.0105717032471731,-0.149096784376362,-0.107655707647443,1.0071697813064e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,-0.0461979819202272,0.00380667818737516,-0.0536590711674826,-0.0387368926729719,1.11781788971134e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,-0.0660941074314728,0.00544690509596906,-0.0767700414195721,-0.0554181734433734,1.12467376755102e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,42146,-0.0697271790809073,0.00575081495559372,-0.080998776393871,-0.0584555817679436,1.16672840727074e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,-0.0604911593398273,0.00498962656788346,-0.0702708274128789,-0.0507114912667757,1.19695158432978e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDK,Midkine,42129,-0.0652153468077836,0.00538247157138472,-0.0757649910876976,-0.0546657025278696,1.29347255686932e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,42185,0.0522315090730108,0.00431802037098126,0.0437681891458876,0.0606948290001341,1.64501760730302e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,-0.0828932717347957,0.00685418237563015,-0.0963274691910308,-0.0694590742785606,1.70946177116788e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,42115,-0.117475067630254,0.00971708156982993,-0.13652054750712,-0.098429587753387,1.78535619328827e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,42137,-0.0315177595776107,0.0026122931039418,-0.0366378540613366,-0.0263976650938848,2.39208049060773e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,-0.0586609077393757,0.00486229263502463,-0.068191001304024,-0.0491308141747274,2.41273140068119e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,42070,-0.0395289933759855,0.00327668772950288,-0.0459513013258111,-0.0331066854261598,2.43930168582369e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BSG,Basigin,42284,-0.0264672098014984,0.00219777103947358,-0.0307748410388666,-0.0221595785641302,3.11793175153021e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,-0.106413342534727,0.00883390446993837,-0.123727795295807,-0.0890988897736483,3.24732137742992e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.0437629806342393,0.00364147101070653,-0.0509002638152241,-0.0366256974532546,4.22321727139707e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,42249,-0.0444597564944323,0.00370251745449106,-0.0517166907052348,-0.0372028222836299,4.7337936104171e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,-0.0623787718012689,0.005195281755923,-0.072561524042878,-0.0521960195596598,4.85673875537498e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,42119,-0.107481390878507,0.00895299016176447,-0.125029251595565,-0.0899335301614486,4.9186844612532e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,42168,-0.0406824977675983,0.00339450279999672,-0.0473357232555919,-0.0340292722796048,6.25782937308239e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,-0.0771934308856446,0.00644426307463262,-0.0898241865119245,-0.0645626752593646,6.80153835573809e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,-0.062920883900692,0.00525146233989989,-0.0732137500868958,-0.0526280177144882,7.16371791330988e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,-0.0790773657873085,0.0066059215187048,-0.0920249719639699,-0.0661297596106471,7.41279805427613e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,-0.0390600021696695,0.00326595824394638,-0.0454612803278044,-0.0326587240115346,9.092097252355e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,39929,-0.0831743879112755,0.0069566981788558,-0.0968095163418329,-0.0695392594807181,9.50352607804931e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,41797,-0.0883764706208124,0.00740119577048498,-0.102882814330963,-0.0738701269106619,1.06823940944486e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,-0.0350560084593138,0.00293975529888169,-0.0408179288451219,-0.0292940880735057,1.27463175812238e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0502507813895107,0.00421371707325828,-0.0585096668530969,-0.0419918959259245,1.36470341952039e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.0575382111395247,0.00482653080299826,-0.0669982115134013,-0.0480782107656481,1.43757414189296e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,-0.0536018932490529,0.00450549916561492,-0.0624326716136581,-0.0447711148844476,1.78169286081063e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,-0.0966610594161454,0.00815077762170458,-0.112636583554686,-0.0806855352776045,2.99037813378162e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0594892212347811,0.00502330302454448,-0.0693348951628883,-0.0496435473066739,3.3903464089748e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,-0.0800956219482824,0.00677147722272203,-0.0933677173048176,-0.0668235265917472,4.3001475801356e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,42296,-0.117518491381537,0.00997250751972383,-0.137064606120196,-0.0979723766428786,6.70952594503004e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,-0.0871028364634781,0.00738880061669899,-0.101584885672208,-0.0726207872547481,6.87041582540945e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,-0.077997337043148,0.0066199555181527,-0.0909724498587273,-0.0650222242275687,7.3926291936119e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,39757,-0.16095596157971,0.0136679953184641,-0.1877452324039,-0.13416669075552,7.99491920692642e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,41843,-0.0487438083605854,0.00414353550406724,-0.0568651379485572,-0.0406224787726136,8.6302933378586e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,42147,-0.057455724946613,0.00488794436816151,-0.0670360959082096,-0.0478753539850165,9.54016823486376e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,-0.0629741375104526,0.00535931274124419,-0.0734783904832912,-0.0524698845376139,9.99101080069735e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,-0.0500765873956075,0.00426791413319608,-0.0584416990966719,-0.0417114756945432,1.22076183667965e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.0597646480072083,0.00511163728850763,-0.0697834570926833,-0.0497458389217334,1.99811694370776e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,41997,-0.0852416408917481,0.00729232452709664,-0.0995345969648575,-0.0709486848186387,2.05560909165181e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,39979,-0.0861888407419982,0.00737338363422158,-0.100640672665072,-0.0717370088189239,2.18769619628944e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.0290881706633937,0.00249052165018578,-0.0339695930977578,-0.0242067482290296,2.28623055169148e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.071005491339506,0.0060801146062599,-0.0829225159677754,-0.0590884667112366,2.32542993718219e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,-0.119972309831016,0.0102882678966325,-0.140137314908416,-0.0998073047536161,2.83121279675967e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,-0.0847258289163689,0.00726169190803797,-0.0989587450561233,-0.0704929127766145,2.85021116670073e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,-0.104085049202739,0.00893062920269886,-0.121589082440029,-0.0865810159654492,3.06153938502016e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,-0.0406056568805028,0.0034854159778488,-0.0474370721970864,-0.0337742415639191,3.22114099479879e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,-0.0719202321638319,0.0061736297487348,-0.0840205464713521,-0.0598199178563117,3.27372766738292e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,42296,-0.106067710959544,0.00910748372083128,-0.123918379052373,-0.0882170428667145,3.36516872783581e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,41959,-0.0531168117571363,0.00456728861736373,-0.0620686974471692,-0.0441649260671034,4.10436551482946e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,-0.0918901761433084,0.00791502019312351,-0.10740361572183,-0.0763767365647863,5.58688076934612e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,-0.044853229423351,0.00387321610943693,-0.0524447329978474,-0.0372617258488546,7.25639968087912e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,-0.0428252287363854,0.00370484087292602,-0.0500867168473204,-0.0355637406254504,9.23955130070945e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.102801301880498,0.00889097367649343,-0.120227610286425,-0.0853749934745708,9.61929820382363e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,-0.0807576412088573,0.00698954710532139,-0.0944571535352872,-0.0670581288824274,9.885755469585e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.0385703148178322,0.00334601921906964,-0.0451285124872087,-0.0320121171484557,1.43891099500813e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAYN,Layilin,41997,-0.0432935709994233,0.00375846208365921,-0.0506601566833953,-0.0359269853154513,1.47469758920807e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,39903,-0.0889160210608559,0.00772234137313765,-0.104051810152206,-0.0737802319695061,1.65659515905423e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,42181,-0.0678215388563108,0.00589428894055732,-0.0793743451798031,-0.0562687325328184,1.69763729311587e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COCH,Cochlin,39958,-0.0559085443426516,0.00485728004381491,-0.0654288132285289,-0.0463882754567744,1.728484186655e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,-0.0906921528829375,0.0078910225898999,-0.106158557159141,-0.0752257486067337,1.97893011576603e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,-0.0519319407262429,0.00451879112213967,-0.0607887713256366,-0.0430751101268491,1.99843145218781e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,-0.0803634599418146,0.00699686552391496,-0.0940773163686879,-0.0666496035149413,2.16970599512153e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,-0.0570322275975074,0.00496610307716234,-0.0667657896287456,-0.0472986655662692,2.17930627088975e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,-0.0353183628892547,0.00307526476361917,-0.0413458818259483,-0.0292908439525612,2.32026224224591e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,42145,-0.0295752680380264,0.00257773057216778,-0.0346276199594752,-0.0245229161165775,2.47864107127589e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,-0.152120523324771,0.0132760515900305,-0.178141584441231,-0.126099462208311,3.16519720587073e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,42185,-0.0500992514013012,0.00437706918848995,-0.0586783070107416,-0.0415201957918609,3.39253511402079e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,-0.0486246081801981,0.00425017407422257,-0.0569549493656744,-0.0402942669947219,3.59089056203478e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,-0.0497066825273337,0.00434585924577196,-0.0582245666490468,-0.0411887984056207,3.98991219312672e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.0364657447657201,0.00319337366778048,-0.0427247571545699,-0.0302067323768704,4.59403575630987e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,39492,-0.0852396969834347,0.00746015039300074,-0.0998615917537161,-0.0706178022131533,4.59805008274173e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,-0.0345354977013201,0.00302633280002645,-0.040467109989372,-0.0286038854132683,5.0144188019457e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,-0.125791187064859,0.0110198166179651,-0.147390027636071,-0.104192346493647,5.13303416253162e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,-0.0628233297885082,0.00552128963506818,-0.0736450574732418,-0.0520016021037745,7.34369020174572e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,-0.0729225530138144,0.00641858352155852,-0.0855029767160691,-0.0603421293115597,8.96477095305645e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,-0.0363803480077937,0.0032080988403439,-0.0426682217348677,-0.0300924742807196,1.12670413619953e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,42137,-0.0695065617067807,0.00614059417653459,-0.0815421262927885,-0.0574709971207729,1.4317940426575e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,42025,-0.0859616651731883,0.00761002529429836,-0.100877314750013,-0.0710460155963636,1.86821095018044e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,0.0717369862685092,0.00635584447907646,0.0592795310895193,0.084194441447499,2.05737632405558e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBIN,Erbin,42070,-0.121620085443847,0.0107865885147296,-0.142761798932717,-0.100478371954977,2.35714338022582e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,-0.045408348666646,0.00402800008357313,-0.0533032288304493,-0.0375134685028426,2.42200756621338e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,-0.0662336072697516,0.00588464600795353,-0.0777675134453405,-0.0546997010941626,2.94844900953668e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,-0.0392829368286839,0.00349663988212854,-0.0461363509976558,-0.0324295226597119,3.70510009288225e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,-0.0335389417573885,0.00298660458362963,-0.0393926867413025,-0.0276851967734744,3.90739346419872e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0301690977768629,0.00268716526774976,0.0249022538520733,0.0354359417016524,4.022415933569e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,41984,-0.0413958327168384,0.0036951013142107,-0.0486382312926913,-0.0341534341409854,5.31112449954992e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,-0.0400737989390464,0.00358124546866643,-0.0470930400576326,-0.0330545578204602,6.1150839639143e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,39929,-0.0339489796652434,0.00303495530139666,-0.0398974920559808,-0.0280004672745059,6.76617966032842e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,-0.0783423801824539,0.00700616263281269,-0.0920744589427668,-0.064610301422141,7.12266565699283e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,-0.130420645963661,0.0116694684969432,-0.15329280421767,-0.107548487709652,7.54919961607871e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,-0.0897733820432847,0.00804176007910292,-0.105535231798326,-0.0740115322882429,8.22947884914577e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,-0.0366070793730773,0.0032920754354013,-0.0430595472264638,-0.0301546115196907,1.33747595491183e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,42081,-0.0492986563812328,0.00443868086759948,-0.0579984708817278,-0.0405988418807378,1.54934241670442e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,-0.0911534267639127,0.00820895789492104,-0.107242984237958,-0.0750638692898675,1.58665874661434e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,-0.0672085303979158,0.00605316236979987,-0.0790727286427235,-0.0553443321531081,1.70939758588191e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,42051,-0.0806310922384917,0.00727186506344094,-0.094883947762836,-0.0663782367141474,1.90341425365242e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,-0.0391299490457929,0.00352997190822756,-0.0460486939859189,-0.0322112041056669,1.95982094734983e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,-0.105373012188288,0.00950204166752522,-0.123997013856638,-0.0867490105199387,1.97523354695742e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,-0.0643136286555399,0.00580255695927446,-0.0756866402957178,-0.0529406170153619,2.00791327201509e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,-0.124068691152968,0.0111951613863309,-0.146011207470177,-0.10212617483576,2.02545414618477e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,-0.0771318267930563,0.00699682058254454,-0.0908455951348436,-0.063418058451269,3.85699183095276e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,-0.0378559924955951,0.00343412082988183,-0.0445868693221635,-0.0311251156690267,4.12362514172509e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,42185,-0.0550055350817544,0.004997257831154,-0.0648001604308162,-0.0452109097326926,4.63812893726059e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,-0.05776372534615,0.00524851381637568,-0.0680508124262463,-0.0474766382660536,4.71534280054233e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,-0.109928961866885,0.0100113551634148,-0.129551217987178,-0.0903067057465918,6.25611449797556e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,39919,-0.0425893649380929,0.0038825333688363,-0.0501991303410121,-0.0349795995351738,7.39956146754747e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.0400907931920248,0.0036571689818073,-0.0472588443963672,-0.0329227419876825,7.59833948827021e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,42249,-0.0314690207895864,0.00287345071845991,-0.0371009841977678,-0.025837057381405,8.51597192157793e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,-0.162874357204125,0.0148694871310894,-0.19201855198106,-0.13373016242719,8.80028476523041e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,-0.054036685973986,0.00493888316373199,-0.0637168969749007,-0.0443564749730713,1.01749808139344e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,39966,0.0663283875963813,0.00607092527876042,0.0544293740500109,0.0782274011427518,1.19358512394821e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,-0.027528056941693,0.00252445254031153,-0.0324759839207036,-0.0225801299626824,1.42729094263853e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,-0.0649187412443677,0.00595899624894453,-0.0765983738922989,-0.0532391085964364,1.60649155470936e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,-0.0314704400897577,0.00289879751841729,-0.0371520832258556,-0.0257887969536598,2.4033431359536e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,-0.0235742452692592,0.00217371169273685,-0.0278347201870234,-0.0193137703514949,2.74406429903375e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,42119,-0.105257537064746,0.00972114560192759,-0.124310982444524,-0.0862040916849681,3.29084095320634e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0609626814857459,0.00563227659797211,-0.0720019436177713,-0.0499234193537206,3.44785194215557e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,39586,-0.0465649215512844,0.00430388147572419,-0.0550005292437038,-0.038129313858865,3.82185229889114e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,-0.0615559212602229,0.0056912499831289,-0.0727107712271555,-0.0504010712932902,3.92676210254958e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,-0.0987456411126891,0.00913678388486162,-0.116653737527018,-0.0808375446983604,4.09455709162862e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,-0.130881022871843,0.0121147399486501,-0.154625913171197,-0.107136132572489,4.51209794036831e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,-0.0593131733771784,0.005496700838536,-0.0700867070207089,-0.0485396397336478,4.90446827445343e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,-0.088029723185388,0.00816782899560622,-0.104038668016776,-0.0720207783539998,5.6568324985698e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,41913,-0.0535147441194846,0.00497011495483395,-0.0632561694309592,-0.0437733188080101,6.34000083717371e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,42016,0.0390626024174143,0.00362893318375031,0.0319498933772637,0.0461753114575649,6.54195324679118e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,42148,-0.0705067266218339,0.00655141446578549,-0.0833474989747735,-0.0576659542688943,6.67865137681637e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,42296,-0.0547984929663748,0.0051032832025124,-0.0648009280432991,-0.0447960578894505,8.63730270989453e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,-0.15495320511948,0.0144370917644759,-0.183249904977853,-0.126656505261108,9.14086029030139e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,-0.0692909002308307,0.00645908893002571,-0.0819507145336811,-0.0566310859279803,9.67068362019118e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NADK,NAD kinase,42145,-0.0618041531235719,0.0057613610586906,-0.0730964207986055,-0.0505118854485383,9.69785548141989e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,42249,-0.0664523807947507,0.00619882147768827,-0.0786020708910197,-0.0543026906984817,1.04555827786501e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,-0.0532521817577102,0.00497452192086985,-0.0630022447226151,-0.0435021187928053,1.2302051655128e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.0350759451670636,0.00327817451008739,-0.0415011672068349,-0.0286507231272923,1.29986890709456e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,42070,-0.0337109322987515,0.0031567196813102,-0.0398981028741195,-0.0275237617233835,1.62769566228356e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,-0.0772543544671306,0.00723526094019308,-0.091435465909909,-0.0630732430243521,1.65087737791885e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,-0.0464342425935685,0.00434734278911473,-0.0549550344602333,-0.0379134507269036,1.67715750109669e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,-0.0603365324158761,0.00565169096816431,-0.0714138467134781,-0.0492592181182741,1.68545225591808e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,39900,-0.0514510387356457,0.00482041335567678,-0.0608990489127722,-0.0420030285585192,1.80884843392665e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,39978,-0.0630418306748912,0.00591024504278551,-0.0746259109587508,-0.0514577503910316,1.9459056215012e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,-0.0871396476706949,0.00817272224633678,-0.103158183273515,-0.0711211120678748,2.03910374704619e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,-0.0823392648836811,0.0077221982448831,-0.097474773443652,-0.0672037563237102,2.04550919156522e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,-0.139181293194997,0.013055317899804,-0.164769716278613,-0.113592870111381,2.08408895727831e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.0376087397387664,0.00352950197664051,-0.0445265636129818,-0.030690915864551,2.08590909470883e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0415799914451386,0.00390379192208069,0.0339285592778605,0.0492314236124167,2.29422442336945e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RETN,Resistin,42105,-0.0480286395367121,0.0045129806293597,-0.0568740815702571,-0.0391831975031671,2.40757712265382e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,-0.0377617051940323,0.00354823914998263,-0.0447162539279983,-0.0308071564600664,2.41020290990239e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,39948,-0.049748500984366,0.00467375543733036,-0.0589090616415335,-0.0405879403271985,2.46917948908993e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,-0.0508174241211376,0.00477634272706207,-0.0601790558661793,-0.041455792376096,2.48542881919527e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,39911,-0.0728302445182698,0.00684499801870764,-0.0862464406349368,-0.0594140484016029,2.58710653430219e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,41992,-0.0563812650500182,0.00530248175985762,-0.0667741292993392,-0.0459884008006973,2.66440707966275e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,-0.0417084569737024,0.0039230261928498,-0.049397588311688,-0.0340193256357168,2.7085344070319e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,42016,-0.059351236871889,0.00559237862063499,-0.0703122989683336,-0.0483901747754445,3.29799159262936e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,-0.0970226607461969,0.00915429783155726,-0.114965084496049,-0.0790802369963447,3.82915275650044e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,-0.0353204239433257,0.00333247058999501,-0.0418520662997159,-0.0287887815869355,3.83829913340239e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,42199,-0.0358992598136519,0.0033876338078202,-0.0425390220769794,-0.0292594975503243,3.88454535575538e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,-0.0927119854282767,0.00874925240875933,-0.109860520149445,-0.0755634507071084,3.91004810641226e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,42105,-0.0556569407349948,0.00525457130228418,-0.0659559004874718,-0.0453579809825178,4.104783099778e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,41900,-0.0629177340811018,0.00594339718621389,-0.074566792566081,-0.0512686755961225,4.38730388725966e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,-0.059672436068016,0.00563429142506088,-0.0707156472611353,-0.0486292248748967,4.39322015600325e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,-0.0880574677508721,0.00832416204806311,-0.104372825365076,-0.0717421101366684,4.76098637944575e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,-0.0434692468961441,0.00411044715525964,-0.051525723320453,-0.0354127704718352,4.92711587965777e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOST,Sclerostin,42129,-0.0431404315260185,0.00408123200233159,-0.0511396462505884,-0.0351412168014486,5.16031756715573e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,-0.0549118476455292,0.00519327696378035,-0.0650906704945387,-0.0447330247965197,5.21823103860144e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,39575,-0.0866308756947931,0.00819319268013241,-0.102689533347853,-0.0705722180417335,5.27253719246118e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,-0.121895961937625,0.0115363145455272,-0.144507138446858,-0.0992847854283916,5.64052639569086e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,-0.0382723231437148,0.00362736033847159,-0.0453819494071191,-0.0311626968803105,6.34286363959366e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,-0.101298185027787,0.00962290249222759,-0.120159073912554,-0.0824372961430214,8.18270774072556e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,39929,-0.0701998941788561,0.00667148205845368,-0.0832759990134253,-0.0571237893442869,8.95683032706742e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,-0.09619008215822,0.00914246866564111,-0.114109320742877,-0.0782708435735634,9.06521256846144e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,42310,-0.063907692833336,0.00608722841321078,-0.0758386605232291,-0.0519767251434429,1.09658975559083e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,-0.03089852710155,0.00294474282578982,-0.036670223040098,-0.0251268311630019,1.17560341263904e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,42083,-0.0388395548866052,0.00370252705971504,-0.0460965079236467,-0.0315826018495638,1.20526093574279e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFH,Complement factor H,39418,-0.0260587185091589,0.0024870546189502,-0.0309333455623013,-0.0211840914560165,1.44890430738176e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,42119,-0.043547173932837,0.00415890531459118,-0.0516986283494357,-0.0353957195162383,1.47305596070381e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,-0.040506820632097,0.00387141906795634,-0.0480948020052914,-0.0329188392589026,1.59950599252019e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,-0.0490478020554142,0.0046950688341631,-0.0582501369703738,-0.0398454671404545,1.9800543343099e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,-0.0753887966129974,0.00721973368042711,-0.0895394746266346,-0.0612381185993603,2.07779794034046e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,39736,-0.0338238785957407,0.0032404231271635,-0.0401751079249811,-0.0274726492665002,2.17492578361844e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,-0.0911331579856605,0.00875129116154938,-0.108285688662297,-0.0739806273090237,2.67773941608946e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,-0.0915883175026706,0.00879124530268116,-0.108819158295926,-0.0743574767094155,2.67827532296612e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,-0.104077608900723,0.00999574403207398,-0.123669267203588,-0.0844859505978584,2.71593945636145e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,42166,-0.0358086300188892,0.00344614219923229,-0.0425630687293844,-0.0290541913083939,3.38975889326471e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,42119,-0.105485879960159,0.010164840185491,-0.125408966723721,-0.0855627931965961,3.89968072763605e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,-0.0266809111619634,0.00257214349215222,-0.0317223124065818,-0.0216395099173451,4.08747683830113e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGN,Mimecan,42137,-0.0471370856450587,0.00455040133585555,-0.0560558722633355,-0.0382182990267818,4.73079345757817e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,-0.0259875477097504,0.002509025353407,-0.0309052374024281,-0.0210698580170727,4.79477930960854e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,39806,-0.0295379734514042,0.00285124137784817,-0.0351264065519866,-0.0239495403508217,4.90526893489527e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,42110,-0.0321606765240342,0.00310799535265278,-0.0382523474152337,-0.0260690056328348,5.31335735276672e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,42144,-0.0355479778964871,0.00343553878357911,-0.0422816339123022,-0.0288143218806721,5.34307463334458e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,0.0240283503269698,0.00232647810417533,0.0194684532427861,0.0285882474111534,6.52459517191632e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.033395935048243,0.00323263922476793,-0.0397319079287882,-0.0270599621676979,6.59091288488773e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,42119,0.0482903935105394,0.00468159267051936,0.0391144718763215,0.0574663151447574,7.45671897392696e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,39657,-0.049701464144481,0.00481804040422467,-0.0591448233367613,-0.0402581049522006,7.75478768719544e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,-0.0378834803490941,0.00367244129771777,-0.0450814652926209,-0.0306854954055673,7.76188851822335e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,-0.112989627181903,0.0109585442380073,-0.134468373888397,-0.0915108804754082,7.79592193001453e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,0.0565357783982335,0.00548436222548022,0.0457864284362922,0.0672851283601747,7.96455499733545e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,-0.0368311114913636,0.00357873538320289,-0.0438454328424412,-0.0298167901402859,9.87349321746071e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,-0.0787254152656452,0.00765862903084901,-0.0937363281661093,-0.0637145023651812,1.12127705820464e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0281329467458347,0.00273848495943254,0.022765516225347,0.0335003772663225,1.14750561329787e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,-0.043589681864962,0.00424151519028145,-0.0519030516379137,-0.0352763120920104,1.15392670865555e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,-0.0638223403481863,0.00621602223182134,-0.0760057439225561,-0.0516389367738165,1.22293618203852e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,-0.0616814440635303,0.00601812670450498,-0.07347697240436,-0.0498859157227005,1.47264939434286e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,-0.0903986607693431,0.00884007854431012,-0.107725214716191,-0.0730721068224953,1.8717372898055e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,-0.0714783342489726,0.00699103694942104,-0.0851807666698379,-0.0577759018281074,1.88929817623335e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,-0.056731512533575,0.0055521889372269,-0.0676138028505397,-0.0458492222166103,2.02650629558604e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,0.0790031268508718,0.00772996437106577,0.0638523966835829,0.0941538570181607,2.05037987320982e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,-0.0417184927581666,0.00408895101261793,-0.0497328367428977,-0.0337041487734354,2.37186539458279e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,39934,-0.115568678843639,0.0113299387070895,-0.137775358709535,-0.0933619989777438,2.51771515436211e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,-0.0542326291547173,0.00532354114729822,-0.0646667698034218,-0.0437984885060128,2.87392814969166e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,42185,-0.0832237139131527,0.00818491534914865,-0.0992661479974841,-0.0671812798288214,3.36545466698719e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.0288794220188908,0.00284179310004135,-0.0344493364949718,-0.0233095075428097,3.56171782731819e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,42144,-0.0255882956548596,0.00252339499576228,-0.0305341498465537,-0.0206424414631656,4.45521318351021e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,-0.106778163415259,0.0105365068412618,-0.127429716824132,-0.0861266100063857,4.75182622078799e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,42070,-0.0758484114623666,0.00748624432671029,-0.0905214503427188,-0.0611753725820145,4.87302194179665e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,41839,-0.0361760099200468,0.00357211260865415,-0.0431773506330089,-0.0291746692070846,5.11108117213958e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,41994,0.0290987696766551,0.00288408202841994,0.0234459689009521,0.0347515704523582,7.48567528814215e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,-0.0399549593004919,0.00396122370098611,-0.0477189577544247,-0.0321909608465591,7.72052964674889e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,-0.133182808793199,0.0132076144805269,-0.159069733175032,-0.107295884411366,7.90384056439036e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,-0.0845458540366764,0.0083808061891789,-0.100972234167467,-0.0681194739058857,7.91720304082636e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,-0.0520112143762064,0.00515702373787845,-0.0621189809024482,-0.0419034478499647,8.11758540946566e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,-0.031474681800049,0.0031229575336017,-0.0375956785659083,-0.0253536850341896,8.3244046188471e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,39930,-0.0935440939788609,0.00928105594197687,-0.111734963625136,-0.0753532243325862,8.61498657761777e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.0304488152965189,0.00302506825979757,-0.0363779490857222,-0.0245196815073157,9.5071559399704e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,42145,0.0539296349168037,0.00535992547088808,0.043424180993863,0.0644350888397443,9.88994085837145e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,-0.0320747386946646,0.00318689607340322,-0.0383210549985349,-0.0258284223907943,9.98647002276718e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,-0.0661829063166364,0.00657845910672069,-0.079076686165809,-0.0532891264674639,1.03793692779877e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,-0.0769215147345453,0.00764963549080883,-0.0919148002965306,-0.06192822917256,1.05322142782797e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,42249,-0.0643753236244014,0.00640364806008828,-0.0769264738221744,-0.0518241734266283,1.07834314950443e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,42181,-0.0324821194926945,0.00323367298379112,-0.0388201185409251,-0.0261441204444639,1.16937640806491e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,-0.10021419748118,0.0099789967806632,-0.11977303117128,-0.08065536379108,1.20135225191966e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,-0.0550483122664095,0.00548958579112822,-0.0658079004170209,-0.0442887241157982,1.38815328355641e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,42107,-0.0302744723817093,0.00301923399918014,-0.0361921710201024,-0.0243567737433163,1.39952476405557e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.0252304871250785,0.00251856561895336,-0.030166875738227,-0.0202940985119299,1.54013119404072e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,-0.0508021861869765,0.00506954756352053,-0.0607384994114768,-0.0408658729624763,1.54364126225512e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,42119,-0.0592844906072358,0.00591896943403553,-0.0708856706979454,-0.0476833105165261,1.56571210259858e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.0283509863832178,0.00283318635202485,-0.0339040316331865,-0.0227979411332491,1.71940571404215e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,39958,-0.0794111013074146,0.00793786732491455,-0.0949693212642472,-0.0638528813505821,1.82870190095651e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGRN,Neugrin,39929,-0.0237664557143755,0.00237580357210627,-0.0284230307157038,-0.0191098807130472,1.83968484673446e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,39929,-0.0646240272189706,0.00647054559151375,-0.0773062965783375,-0.0519417578596036,2.16185480509756e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,-0.03963888302808,0.00397253985326049,-0.0474250611404706,-0.0318527049156894,2.29319350595316e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,39709,-0.0545052230483907,0.00546076565963065,-0.0652083237412668,-0.0438021223555146,2.30952418829508e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,-0.108407498194195,0.0108641576328212,-0.129701247154524,-0.0871137492338654,2.36434404502178e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,-0.022927542850338,0.0022996625977552,-0.0274348815419382,-0.0184202041587378,2.5706541599182e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,39736,-0.0736078794409655,0.00739416600322139,-0.0881004448072794,-0.0591153140746515,3.00335302638116e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0410777196208712,0.00412984669465867,-0.0491722191424023,-0.0329832200993402,3.15374634801126e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,-0.0770385507577732,0.00775303959236861,-0.0922345083588157,-0.0618425931567307,3.58961819974114e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,39638,-0.0779641636742518,0.00784688776504634,-0.0933440636937426,-0.062584263654761,3.64233570622062e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,-0.0650778054601381,0.00655620535909915,-0.0779279679639725,-0.0522276429563038,4.00469805340827e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,-0.065477301164677,0.00661561218227402,-0.0784439010419341,-0.0525107012874199,5.10766437447994e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,-0.0580297504629349,0.00587290979920813,-0.0695406536693828,-0.046518847256487,6.01416989554157e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,-0.0554255610087663,0.00561753957730541,-0.0664359385802849,-0.0444151834372477,6.97356017152945e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,42181,-0.0418615944272045,0.00424731490710026,-0.050186331645121,-0.033536857209288,7.70189203533057e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,42119,-0.0899450111233041,0.00912931435793224,-0.107838467264851,-0.0720515549817569,7.99394529222443e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELP,P-selectin,42217,-0.057822212871435,0.00587840483244752,-0.0693438863430321,-0.0463005393998378,9.34566539392688e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,-0.0580917960693072,0.00590708895664762,-0.0696696904243366,-0.0465139017142779,9.56869439531775e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRN,Progranulin,42077,-0.0259248970174815,0.00264275657973737,-0.0311046999137667,-0.0207450941211962,1.21658839408529e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,-0.037841402852388,0.00385670234678978,-0.0454005394520959,-0.03028226625268,1.23196375043417e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,-0.0868777048681868,0.0088565785691711,-0.104236598863762,-0.0695188108726114,1.26215810483331e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.050261363925117,0.00513274895318084,-0.0603215518733515,-0.0402011759768826,1.44426136816714e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,42296,-0.049120612341825,0.00501815778126298,-0.0589562015931005,-0.0392850230905496,1.49460533676377e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,-0.0202203255902921,0.00206638502025913,-0.02427044023,-0.0161702109505842,1.54295967791993e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,-0.0261334805084691,0.00267089727474558,-0.0313684391669705,-0.0208985218499678,1.55484899214305e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,-0.0981428446421896,0.0100501297358491,-0.117841098924454,-0.0784445903599253,1.8784188288665e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,-0.0532909418025808,0.00545773208698852,-0.0639880966930783,-0.0425937869120833,1.90586412688514e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,41839,-0.0530927990444291,0.00544126938016646,-0.0637576870295553,-0.0424279110593028,2.0401438322024e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,-0.0725542840936725,0.00743366383242246,-0.0871242652052205,-0.0579843029821245,2.05421904507457e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,42070,-0.0329783545769028,0.00338366474118572,-0.0396103374696268,-0.0263463716841788,2.26713208362632e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,41693,-0.0925897399877309,0.00950016934318938,-0.111210071900382,-0.0739694080750797,2.28328895594688e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREH,Trehalase,39966,-0.0776340405670131,0.00796744195503265,-0.0932502267988771,-0.0620178543351491,2.39549565038596e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,-0.0935609875227693,0.00963858677437426,-0.112452617600543,-0.0746693574449958,3.45415591590871e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,-0.0579441163032641,0.0059724869709131,-0.0696501907662538,-0.0462380418402744,3.50973806437175e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,-0.100328396391231,0.0103447647402751,-0.12060413528217,-0.0800526575002917,3.61426440023443e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,-0.0502556281493647,0.00518896374710073,-0.0604259970936822,-0.0400852592050473,4.27121588168431e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.0444280354268773,0.00458782197311749,-0.0534201664941876,-0.035435904359567,4.29595051577988e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.0419157049035016,0.0043293352593984,-0.0504012020119224,-0.0334302077950807,4.38335546472554e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,42016,-0.061720566396769,0.00637937511309825,-0.0742241416184416,-0.0492169911750965,4.54541792032907e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,41900,-0.050723251913197,0.00524289951852131,-0.0609993349694988,-0.0404471688568953,4.56795633651131e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNST,Consortin,42145,-0.111043952586392,0.0114847719875956,-0.133554105682079,-0.0885337994907042,4.82062730188127e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,42232,-0.0427329022189439,0.00442172929810305,-0.0513994916432259,-0.0340663127946619,5.03062842027568e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,-0.0422944749695343,0.00437509019923746,-0.0508696517600397,-0.0337192981790289,5.05905565928518e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.0315958873583404,0.00327371680512471,-0.0380123722963848,-0.025179402420296,5.69630894227311e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,39919,-0.0859438416279554,0.00890602661307426,-0.103399653789581,-0.0684880294663299,5.96690801603927e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,-0.0282053000349996,0.00292371836382106,-0.0339357880280889,-0.0224748120419103,6.14950590608006e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,42196,-0.0300357725744749,0.00311643579829311,-0.0361439867391294,-0.0239275584098204,6.50154181553681e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,42249,-0.0373613673224866,0.00387783817922333,-0.0449619301537643,-0.0297608044912088,6.70651449089047e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,39649,-0.046797177620721,0.00485726470099866,-0.0563174164346784,-0.0372769388067636,6.97091340714953e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,42137,-0.0455900877909041,0.00473525387017157,-0.0548711853764404,-0.0363089902053678,7.17054814392116e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,-0.0678582810322246,0.00704851566158315,-0.0816733717289276,-0.0540431903355216,7.42561802658607e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,-0.0551534596435888,0.00573592470979545,-0.0663958720747879,-0.0439110472123897,8.35946657277108e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,-0.0242933811132812,0.00253019747545393,-0.0292525681651709,-0.0193341940613915,9.25539631473162e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,-0.0401724819425196,0.00418756598209783,-0.0483801112674314,-0.0319648526176078,9.98447993330711e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,39638,-0.0319196637483939,0.00332664109938428,-0.0384398803031871,-0.0253994471936007,1.01829629000621e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,-0.0266837043973112,0.00278237065530617,-0.0321371508817112,-0.0212302579129111,1.0297717773393e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,-0.0558241585751339,0.00582656528172863,-0.067244226527322,-0.0444040906229458,1.12416678639559e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.0436165140128053,0.00456668996885548,-0.0525672263517621,-0.0346658016738486,1.5056148350034e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,42119,-0.0811437534469506,0.00850542617712725,-0.09781438875412,-0.0644731181397812,1.66544414514979e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,42217,-0.101356308599433,0.010629684773092,-0.122190490754693,-0.0805221264441726,1.74552477241768e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,42137,-0.0381012950633476,0.00399649908853146,-0.0459344332768693,-0.0302681568498259,1.77314508603641e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,42145,-0.0430652650113781,0.004519269052584,-0.0519230323544428,-0.0342074976683135,1.84947092090013e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,-0.0679126328647311,0.0071303910882576,-0.081888199397716,-0.0539370663317462,2.00304879970905e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.0450783640170039,0.00475086385981198,-0.0543900571822354,-0.0357666708517724,2.8203338296239e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,-0.072827365608426,0.00768314689300255,-0.087886333518711,-0.057768397698141,3.00041257066476e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,-0.0700157766671827,0.00740530737001698,-0.084530179112416,-0.0555013742219495,3.75953514468048e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,41839,-0.0708883013552614,0.00751049022317257,-0.0856088621926796,-0.0561677405178432,4.40165728391612e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,39919,-0.0222153826977957,0.00235341891522627,-0.0268280837716392,-0.0176026816239522,4.47178082137121e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,-0.0726509979839682,0.00770950852255921,-0.0877616346881843,-0.0575403612797522,5.20259243488098e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,-0.0242310830227995,0.0025726961126163,-0.0292735674035275,-0.0191885986420716,5.30002343745152e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,-0.0279876420771357,0.00297825121170917,-0.0338250144520857,-0.0221502697021858,6.47216143646738e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,-0.0442560437529321,0.00471118545096351,-0.0534899672368206,-0.0350221202690436,6.9208906630566e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.029470242313578,0.0031417967908401,-0.0356281640236246,-0.0233123206035314,7.65133011829061e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,-0.113704376607229,0.0121189710544323,-0.137457559873917,-0.089951193340542,7.67929004921446e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,42146,-0.0557900125980585,0.00595276336393675,-0.0674574287913745,-0.0441225964047424,8.21822700033056e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,-0.0765100239966814,0.00817276760835361,-0.0925286485090544,-0.0604913994843083,9.36154095983374e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,-0.0579299609451892,0.00619866144562593,-0.070079337378616,-0.0457805845117624,1.08474409850179e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,-0.032020158009757,0.00342768519943791,-0.0387384210006553,-0.0253018950188587,1.09276904201346e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NBN,Nibrin,41913,-0.0534460814147903,0.00572451509989785,-0.0646661310105901,-0.0422260318189905,1.15306123904514e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,39929,-0.0536018783240156,0.00574927044780437,-0.0648704484017122,-0.042333308246319,1.3369755963252e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.0789311924008838,0.00847638587722306,-0.095544908720241,-0.0623174760815266,1.44687174412216e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,-0.0666386800679808,0.00715697472018367,-0.0806663505195408,-0.0526110096164208,1.45915343820227e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,-0.0271647104925674,0.00292410810842892,-0.0328959623850881,-0.0214334586000468,1.77528723311333e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,-0.0486659128193183,0.00524192412185363,-0.0589400840981514,-0.0383917415404851,1.88346825400335e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,0.0263343948048494,0.00283708145696108,0.0207737151492057,0.0318950744604931,1.90876165277617e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,-0.0730764420212007,0.0078701318403844,-0.0885019004283541,-0.0576509836140473,1.91413521254027e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,-0.0623674292496463,0.00672384260109879,-0.0755461607477999,-0.0491886977514926,2.03153312468978e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,42119,-0.0786389462101512,0.00847988485500765,-0.0952595205259662,-0.0620183718943362,2.06901695297638e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,-0.0294873998897142,0.00318275925220696,-0.0357256080240399,-0.0232491917553886,2.24657743562773e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,42249,-0.110033768923939,0.0118901872727395,-0.133338535978509,-0.0867290018693699,2.47582288698511e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,-0.0754794469867465,0.00815942895892869,-0.0914719277462468,-0.0594869662272463,2.57049748773949e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,-0.0816903099186467,0.00884250250474989,-0.0990216148279565,-0.064359005009337,2.94787569822874e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,-0.0505554480862591,0.00547588647978142,-0.0612881855866307,-0.0398227105858875,3.03032159943059e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,-0.0761704008963735,0.00825240024034654,-0.0923451053674527,-0.0599956964252943,3.18281850770341e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,41843,-0.0958435342008582,0.0103987901974266,-0.116225162987814,-0.0754619054139022,3.5169691295679e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,-0.103730240083392,0.0112648679968851,-0.125809381357287,-0.0816510988094975,3.79179851692233e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,41820,-0.0462118913391395,0.0050186393016708,-0.0560484243704143,-0.0363753583078647,3.8144933270163e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,-0.0284123200430518,0.00309309514748319,-0.0344747865321188,-0.0223498535539847,4.80157385620111e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,-0.0822862197592748,0.00896121344754255,-0.0998501981164582,-0.0647222414020914,4.94209334313637e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,-0.0225202540713467,0.00245646158916142,-0.0273349187861031,-0.0177055893565903,5.65763979474378e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,-0.0480551306880514,0.00524640294605462,-0.0583380804623184,-0.0377721809137843,6.10005779109379e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,39958,-0.0524747496143785,0.00572987686684154,-0.0637053082733879,-0.041244190955369,6.18468702363737e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KAZN,Kazrin,39930,-0.101922238299873,0.011134995006103,-0.123746828511835,-0.0800976480879114,6.46434694904369e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,-0.108904399816311,0.0119145723133703,-0.132256961550517,-0.0855518380821052,7.0950069893122e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,-0.0582484098611674,0.00637377740769366,-0.070741013580247,-0.0457558061420879,7.38945105829915e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASPN,Asporin,39958,0.0269401046283671,0.00294950108415261,0.021159082503428,0.0327211267533063,7.73200923216482e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,-0.085484408202243,0.00937157578851548,-0.103852696747733,-0.0671161196567527,8.64368794397277e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,-0.0785267613417041,0.00861477068295508,-0.0954117118802961,-0.0616418108031122,9.15693012218187e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,0.0380529911966709,0.00419358224708171,0.0298335699923907,0.046272412400951,1.30234026234494e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,42153,0.0485036179892278,0.00534648324925637,0.0380245108206853,0.0589827251577703,1.32662823550026e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,41913,-0.0424253524622987,0.00468003974908513,-0.0515982303705056,-0.0332524745540919,1.41591282117029e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,42137,-0.0257797049322148,0.00284438340561572,-0.0313546964072216,-0.020204713457208,1.43623853793925e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,42070,-0.0711969597685389,0.00787722400698111,-0.0866363188222218,-0.0557576007148559,1.80509618548058e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,42296,0.00876817794583142,0.000970165189766731,0.00686665417388863,0.0106697017177742,1.80975018370115e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,-0.0450919269788519,0.00498957342421687,-0.0548714908903169,-0.0353123630673868,1.823464938013e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,39575,-0.0468223542966964,0.00518192793449737,-0.0569789330483112,-0.0366657755450815,1.90231482313693e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,-0.0830020530509571,0.00921333946451492,-0.101060198401406,-0.0649439077005079,2.41385757194573e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,-0.117526939319596,0.0130751511405051,-0.143154235554986,-0.0918996430842057,2.83275094990193e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,-0.0597315201422876,0.00666884843035346,-0.0728024630657804,-0.0466605772187948,3.78376963202108e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,-0.057590542269565,0.00643020800312982,-0.0701937499556995,-0.0449873345834306,3.79292673683183e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,-0.0259547998992335,0.00289757813498943,-0.0316340530438128,-0.0202755467546542,3.84076473841106e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,42249,0.0353212299129743,0.00394670785163056,0.0275856825237784,0.0430567773021702,4.02450417805791e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,39919,-0.0591708416054624,0.00661412799923602,-0.072134532483965,-0.0462071507269598,4.25323093128045e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,-0.0594710908123623,0.00665211754709575,-0.0725092412046699,-0.0464329404200546,4.5072749334246e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,-0.0497047283732359,0.00556096213883951,-0.0606042141653613,-0.0388052425811105,4.58009695135401e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,39919,-0.0382303656982937,0.00427907993043711,-0.0466173623619505,-0.029843369034637,4.7323913065186e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,-0.0294991678524203,0.0033059227309577,-0.0359787764050974,-0.0230195592997432,5.22523797490761e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,-0.0545039921255984,0.00610821954004142,-0.0664761024240796,-0.0425318818271172,5.24466574735698e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,-0.0657305700451774,0.00736857957262099,-0.0801729860075145,-0.0512881540828403,5.24643445948349e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,42296,-0.0549553169533198,0.00616495520842538,-0.0670386291618335,-0.042872004744806,5.52981748664113e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,39934,-0.0521302370735438,0.00585739111260622,-0.063610723654252,-0.0406497504928356,6.43705029742886e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0559332352301922,0.00628678034373263,-0.0682553247039082,-0.0436111457564762,6.47242190900826e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,42016,0.0244590689854077,0.00274942817535787,0.0190701897617063,0.0298479482091092,6.51900562866629e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,-0.0513097970720012,0.00577012375645336,-0.0626192396346498,-0.0400003545093526,6.90934771144296e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,-0.0591007355339494,0.00666524303950138,-0.0721646118913721,-0.0460368591765267,8.64253852225121e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0391334369330204,0.00441763555955162,-0.0477920026297416,-0.0304748712362992,9.10364763562498e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,39638,-0.0276005418581919,0.00311509392300604,-0.0337061259472838,-0.0214949577691001,9.20492775510545e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,42299,-0.0316854403347751,0.00357903733020636,-0.0387003535019796,-0.0246705271675706,9.5481371860855e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,0.0288691753380453,0.00326256287153951,0.0224745521098279,0.0352637985662628,9.93283706269775e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,-0.0593421094105729,0.00671825523176588,-0.072509889664834,-0.0461743291563117,1.16912723030812e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,-0.0545707857647714,0.00618224065285119,-0.0666879774443597,-0.0424535940851831,1.20456026998336e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,-0.0551772573139673,0.00626880004535234,-0.0674641054028579,-0.0428904092250767,1.50957600046386e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,-0.0735166129892443,0.00835019575050935,-0.0898829966602427,-0.057150229318246,1.51424433013991e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,41638,-0.0218849136484648,0.00248948501706025,-0.0267643042819029,-0.0170055230150267,1.66722932580587e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,42145,0.0291511804745166,0.00331764328207434,0.0226485996416509,0.0356537613073823,1.72323639833269e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,42070,-0.0824997107734225,0.00938913529589784,-0.100902415953382,-0.0640970055934627,1.72419693252692e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.0315693067444707,0.00359210468957784,-0.0386098319360433,-0.0245287815528982,1.73909399726515e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,-0.0456241289118241,0.005196033973902,-0.055808355500672,-0.0354399023229762,1.8598706364196e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,42144,-0.0273860036506639,0.00312474357700907,-0.0335105010616017,-0.0212615062397261,2.10179708839782e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,39930,-0.0649418413399174,0.00741063092020062,-0.0794666779435106,-0.0504170047363242,2.16501371461456e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,42181,-0.049605950615668,0.0056700848925179,-0.0607193170050031,-0.0384925842263329,2.40946234619738e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,39934,-0.0480863448570222,0.00550265730739208,-0.0588715531795106,-0.0373011365345337,2.68801964851448e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,39736,-0.0317611261553752,0.00363490417244661,-0.0388855383333706,-0.0246367139773798,2.71646559981326e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,-0.0669799690564549,0.0076721082275077,-0.08201730118237,-0.0519426369305398,2.83428209230551e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,42217,-0.0429234322643221,0.00492131342361887,-0.052569206574615,-0.0332776579540291,3.04836221593355e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,-0.0724863837549417,0.00831485503828257,-0.0887834996299755,-0.0561892678799078,3.23383948530818e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.0466922141835652,0.00535811203257197,-0.0571941137674063,-0.0361903145997242,3.33166079600031e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.0587996634037587,0.00676902258950616,-0.0720669476791908,-0.0455323791283266,4.24679501922992e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,42262,-0.101473231063188,0.011689660016606,-0.124384964695735,-0.0785614974306401,4.37831323843172e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,-0.0634870494194562,0.00731488526112805,-0.0778242245312672,-0.0491498743076452,4.43870372764402e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,42247,-0.0471245870217996,0.00543354301664209,-0.0577743313344181,-0.0364748427091811,4.68348312242871e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,39736,-0.0467784364664047,0.00539858895115534,-0.0573596708106692,-0.0361972021221402,5.14131113701385e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,-0.0697320327095625,0.00804852884667599,-0.0855071492490475,-0.0539569161700776,5.17445966957982e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,-0.0409036151231683,0.00472254537015197,-0.0501598040486662,-0.0316474261976704,5.19720537633896e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,41997,-0.0573818132442615,0.0066288141234647,-0.0703742889262523,-0.0443893375622707,5.41869438003381e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,-0.053166072970366,0.0061418436818746,-0.0652040865868402,-0.0411280593538918,5.42788047271026e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,42145,-0.112126163541352,0.0129651707650681,-0.137537898240885,-0.0867144288418183,5.81150077355158e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,42262,0.04223307815936,0.00488593686546237,0.0326566419030537,0.0518095144156662,6.03608723420157e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,39929,-0.0428379004369025,0.00496915788169945,-0.0525774498850334,-0.0330983509887715,7.53390277714601e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.0228270598316122,0.00264992408325959,0.0176332086284234,0.028020911034801,7.80302453378754e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,-0.0515312107654546,0.00598276285476773,-0.0632574259607993,-0.0398049955701098,7.87847097313105e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,41742,0.0829950249638222,0.00965175948081053,0.0640775763814335,0.101912473546211,8.94787519058687e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,39929,-0.0628339327487308,0.00730678953952622,-0.0771552402462022,-0.0485126252512594,9.06651269352667e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,39813,-0.10045106341763,0.0116949444291402,-0.123373154498745,-0.0775289723365156,9.90840131695301e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,42145,-0.0366894860554428,0.00427323525593304,-0.0450650271570715,-0.028313944953814,9.98868467168176e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,-0.0280481670225957,0.00326667406452955,-0.0344508481890736,-0.0216454858561178,1.02170231079469e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,-0.0406006647061043,0.00473086911632591,-0.0498731681741031,-0.0313281612381056,1.05628046604628e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,-0.0717994232009079,0.00836898529809078,-0.0882026343851658,-0.05539621201665,1.06054765615133e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.0296932084585075,0.00347251482263693,0.0228870794061391,0.0364993375108759,1.35085480447215e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,-0.0174359204432605,0.00204195605737046,-0.0214381543157066,-0.0134336865708143,1.49977795219173e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0572282006257691,0.00672756271575738,-0.0704142235486535,-0.0440421777028846,1.97946474291531e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,-0.0579790878707264,0.00681797149761185,-0.0713423120060456,-0.0446158637354071,2.06366998971547e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,39638,-0.0209407201285803,0.00246537577866723,-0.025772856654768,-0.0161085836023925,2.25380387555758e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,-0.0857413820342517,0.0100991636515647,-0.105535742791318,-0.0659470212771849,2.28099762082036e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,39930,-0.064394224246525,0.00758495444315761,-0.0792607349551139,-0.0495277135379361,2.32891082881236e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,-0.0430041856388804,0.00506668432124114,-0.0529348869085131,-0.0330734843692478,2.37085038490517e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0283549654014426,0.00334537238388587,-0.0349118952738589,-0.0217980355290263,2.57361164477828e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,42145,-0.0313102773649537,0.00369506839025915,-0.0385526114098616,-0.0240679433200457,2.62429806089884e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0424983366437737,0.00501907919653153,-0.0523357318689755,-0.0326609414185719,2.76669829209942e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,-0.0651310279944219,0.00769362676535756,-0.0802105364545228,-0.0500515195343211,2.80704843373689e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,41843,-0.0550807319669223,0.00650853778346983,-0.0678374660225231,-0.0423239979113214,2.8813944433832e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,-0.0775412775730961,0.00916047093026787,-0.0954958005964211,-0.059586754549771,2.88242627423704e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,39876,-0.0423905989024591,0.00501279822506964,-0.0522156834235956,-0.0325655143813226,3.09492842132446e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,-0.022911698516255,0.0027112428878888,-0.0282257345765171,-0.017597662455993,3.19421972978322e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,39929,-0.0972771388785611,0.0115111547426297,-0.119839002174115,-0.0747152755830068,3.24956886106921e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,39736,-0.0486897601571485,0.00577165839315265,-0.0600022106077277,-0.0373773097065693,3.68886283172954e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,41839,-0.0604393942959179,0.00717511091026653,-0.0745026116800403,-0.0463761769117955,4.02850678678639e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,42119,-0.0292445814493827,0.00347366922745578,-0.0360529731351961,-0.0224361897635694,4.17872668024801e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,-0.0574112672265408,0.00682362813457461,-0.070785578370307,-0.0440369560827746,4.36826024554054e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,-0.0644383714048375,0.00766495950020659,-0.0794616920252425,-0.0494150507844326,4.62869584286224e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,-0.0494746547177485,0.00588350947536577,-0.0610063332894654,-0.0379429761460316,4.64112336015695e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,-0.0652095017648604,0.00776932020082222,-0.0804373693584719,-0.0499816341712488,5.19613426681978e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,-0.0586451555481676,0.00698990462061147,-0.072345368604566,-0.0449449424917691,5.4380848412516e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,42137,-0.0398399883004552,0.00475302122590328,-0.0491559099032257,-0.0305240666976848,5.71145320111452e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,42185,0.058864198691929,0.00702549377180578,0.0450942308991897,0.0726341664846683,5.87495961413111e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,-0.048348690497513,0.00577532978937955,-0.0596683368846969,-0.0370290441103291,6.24814335144667e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,39636,-0.0397858400231065,0.00475300476610989,-0.0491017293646819,-0.0304699506815312,6.42020549662269e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,-0.0202950402058098,0.00242631484404271,-0.0250506173001335,-0.0155394631114861,6.62652237215541e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,-0.0445237494166688,0.00532316993745271,-0.0549571624940761,-0.0340903363392615,6.78881461654435e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,-0.0507676439582285,0.00607764309211916,-0.062679824418782,-0.0388554634976749,7.29249429040627e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,42296,-0.0375562112947758,0.00449948770747312,-0.0463752072014231,-0.0287372153881285,7.68216101112318e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,-0.0670171216909416,0.00802949161808109,-0.0827549252623805,-0.0512793181195026,7.8779742826833e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,-0.0675890083447319,0.00810244165582382,-0.0834697939901466,-0.0517082226993172,8.03177935992562e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,41756,-0.0645988179797526,0.00774814471164404,-0.0797851816145749,-0.0494124543449303,8.34873768591555e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,39736,-0.0477683642262622,0.00572892880103706,-0.0589970646762948,-0.0365396637762296,8.4371441854439e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,-0.0980055970240346,0.0117636183953893,-0.121062289078998,-0.0749489049690715,8.77188740158622e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0268544957018206,0.00322556172011886,-0.0331765966732536,-0.0205323947303877,9.3587788520871e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,-0.0832909764568795,0.0100216877401981,-0.102933484427668,-0.0636484684860911,1.03974638732956e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,39990,0.0435895971350859,0.00524626427820567,0.0333069191498028,0.053872275120369,1.07709886839053e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,-0.0606342626565699,0.00730434660464827,-0.0749507820016806,-0.0463177433114593,1.12887550880508e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,42181,-0.0193682990717447,0.0023348188431244,-0.0239445440042685,-0.0147920541392209,1.18321078402146e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,-0.0582216513143504,0.0070193518997736,-0.0719795810379067,-0.0444637215907942,1.21408787236605e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,0.0458861907714945,0.00553997447151396,0.0350278408073271,0.0567445407356618,1.31606577255888e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,42224,-0.0624562218196577,0.00754668066091125,-0.0772477159150438,-0.0476647277242717,1.39156012198951e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,39638,-0.076876861885959,0.00929333042673991,-0.0950917895223692,-0.0586619342495488,1.46533344563206e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,-0.0679809128140732,0.00821915412071578,-0.0840904548906761,-0.0518713707374703,1.48039587119839e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,41843,-0.083841662879184,0.0101446708361857,-0.103725217718108,-0.0639581080402599,1.53411759713855e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,41839,-0.071240472990446,0.00862363222347779,-0.0881427921484625,-0.0543381538324296,1.57993760979911e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,-0.0498759034763175,0.00603897857319952,-0.0617123014797886,-0.0380395054728465,1.63205678416112e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPSE,Heparanase,39866,-0.0835335679051805,0.0101159408020823,-0.103360811877262,-0.0637063239330991,1.65187445370826e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,-0.0488213966410433,0.0059139472612151,-0.0604127332730249,-0.0372300600090617,1.68301280075138e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,42119,-0.0348340826209224,0.00422271351231064,-0.0431106011050513,-0.0265575641367935,1.74073458385188e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,39930,-0.0505180288414727,0.00613883130408255,-0.0625501381974745,-0.0384859194854709,2.08970371283958e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,-0.062546039212317,0.00760540713303404,-0.0774526371930637,-0.0476394412315703,2.15153794701051e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,42035,-0.0588236778771201,0.00715602327096007,-0.0728494834882019,-0.0447978722660384,2.21737037634907e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2,Complement C2,42199,-0.0195798685339185,0.00238379591587134,-0.0242521085290263,-0.0149076285388107,2.33634262360314e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,-0.0233485753000377,0.00285107241361349,-0.0289366772307201,-0.0177604733693553,2.91434413529799e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,-0.0214775203409971,0.00262442590916475,-0.0266213951229601,-0.0163336455590342,2.99587904617105e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,-0.0518491392979013,0.00633576068516521,-0.0642672302408251,-0.0394310483549775,2.99773532778769e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,-0.0493598894029331,0.00603405587597545,-0.0611866389198449,-0.0375331398860212,3.08894210813346e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,42296,-0.0306283078674013,0.0037467004540479,-0.0379718407573352,-0.0232847749774674,3.22376106879945e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,-0.032454444668004,0.00396940319038877,-0.040234474921166,-0.0246744144148421,3.25049897553819e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,-0.0940310683392496,0.0115027748851932,-0.116576507114228,-0.0714856295642709,3.28304946343348e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,-0.068542060789428,0.00842940288093526,-0.0850636904360611,-0.0520204311427949,4.700489252129e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,-0.0429072761565063,0.0052829387820705,-0.0532618361693645,-0.0325527161436481,4.98314359662691e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,-0.0622329585063101,0.00766389938867918,-0.0772542013081213,-0.047211715704499,5.14134467179208e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,-0.0646642547521402,0.00798688426152047,-0.0803185479047203,-0.0490099615995601,6.14973212717301e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,39919,-0.0284619714211123,0.003515350817301,-0.0353520590230223,-0.0215718838192023,6.23599957922491e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,39575,-0.0337726532391164,0.00417326314066025,-0.0419522489948105,-0.0255930574834223,6.45509068376429e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,42119,-0.0408012437825359,0.00504622608227644,-0.0506918469037977,-0.0309106406612741,6.71468310382098e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,42113,-0.0250733804885196,0.00310110257772574,-0.031151541540862,-0.0189952194361771,6.72507861145392e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,39929,-0.0651990041765659,0.00806233176538909,-0.0810011744367285,-0.0493968339164032,6.74464157773241e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,-0.036829507557638,0.00455504236149642,-0.045757390586171,-0.027901624529105,6.83521297487494e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,-0.125342730808021,0.0155159983229106,-0.155754087520926,-0.0949313740951165,7.23328090071623e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,-0.0474445610250755,0.00587654386238684,-0.0589625869953537,-0.0359265350547973,7.401564204393e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,39638,-0.0594666618139354,0.00736767649381945,-0.0739073077418215,-0.0450260158860493,7.67718137407893e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,-0.0452362573535802,0.00560737399326425,-0.0562267103803781,-0.0342458043267823,7.78957464431686e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.0442893125872748,0.00550833866425659,-0.0550856563692178,-0.0334929688053319,9.7097047980945e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,-0.0703954941156201,0.00875505328071827,-0.0875553985458279,-0.0532355896854123,9.82924570121618e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,41843,-0.0456529710767011,0.00568875009100453,-0.05680292125507,-0.0345030208983322,1.09913554099185e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,-0.0577563251108833,0.00720022282127283,-0.071868761840578,-0.0436438883811885,1.14957790325392e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,-0.0565181669581378,0.00704822906688302,-0.0703326959292285,-0.0427036379870471,1.15418043198738e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,-0.0387798114696381,0.00483785273905735,-0.0482620028381905,-0.0292976201010857,1.18226388119171e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,39930,-0.0578600231851002,0.0072197736420561,-0.0720107795235301,-0.0437092668466702,1.2181340711195e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,39638,-0.037767900163545,0.00471331242789222,-0.0470059925222138,-0.0285298078048763,1.23182965105037e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,42262,-0.0237297081071595,0.00296511161480506,-0.0295413268721774,-0.0179180893421416,1.31191757045747e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,-0.0922642663365175,0.0115300610547785,-0.114863186003883,-0.0696653466691517,1.32219020568064e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,-0.0309989262421526,0.00387350589314517,-0.0385909977927171,-0.0234068546915881,1.33766447502044e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,39736,-0.0563973669106658,0.00705699143018158,-0.0702290701138217,-0.0425656637075099,1.46215876922343e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,-0.0344477756529372,0.00431362587090418,-0.0429024823599094,-0.025993068945965,1.530856941987e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,42137,-0.0638369157989255,0.00800796389870169,-0.0795325250403808,-0.0481413065574702,1.69007010157173e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,-0.0647186207699545,0.00812387713032385,-0.0806414199453892,-0.0487958215945197,1.78877139874695e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,-0.0300089777881047,0.00377041761007834,-0.0373989963038583,-0.0226189592723512,1.8707686106271e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.0229511376195914,0.0028832385716698,0.0172999900191186,0.0286022852200642,1.88086852169174e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,-0.084025654686007,0.0105582720024472,-0.104719867810804,-0.0633314415612105,1.91018441783462e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,-0.0867750208456431,0.0109087037224754,-0.108156080141695,-0.0653939615495913,1.96695717585965e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,42262,-0.039166571747031,0.0049271713342402,-0.0488238275621418,-0.0295093159319202,2.02531733799166e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,0.032394369543124,0.00407576427344211,0.0244058715671774,0.0403828675190705,2.04299420779812e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,-0.0867455496521791,0.0109124634814079,-0.108133978075739,-0.0653571212286197,2.0597067801842e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,-0.0818966611582151,0.0103072252360444,-0.102098822620862,-0.0616944996955682,2.12074192359599e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,-0.0355718070277718,0.00447834858409024,-0.0443493702525887,-0.0267942438029549,2.12534742298502e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0268351627113129,0.00338531010243024,-0.0334703705120762,-0.0201999549105496,2.42096532799494e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,-0.023155573096169,0.0029280944686717,-0.0288946382547656,-0.0174165079375725,2.85664454335918e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,0.0351390696845979,0.00444514890724386,0.0264265778263999,0.0438515615427958,2.88408678242546e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,-0.0556439689270105,0.00703750708395422,-0.0694374828115608,-0.0418504550424602,2.88625835124223e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,-0.0214621848731674,0.00271511411983062,-0.0267838085480354,-0.0161405611982993,2.94117772282594e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,-0.0341489776407834,0.0043216126304349,-0.0426193383964358,-0.025678616885131,3.00068833580812e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,-0.0866279163061461,0.0109713724811617,-0.108131806369223,-0.0651240262430692,3.10449791123077e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,39638,-0.0431539227533398,0.00546953313177099,-0.053874207691611,-0.0324336378150687,3.31057020816638e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,39930,-0.0283595163786523,0.00359753381454629,-0.035410682655163,-0.0213083501021416,3.48756904439202e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,42085,-0.06447823855548,0.00819822851507333,-0.0805467664450238,-0.0484097106659363,3.97366514792647e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,0.0356838228111464,0.00453810571548542,0.0267891356087949,0.0445785100134978,4.02634881879619e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,-0.0313863066007648,0.00399238122243269,-0.0392113737967329,-0.0235612394047967,4.14918757867685e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,-0.0237988793283928,0.003031428489531,-0.0297404791678735,-0.017857279488912,4.45166276508266e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,-0.0568316348035763,0.00724065273294557,-0.0710233141601496,-0.042639955447003,4.50902503497852e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,-0.0273640180109293,0.00349095145128139,-0.0342062828554408,-0.0205217531664177,4.96349111495041e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,-0.105581049040967,0.0134779996235207,-0.131997928303068,-0.0791641697788667,5.09209460223407e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,42070,-0.0487042397119602,0.00622613491698279,-0.0609074641492465,-0.036501015274674,5.56034347074864e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,39919,-0.0336105255849089,0.00430084855352106,-0.0420401887498102,-0.0251808624200077,5.98914656104777e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,-0.047001239126197,0.00601501370061829,-0.0587906659794089,-0.0352118122729851,6.04260335744287e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,-0.0457384646635865,0.00585483288752279,-0.0572139371231312,-0.0342629922040418,6.1195282532813e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,-0.0501133959208593,0.00641730094582829,-0.0626913057746827,-0.0375354860670358,6.17996055656008e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,-0.0450545034479997,0.00576875294621051,-0.0563612592225723,-0.0337477476734271,6.21692028272206e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,0.0351721834745901,0.0045091913634998,0.0263341684021305,0.0440101985470497,6.6387391676352e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0196681234296308,0.0025275025260887,0.0147142184784969,0.0246220283807646,7.6729554272314e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.0246058684579654,0.00316361736058049,0.0184051784312276,0.0308065584847031,7.91170962249102e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,41843,-0.0317345673792681,0.00408294946427572,-0.0397371483292485,-0.0237319864292877,8.26348477428867e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,39649,-0.0410624029778529,0.0052874660088899,-0.0514258363552771,-0.0306989696004287,8.81715207072746e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,-0.0372141135035206,0.00479516203304859,-0.0466126310882958,-0.0278155959187453,9.04855733710473e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.0302860124096098,0.00391252127486033,-0.037954554108336,-0.0226174707108835,1.07168133856791e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,-0.0287214754380407,0.00371216545334826,-0.0359973197266033,-0.0214456311494781,1.087818072591e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,-0.0396891596209606,0.00513175776958817,-0.0497474048493534,-0.0296309143925678,1.12996408706576e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,42103,-0.0540171831026597,0.00698896346444248,-0.067715551492967,-0.0403188147123524,1.16096545615831e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,39649,-0.108003681251671,0.0139713417147739,-0.135387511012628,-0.0806198514907143,1.16533998837762e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,-0.0479775482150542,0.0062141442007856,-0.060157270848594,-0.0357978255815145,1.25415929212452e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,39930,-0.0286204410717146,0.00370799774859331,-0.0358881166589574,-0.0213527654844717,1.27522300657608e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,-0.0300257675770518,0.00389227545518512,-0.0376546274692146,-0.0223969076848889,1.30392236157349e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,-0.0414805447179203,0.00537962738157853,-0.0520246143858142,-0.0309364750500264,1.35892478140693e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,-0.0746979862122944,0.00969716759451965,-0.0937044346975529,-0.0556915377270359,1.43869560210972e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,39919,-0.0393705215942297,0.00511256818031995,-0.0493911552276568,-0.0293498879608026,1.46555004663075e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,41900,-0.0438215984521783,0.0056923354140405,-0.0549785758636977,-0.0326646210406589,1.47536182932466e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,-0.0788104901716412,0.0102388208778301,-0.0988785790921881,-0.0587424012510942,1.48765289140353e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,41913,-0.0926830572824526,0.0120414625673393,-0.116284323914438,-0.0690817906504676,1.49095206474042e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,-0.0622556840621342,0.00809277586905821,-0.0781175247654883,-0.0463938433587801,1.53942923527115e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0363989167511852,0.00473245625659492,-0.0456745310141112,-0.0271233024882591,1.55548634981624e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,39657,-0.0355673021984052,0.00464572612086771,-0.0446729253953059,-0.0264616790015045,2.07926226145957e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,-0.0230705903759892,0.00301915375157357,-0.0289881317290734,-0.017153049022905,2.32081471709627e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0327767264775824,0.00429295860114396,-0.0411909253358246,-0.0243625276193403,2.41032507476028e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,41843,-0.0358443580156312,0.00469786502357828,-0.0450521734618446,-0.0266365425694177,2.50908069167465e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGMN,Legumain,42185,-0.0291986337799573,0.00383269462747269,-0.0367107152498038,-0.0216865523101109,2.73997960035314e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,41997,-0.0641157435703268,0.00844631782857152,-0.080670526514327,-0.0475609606263266,3.38476479216618e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,39886,-0.0229275629778572,0.00302491955221098,-0.0288564053001907,-0.0169987206555237,3.73872752525593e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,-0.0405491695307176,0.00535476204286177,-0.0510445031347267,-0.0300538359267085,3.89450339570591e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,-0.0684281732885272,0.00904286017599543,-0.0861521792334782,-0.0507041673435761,4.06182134232995e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,42262,-0.0324854259023905,0.00429322937466332,-0.0409001554767306,-0.0240706963280504,4.07378947351897e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,-0.0642854960963183,0.00850697752592726,-0.0809591720471357,-0.0476118201455009,4.39589286633085e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,42247,-0.0244010161591614,0.00323212594647645,-0.0307359830142552,-0.0180660493040675,4.64516340588572e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,0.0357961633712266,0.00474083730695888,0.0265041222495872,0.045088204492866,4.66510643181869e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,42057,-0.0443035509671486,0.00587095323830031,-0.0558106193142172,-0.03279648262008,4.76784625462391e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,-0.0286443018566772,0.0037971514256364,-0.0360867186509245,-0.0212018850624298,4.92659570092913e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,41992,-0.0411826685520327,0.00546343172127983,-0.0518909947257412,-0.0304743423783242,5.08344628887169e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,-0.0385762010516309,0.00511756807666038,-0.0486066344818852,-0.0285457676213765,5.13632295677899e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPL,Periplakin,39657,-0.0258513549504654,0.00343118700032441,-0.0325764814711012,-0.0191262284298295,5.29557780395966e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,-0.0665753533304494,0.00887737671182328,-0.083975011685623,-0.0491756949752758,6.80809281983152e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.0473866401277156,0.00632113794846853,0.0349972097487173,0.0597760705067139,6.96508008149428e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,39958,-0.0241482844383826,0.00322699292620957,-0.0304731905737533,-0.0178233783030118,7.78805796481654e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,41740,-0.0658301227554,0.00880166106442958,-0.083081378441682,-0.0485788670691181,7.94667704879681e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWC2,Brorin,41973,-0.0322336136803395,0.00431046570555564,-0.0406821264632285,-0.0237851008974504,8.01648046716673e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,-0.0527389047361522,0.00705306184603764,-0.066562905954386,-0.0389149035179184,8.15584987493016e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,39486,-0.0660626177611497,0.00883882003739624,-0.0833867050344464,-0.0487385304878531,8.36730196333178e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,-0.0621476445678404,0.00831840065396122,-0.0784517098496044,-0.0458435792860764,8.44379906760932e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,-0.0546614551434192,0.00731490102846215,-0.068998661159205,-0.0403242491276334,8.45053748586368e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,-0.0311551810854804,0.0041700760483083,-0.0393285301401646,-0.0229818320307961,8.53452695790704e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,41839,-0.0376477265972834,0.00504083395761795,-0.0475277611542146,-0.0277676920403523,8.61544887175306e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,-0.060823277876019,0.00814687047139656,-0.0767911439999562,-0.0448554117520818,8.8833103786851e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,-0.034635156776836,0.00464220725309885,-0.0437338829929098,-0.0255364305607623,9.11731439682377e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,-0.0486751359150092,0.00653242244210895,-0.0614786839015427,-0.0358715879284756,9.9120511947919e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,-0.042168902096452,0.00566182324300033,-0.0532660756527327,-0.0310717285401714,1.00572621029207e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,-0.079979724427134,0.0107390037198996,-0.101028171718137,-0.0589312771361308,1.00812771786522e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,42016,-0.075688058638752,0.0101788709232637,-0.0956386456483488,-0.0557374716291551,1.10236603197474e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.0169912453896776,0.00228535072420475,-0.0214705328091189,-0.0125119579702363,1.12232314139426e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,42310,-0.015428656039345,0.00207563332217408,-0.0194968973508062,-0.0113604147278838,1.12252927059917e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.0511282320726516,0.00687723565324345,-0.0646076139530087,-0.0376488501922944,1.12800327778373e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,0.0263742864779865,0.00355228377304631,0.0194118102828157,0.0333367626731572,1.19810734235009e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,-0.0457270378406558,0.00616117630091976,-0.0578029433904585,-0.0336511322908531,1.23815417898839e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.03162946324588,0.00426698124061552,0.0232661800142736,0.0399927464774864,1.31310216373505e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.0820105206472081,0.0110753857426754,-0.103718276702852,-0.0603027645915644,1.39223792375035e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.0214522160291152,0.00289827399248963,-0.0271328330543949,-0.0157715990038355,1.42253585005998e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,39649,-0.0339439990264318,0.00458613839041579,-0.0429328302716467,-0.0249551677812168,1.4450939112767e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,-0.0446628727295484,0.00604179730296004,-0.0565047954433501,-0.0328209500157468,1.54745358436651e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,42137,-0.0495996695748073,0.00671666800642145,-0.0627643388673934,-0.0364350002822212,1.61886525791307e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.023264969545839,0.00315209719047974,-0.0294430800391793,-0.0170868590524987,1.68365754886031e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,-0.0369095308489374,0.005001174070468,-0.0467118320270547,-0.0271072296708201,1.69145713938183e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,-0.0277429545219715,0.00376188401431577,-0.0351162471900304,-0.0203696618539126,1.76151446560441e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.0426169429565681,0.00578690826885267,-0.0539592831635193,-0.0312746027496169,1.90328740900905e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,-0.0414243897499866,0.00562576282224401,-0.0524508848815848,-0.0303978946183883,1.92142010894054e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,42145,-0.0200865007364608,0.00272960509005388,-0.0254365267129664,-0.0147364747599552,1.96314084050982e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,-0.0266290314955896,0.00361984873822347,-0.0337239350225076,-0.0195341279686716,1.99838035507016e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,0.060989201638203,0.00829157552612124,0.0447377136070053,0.0772406896694006,2.01030581914004e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,42189,-0.0279678060512367,0.00380293930582596,-0.0354215670906556,-0.0205140450118178,2.02972707721758e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0322148774197928,0.00438110885628386,-0.0408018507781092,-0.0236279040614764,2.04624857231921e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,-0.0230599933546461,0.00313866693486104,-0.0292117805469737,-0.0169082061623184,2.16878953966822e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,39657,-0.035364323156681,0.00481344264646183,-0.0447986707437462,-0.0259299755696158,2.16999035402023e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,41751,-0.0582956013312453,0.00793853876681535,-0.0738551373142033,-0.0427360653482872,2.20538905953097e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,-0.0518244835490455,0.007061975292657,-0.0656659551226533,-0.0379830119754378,2.31220475009056e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,-0.0417979750300658,0.00569912661862302,-0.052968263202567,-0.0306276868575647,2.35908270236307e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.0235579315691067,0.00321354528094884,-0.0298564803197664,-0.017259382818447,2.41892173648646e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0257030692178964,0.00350627343776158,-0.0325753651559091,-0.0188307732798837,2.45013768007573e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.0283355042511939,0.00387201111332134,-0.0359246460333037,-0.020746362469084,2.68646939724816e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,42137,0.0383031276076781,0.00523864340401131,0.028035386535816,0.0485708686795403,2.78689283234723e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,-0.0660594013467224,0.00904080434557064,-0.0837793778640409,-0.0483394248294039,2.92448182493775e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,39736,0.0364024258064683,0.00498276812774806,0.0266362002760821,0.0461686513368545,2.94761402604861e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,-0.0409281733009005,0.00560225816464143,-0.0519085993035977,-0.0299477472982033,2.94948775407257e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,-0.0680786549111324,0.00931933941336906,-0.0863445601613358,-0.0498127496609291,2.96178110139915e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,42119,-0.0510186548770738,0.00698888091421392,-0.0647168614689331,-0.0373204482852145,3.0389087693228e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,-0.0555621050507997,0.00761390638445318,-0.0704853615643279,-0.0406388485372715,3.12894400712512e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,-0.0308062726887926,0.00422266439999479,-0.0390826949127824,-0.0225298504648028,3.14518152308949e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,-0.032030285422623,0.00439476563585964,-0.0406440260689079,-0.0234165447763381,3.35344336621801e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,-0.021798129270274,0.00299153235601626,-0.0276615326880659,-0.0159347258524821,3.3967404721104e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,42143,-0.0810669171157078,0.0111291459697069,-0.102880043216333,-0.0592537910150822,3.41463166241966e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.0343492456015426,0.00471726173730888,0.0251034125964172,0.043595078606668,3.48073014939873e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,39701,-0.0503591225696263,0.00691474808735189,-0.063912028820836,-0.0368062163184166,3.48953170418774e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,39946,-0.0368246853209568,0.00505724273406022,-0.0467368810797148,-0.0269124895621987,3.51777924677935e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,42020,-0.0538602511717302,0.00740922580451375,-0.0683823337485772,-0.0393381685948833,3.81201454535945e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,41647,-0.0471134729046413,0.00648823684504812,-0.0598304171209356,-0.034396528688347,4.04914447980569e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,-0.0188926776808503,0.00260526658111198,-0.0239990001798297,-0.0137863551818708,4.335682138899e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,-0.0389241331483237,0.00536945285948195,-0.0494482607529084,-0.0284000055437391,4.42445164633429e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,39929,-0.0717417559487471,0.00989599956032343,-0.091137915086981,-0.0523455968105132,4.45306532803428e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,-0.0250097780422158,0.00345287331658766,-0.0317774097427276,-0.018242146341704,4.61663091926769e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,-0.070901250903396,0.0097934537161374,-0.0900964201870253,-0.0517060816197667,4.74492329422826e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0402625556930479,0.00556605561467734,-0.0511720246978155,-0.0293530866882803,5.00769848698158e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,-0.0795774136758142,0.0110042099675134,-0.10114566521214,-0.0580091621394879,5.03206842231744e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,-0.0425750968450344,0.00589237211847915,-0.0541241461972535,-0.0310260474928152,5.32293764573228e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,-0.0367304838401836,0.00508399386974705,-0.0466951118248878,-0.0267658558554794,5.3415186436641e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,39347,-0.0949981108593497,0.0131489679066127,-0.120770087956311,-0.0692261337623889,5.36017729972589e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,42073,-0.0294183461252115,0.00407359962280316,-0.0374026013859057,-0.0214340908645173,5.40927874557866e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,-0.0342790999406393,0.0047482013561314,-0.0435855745986569,-0.0249726252826218,5.50212267511825e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,-0.0497391876942459,0.00689074297696805,-0.0632450439291033,-0.0362333314593886,5.55257129238663e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,-0.0383068756189838,0.00530632928472384,-0.0487072810170426,-0.0279064702209251,5.57382740327555e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,39929,-0.0552868342714883,0.00766081336689987,-0.0703020284706121,-0.0402716400723646,5.66118018079953e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PI3,Elafin,41966,-0.042696061269503,0.00592630271175528,-0.0543116145845434,-0.0310805079544627,6.13769478996664e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,39934,-0.0507606250201918,0.00705914016065086,-0.0645965397350675,-0.0369247103053161,6.84848617779895e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,39586,-0.0417004411028803,0.0057992995954828,-0.0530670683100266,-0.030333813895734,6.87003339537952e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,-0.035101729564403,0.00488345593889849,-0.0446733032046441,-0.025530155924162,6.92198855266284e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,-0.0250719091735528,0.00348862180129173,-0.0319096079040846,-0.0182342104430211,6.98349345927749e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,39930,-0.0453143330700259,0.00631015375058074,-0.0576822344211641,-0.0329464317188876,7.34427720236056e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,42262,-0.016773069499388,0.00233655997215497,-0.0213527270448117,-0.0121934119539642,7.41018750297365e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,-0.065908739604578,0.00919165340405372,-0.0839243802765233,-0.0478930989326327,7.8621401113977e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,39930,-0.0278969542782107,0.0038971108773176,-0.0355352915977532,-0.0202586169586682,8.66917251229413e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,-0.0357830778223074,0.00500221297187419,-0.0455874152471808,-0.025978740397434,8.90604789449491e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,0.0261930735842973,0.00366224616815137,0.0190150710947206,0.0333710760738739,8.97954903245606e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,-0.0718006114086286,0.0100431184709101,-0.0914851236116125,-0.0521160992056448,9.26294800719453e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,42275,-0.0513705590516158,0.00718906462033152,-0.0654611257074656,-0.0372799923957661,9.41043572457219e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,-0.0450765726112066,0.00630832926949427,-0.0574408979794154,-0.0327122472429978,9.4216165221887e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,39990,0.0404926220224959,0.00567668386629331,0.029366321644561,0.0516189224004308,1.0404759674129e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,-0.0274451891676755,0.00385769366785201,-0.0350062687566655,-0.0198841095786856,1.18099925867008e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,-0.0404576187174753,0.0056897174296116,-0.0516094648795141,-0.0293057725554366,1.22445650924769e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,-0.0343530498628557,0.0048341261732257,-0.0438279371623781,-0.0248781625633333,1.26318353657487e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,-0.042115612694911,0.00592663507834412,-0.0537318174484655,-0.0304994079413566,1.26715483366084e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,-0.0326196934641547,0.00459404813621862,-0.0416240278111432,-0.0236153591171662,1.30717493594707e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,-0.0600781980163805,0.00847222919995657,-0.0766837672482953,-0.0434726287844656,1.39619680700241e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,-0.0907381905007169,0.0128080005076322,-0.115841871495676,-0.0656345095057577,1.48105063561181e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,-0.0423612907318218,0.00598641816653063,-0.0540946703382219,-0.0306279111254218,1.55577631893206e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,39979,0.0226733598792643,0.00320469823317917,0.0163921513422331,0.0289545684162955,1.58182251624517e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAT,Catalase,39827,-0.03931989614268,0.00555928641858592,-0.0502160975231084,-0.0284236947622516,1.60830722084623e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,-0.0464034378556659,0.00656521016394994,-0.0592712497770078,-0.033535625934324,1.64718329758887e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,-0.0327744547445373,0.00463599954070954,-0.041861013844328,-0.0236878956447466,1.64809035250835e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,-0.0500273137005409,0.00708657291163282,-0.0639169966073412,-0.0361376307937406,1.7693088250213e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,-0.0660547744813862,0.00935828126519089,-0.0843970057611604,-0.0477125432016121,1.78482377319809e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,-0.0306912061630796,0.00434911418974726,-0.0392154699749842,-0.0221669423511749,1.7857032195664e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,42107,-0.0679389086661858,0.00964937182344517,-0.0868516774401384,-0.0490261398922333,2.00432946114149e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,-0.036746466064744,0.00521912670338276,-0.0469759544033742,-0.0265169777261138,2.02575339501055e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,-0.0200221736646401,0.00284715917709574,-0.0256026056517477,-0.0144417416775324,2.14768993581581e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,42170,0.027433431887006,0.0039042691499179,0.0197810643531669,0.035085799420845,2.21846357900746e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,42169,0.0201979433765096,0.00288478263321431,0.0145437694154096,0.0258521173376096,2.65055587664429e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,-0.0499967988108481,0.00714103531079944,-0.063993228020015,-0.0360003696016812,2.65473735151566e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,41839,-0.0267472777001166,0.00382027074286167,-0.0342350083561255,-0.0192595470441077,2.65620801830643e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,-0.0913957769687495,0.0130598634733154,-0.116993109376448,-0.0657984445610514,2.71823823440117e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,-0.0225685958999869,0.00322899586114462,-0.0288974277878304,-0.0162397640121435,2.88983745067552e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,42249,-0.0213920167613313,0.00306355598811826,-0.0273965864980431,-0.0153874470246195,3.0286399376596e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,-0.0302378616366051,0.00433089438789428,-0.0387264146368778,-0.0217493086363323,3.04839410004272e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.0200669627299823,0.00287668604633915,-0.025705267380807,-0.0144286580791575,3.18353575980729e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,-0.0236072642974028,0.00338818961260136,-0.0302481159381014,-0.0169664126567041,3.40960949476577e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.0279686218893784,0.00401567932181039,-0.0358393533601267,-0.02009789041863,3.4391845703052e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,-0.0451193367292006,0.00648097608418277,-0.0578220498541989,-0.0324166236042024,3.54994915805728e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,-0.0254080922323305,0.0036586497301085,-0.0325790457033431,-0.0182371387613178,4.0045436958968e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,-0.0793743695157974,0.0114337388578383,-0.101784497677161,-0.0569642413544343,4.0731816890337e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,-0.0152268980364251,0.00219485068340509,-0.0195288053758991,-0.0109249906969511,4.17163083571476e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,42145,-0.0334961177658093,0.00482952514713167,-0.0429619870541874,-0.0240302484774312,4.2256359346897e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,-0.0266428408776072,0.00384179460751694,-0.0341727583083404,-0.019112923446874,4.24681357844304e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,-0.0384327616857687,0.0055428065635015,-0.0492966625502316,-0.0275688608213057,4.31959286387775e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,42137,-0.0369966625062645,0.00533742851548082,-0.0474580223966069,-0.0265353026159221,4.35097724644942e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,-0.0311914655571198,0.00450155782051021,-0.0400145188853199,-0.0223684122289198,4.47314410538756e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,-0.0447094781988508,0.0064622698370515,-0.0573755270794717,-0.0320434293182299,4.81732106689472e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,-0.0553635837197147,0.00803036062373526,-0.0711030905422359,-0.0396240768971936,5.7014286778668e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,-0.0304475720976102,0.00442117458693428,-0.0391130742880014,-0.021782069907219,6.01913447155255e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,-0.0491402724231385,0.00714345633840268,-0.0631414468464077,-0.0351390979998692,6.35273219203136e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,-0.0360573156477916,0.00524938258423351,-0.0463461055128893,-0.0257685257826939,6.75338577954207e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,-0.0514703378106607,0.00749984018248119,-0.0661700245683239,-0.0367706510529976,7.04236434020284e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,-0.0440531425948027,0.00642121542416232,-0.0566387248261608,-0.0314675603634445,7.16385419548863e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,-0.0627888039333358,0.00915421042298986,-0.0807310563623959,-0.0448465515042757,7.30226970783e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,-0.0179972007437889,0.00262440531528125,-0.0231410351617402,-0.0128533663258377,7.37532190579957e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,41846,-0.0406261454609858,0.00592556006822431,-0.0522402431947055,-0.0290120477272661,7.390926302491e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,39757,-0.0392909138363205,0.0057418279627086,-0.0505448966432293,-0.0280369310294116,8.16562448739143e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,0.0107817768642293,0.00157655128106185,0.00769173635334807,0.0138718173751105,8.39390697244472e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,42099,-0.0346973807447737,0.00507769310662293,-0.0446496592337546,-0.0247451022557927,8.65447664524544e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,-0.0374649789186193,0.0054838860163385,-0.0482133955106427,-0.0267165623265958,8.7501610199043e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,0.0111585031680706,0.00163423202368277,0.00795540840165232,0.0143615979344888,9.05023733411259e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,-0.0446919698815292,0.00655968050790777,-0.0575489436770285,-0.03183499608603,9.96252709353659e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.0275187380950151,0.00404050503885895,-0.0354381279711787,-0.0195993482188516,1.01306076495777e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,-0.0197775019641303,0.00290465308882397,-0.0254706220182253,-0.0140843819100353,1.03441247878759e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,-0.0642572267259332,0.00943805639259114,-0.0827558172554119,-0.0457586361964546,1.03741734301355e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,-0.0377516097295028,0.00555317668571447,-0.0486358360335032,-0.0268673834255025,1.1134015190947e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,-0.073381913269487,0.0108044012874364,-0.0945585397928624,-0.0522052867461116,1.15296728605242e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,42249,-0.0200639505964891,0.00295666675342527,-0.0258590174332026,-0.0142688837597756,1.20037955324363e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,-0.0118925235150093,0.00175266987266712,-0.0153277564654368,-0.0084572905645817,1.2153244555369e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,-0.0450252320159477,0.00663981079843702,-0.0580392611808842,-0.0320112028510111,1.25192214718113e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,-0.0241449512349567,0.00356124386620553,-0.0311249892127195,-0.0171649132571938,1.25340071451558e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,-0.0234707157500501,0.00346186784552723,-0.0302559767272834,-0.0166854547728167,1.25369381286681e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,0.0572777466211388,0.00845088468162598,0.0407140126451519,0.0738414805971257,1.27136336440639e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,-0.0166569798265712,0.00245953471991658,-0.0214776678776077,-0.0118362917755347,1.31818985582449e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,-0.0316362207205971,0.00468254015524443,-0.0408139994248762,-0.022458442016318,1.47444740398353e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,42119,-0.0275657187510699,0.00408403781434525,-0.0355704328671866,-0.0195610046349532,1.5427235359627e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,-0.0178308885976036,0.0026472656408867,-0.0230195292537416,-0.0126422479414657,1.69839994561914e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,-0.0418015929839134,0.00620608826468383,-0.0539655259826937,-0.0296376599851331,1.71383000309292e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,42113,-0.0170472210326386,0.00253285290420479,-0.02201161272488,-0.0120828293403972,1.75969206251349e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,41900,-0.0332097894348985,0.00493570901603245,-0.0428837791063221,-0.0235357997634749,1.78470554407886e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.0201348346276646,0.00299406734794606,0.0142664626256903,0.0260032066296389,1.82659756892122e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,42070,-0.0393668049258088,0.00586377244915222,-0.0508597989261472,-0.0278738109254705,1.97536491339034e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,-0.0332584761514926,0.00496033947018652,-0.0429807415130582,-0.023536210789927,2.09647338251617e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,-0.0243635140364048,0.00363476723612804,-0.0314876578192157,-0.0172393702535938,2.12401904753616e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,-0.0395631314008206,0.00591769379557973,-0.0511618112401569,-0.0279644515614844,2.38975129265682e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,41913,-0.0499930277961574,0.0074789355947944,-0.0646517415619545,-0.0353343140303604,2.40927989528492e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,-0.0210883168597461,0.0031548043986753,-0.0272717334811496,-0.0149049002383425,2.42553599355581e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",39979,-0.0117993605499915,0.00176670819604456,-0.0152621086142388,-0.00833661248574415,2.5225709275245e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,-0.0622335106250963,0.00932643454528277,-0.0805133223338505,-0.043953698916342,2.62671604922426e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,-0.0171463411293997,0.0025733518379892,-0.0221901107318585,-0.0121025715269409,2.78649358283811e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,-0.0367890329681545,0.0055226704908423,-0.0476134671302055,-0.0259645988061036,2.81837311798867e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,-0.047247838426354,0.00709575880047956,-0.0611555256752939,-0.0333401511774141,2.87098916347771e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,42310,-0.0178270423183667,0.0026786370322109,-0.0230771709015001,-0.0125769137352334,2.93533352511685e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,-0.0160748415575931,0.00241616320051039,-0.0208105214305935,-0.0113391616845927,2.97985611036328e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,39958,-0.0457862380191188,0.00688811287699699,-0.0592869392580329,-0.0322855367802047,3.12533821925035e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,-0.0188298716055023,0.0028352562089173,-0.0243869737749802,-0.0132727694360244,3.22752409433133e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,39990,-0.0190785371052588,0.00287249550154303,-0.0247086282882831,-0.0134484459222345,3.23984372434593e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,42185,-0.0649271420129905,0.00978673323448523,-0.0841091391525815,-0.0457451448733994,3.38624568404629e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,-0.065424808044286,0.00986362871765715,-0.0847575203308941,-0.046092095757678,3.41689742639699e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,39850,-0.0693407626115848,0.0104699576786091,-0.0898618796616587,-0.0488196455615109,3.68443772186178e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,-0.0263255431997693,0.00397682951843211,-0.0341201290558962,-0.0185309573436423,3.76513868216184e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,39736,-0.052157863659367,0.00788226780414553,-0.0676071085554922,-0.0367086187632417,3.83089339579191e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,41890,-0.0393897979354425,0.00596102199556999,-0.0510734010467597,-0.0277061948241253,4.04687055829102e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,-0.0900222501552428,0.0136397491306359,-0.116756158451289,-0.0632883418591963,4.2647766574401e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,42016,-0.0254274561564135,0.00385278100911776,-0.0329789069342844,-0.0178760053785427,4.27276824318297e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,39934,0.0342788705504257,0.00520496851506073,0.0240771322609067,0.0444806088399447,4.72460978542016e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,-0.024567615238801,0.00373562908005012,-0.0318894482356992,-0.0172457822419027,4.99189121895585e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,-0.0473250602250558,0.00720554766344338,-0.0614479336454049,-0.0332021868047068,5.29485766193887e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,42145,-0.0471329489701431,0.00718126374124865,-0.0612082259029905,-0.0330576720372958,5.45371363375033e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,39958,-0.0189535013548378,0.0028880958360924,-0.0246141691935789,-0.0132928335160967,5.51679855614904e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,-0.0636147062411133,0.00969978296887107,-0.0826262808601006,-0.044603131622126,5.68324422326631e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,-0.0326990120996348,0.00499539372001127,-0.0424899837908569,-0.0229080404084127,6.13074122322172e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,39736,-0.0407329143464473,0.00622675195249249,-0.0529373481733326,-0.028528480519562,6.35326605006804e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,-0.0384763385628812,0.00589382407415657,-0.050028233748228,-0.0269244433775343,6.93897258999172e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,-0.0202635202428821,0.00310498484824654,-0.0263492905454453,-0.0141777499403189,7.04237295148816e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,41900,-0.050113035699029,0.00768434155592348,-0.065174345148639,-0.035051726249419,7.21485893669236e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,-0.025048748893334,0.00384336657401572,-0.0325817473784048,-0.0175157504082632,7.46736850858013e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,-0.0147350578996073,0.00226423084798245,-0.0191729503616529,-0.0102971654375617,7.89818186282878e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.0196184068551509,0.00301591274961903,-0.0255295958444042,-0.0137072178658975,8.09740139553844e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,39575,-0.0456514318947313,0.00702003754754696,-0.0594107054879233,-0.0318921583015393,8.2145208873633e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,-0.0272565762349977,0.00419740372109581,-0.0354834875283455,-0.01902966494165,8.67123853781682e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,-0.0525881672271178,0.00810012062669201,-0.0684644036554341,-0.0367119307988014,8.75015359964216e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,-0.0611101501845442,0.00941679542811369,-0.079567069223647,-0.0426532311454413,8.97148054336968e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,-0.0379236634947165,0.00584671601748355,-0.0493832268889842,-0.0264641001004487,9.1005373824775e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.0215014071504407,0.00331603408480152,-0.0280008339566517,-0.0150019803442297,9.24299254602305e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,-0.023997765026524,0.00370486384085371,-0.0312592981545972,-0.0167362318984507,9.73290800173619e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,39826,0.0757186021450095,0.0116906585950291,0.0528049112987525,0.0986322929912665,9.75731620167359e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEXN,Nexilin,39990,-0.0480225802342612,0.00741822106035787,-0.0625622935125626,-0.0334828669559597,9.96288363596632e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.0201060573806371,0.00310754491753313,-0.026196845419002,-0.0140152693422721,1.01325954564463e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0223370329415118,0.00345561915814979,0.0155640193915382,0.0291100464914854,1.0628231587149e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,-0.0614395721468813,0.00951339575785093,-0.0800858278322692,-0.0427933164614935,1.10268782509562e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,-0.0407741193297359,0.006323652471427,-0.0531684781737328,-0.0283797604857389,1.18040310317932e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,42148,-0.0642568065791364,0.00996935721922857,-0.0837967467288244,-0.0447168664294484,1.19175093088283e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,-0.0575348084996785,0.00893315329901321,-0.0750437889657444,-0.0400258280336126,1.23910333218258e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,-0.048741623155999,0.00757937562352418,-0.0635971993781064,-0.0338860469338916,1.31122412953023e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,-0.0820833564156624,0.0127625452762532,-0.107097945157119,-0.057068767674206,1.31366365947267e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,39657,-0.0335300769684383,0.0052191155726713,-0.043759543490874,-0.0233006104460025,1.37762374930704e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,-0.0497197645564185,0.00774866767444446,-0.0649071531983296,-0.0345323759145073,1.45094479481951e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0244729405756989,0.00381493811571435,-0.0319502192824991,-0.0169956618688988,1.46405716204738e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,-0.029395663133635,0.00458761368780302,-0.0383873859617289,-0.0204039403055411,1.53833938551769e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.0396656514380036,0.00619376614344322,-0.0518054330791523,-0.0275258697968549,1.56275305336694e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,42123,-0.0242658362492765,0.00379180543466619,-0.0316977749012223,-0.0168338975973308,1.60977352822958e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,-0.0470160744182371,0.00734716772095481,-0.0614165231513085,-0.0326156256851656,1.62547380812143e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,-0.0150128719726989,0.00234655338610535,-0.0196121166094654,-0.0104136273359324,1.62780413321992e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,39586,-0.0284917172984418,0.0044559144413908,-0.0372253096035677,-0.0197581249933158,1.68011831661922e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,42085,-0.0563534906270521,0.00882210630843628,-0.0736448189915873,-0.039062162262517,1.73859966406717e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,39575,-0.0397279810063193,0.00621946705204679,-0.051918136428331,-0.0275378255843076,1.75233318598004e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,-0.0556415294248356,0.00873028248517016,-0.0727528830957691,-0.038530175753902,1.90890153052259e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,39990,-0.0196211671338511,0.00308274697164011,-0.0256633511982657,-0.0135789830694365,2.03013206927325e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,-0.0387307255029627,0.00609030135885563,-0.0506677161663198,-0.0267937348396057,2.09182826140851e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C7,Complement component C7,39722,-0.0224048475811804,0.00353360414799628,-0.0293307117112531,-0.0154789834511077,2.37884037720608e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,-0.023029373792018,0.00363863074382851,-0.0301610900499219,-0.0158976575341141,2.54413200661346e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,42166,-0.0582965655886416,0.00921330764491032,-0.0763546485726658,-0.0402384826046174,2.57109857490911e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,-0.0618997174473681,0.00979261898271347,-0.0810932506534865,-0.0427061842412497,2.68072923133314e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,-0.0798179300792402,0.0126347209193456,-0.104581983081158,-0.0550538770773229,2.76061072147068e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.0335196747160367,0.00531061326379166,-0.0439284767130684,-0.0231108727190051,2.84555185119489e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,41839,-0.0302795357465714,0.00480032911082721,-0.0396881808037927,-0.0208708906893501,2.92026582621521e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,42262,-0.0267822343659029,0.00424613870491453,-0.0351046662275353,-0.0184598025042704,2.92442667600287e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAX,Protein max,41839,-0.0706600840448021,0.011202983045409,-0.0926179308138038,-0.0487022372758005,2.93058821314669e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,42015,-0.0392542926058482,0.00622460640750306,-0.0514545211645542,-0.0270540640471422,2.94730427298737e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,39586,-0.0431169896004081,0.00683915644954829,-0.0565217362415228,-0.0297122429592935,3.00352397102328e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.0177243399069874,0.00281412746473957,-0.023240029737877,-0.0122086500760979,3.10185964170575e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,42181,-0.0223125801536076,0.00354961621342138,-0.0292698279319135,-0.0153553323753017,3.35898440794649e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,42062,-0.0213919534876452,0.00340467858941844,-0.0280651235229054,-0.0147187834523851,3.42097927088856e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,39930,-0.0525794528733029,0.00836793987675058,-0.068980615031734,-0.0361782907148718,3.43312423971359e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,-0.069147536888797,0.0110094285308714,-0.0907260168093049,-0.0475690569682891,3.47285569449798e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,-0.0273512818236181,0.00435763022914129,-0.035892237072735,-0.0188103265745012,3.56681865161329e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,39657,-0.0283732593155045,0.0045303384432642,-0.0372527226643023,-0.0194937959667066,3.91801103657723e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,-0.0744543700879878,0.0118902000851657,-0.0977591622549127,-0.051149577921063,3.92022724462587e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,42145,-0.0255624256604521,0.00409081081948362,-0.0335804148666399,-0.0175444364542642,4.26161468708786e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,39990,-0.0498084318732524,0.00797132987116402,-0.0654322384207339,-0.034184625325771,4.29352404084067e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,41900,-0.0293834291190856,0.00470979005049363,-0.0386146176180532,-0.0201522406201181,4.54314087962053e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,42137,0.0207591432472325,0.00333123673243014,0.0142299192516694,0.0272883672427956,4.75192349978914e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,39897,-0.0581534371801546,0.00933490509340585,-0.0764498511632301,-0.0398570231970791,4.84024555866923e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,-0.0222816077613121,0.0035894734385198,-0.0293169757008109,-0.0152462398218133,5.54348077529807e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,41913,-0.0334357963966754,0.00539759525462117,-0.0440150830957329,-0.0228565096976179,6.01643123972472e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,-0.0348831544595666,0.00563375186703262,-0.0459253081189505,-0.0238410008001826,6.12326100912035e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,-0.0406650566400774,0.00656991252376872,-0.053542085186664,-0.0277880280934907,6.20462157219688e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,-0.02137086705138,0.00345378914259579,-0.0281402937708677,-0.0146014403318922,6.28433719259404e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,41910,-0.0479889716502596,0.00775947016351517,-0.0631975331707494,-0.0327804101297699,6.40951822161285e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,42137,0.0170285909554667,0.00275762904044602,0.0116236380361925,0.0224335438747409,6.80192332001318e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,42016,-0.027641940183831,0.00448392741317676,-0.0364304379136575,-0.0188534424540046,7.26540747563197e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,-0.0367325178502047,0.00595799887001016,-0.0484101956354246,-0.0250548400649848,7.2796044659565e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,41797,-0.0308020602446296,0.00500192992763892,-0.0406058429028019,-0.0209982775864573,7.57905601583157e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,39638,0.0280204552926214,0.00456126397578557,0.0190803779000816,0.0369605326851611,8.36963949495578e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,39657,-0.0303734284241163,0.00495269977691018,-0.0400807199868603,-0.0206661368613724,8.93506442294742e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,-0.0587609174880079,0.0095833210754112,-0.0775442267958139,-0.039977608180202,8.94833899760458e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,39966,-0.0554018658959862,0.00903736657269691,-0.0731151043784721,-0.0376886274135002,9.06165228527544e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,-0.0238715851385183,0.00389621306802516,-0.0315081627518476,-0.016235007525189,9.21667370318462e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.0223245865440037,0.00364958446817719,-0.029477772101631,-0.0151714009863764,9.79452587908334e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,41900,-0.0544358370219747,0.00891879790618383,-0.071916680918095,-0.0369549931258545,1.06658788060054e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,-0.0291901781153353,0.00478271277702397,-0.0385642951583023,-0.0198160610723684,1.06822460409192e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0383071933309459,0.00628458184827206,-0.0506249737535591,-0.0259894129083326,1.12077669343198e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,-0.0113067797670788,0.00185526441354837,-0.0149430980176336,-0.00767046151652402,1.12807586257359e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,39736,-0.0254791251457329,0.00418318423604917,-0.0336781662483893,-0.0172800840430765,1.16023694232617e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,39930,-0.0404187225072731,0.0066420898087073,-0.0534372185323394,-0.0274002264822068,1.20074431094412e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DMD,Dystrophin,39638,-0.0332551347397893,0.00546598295361724,-0.043968461328879,-0.0225418081506995,1.21094115788886e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPART,Spartin,39736,-0.0502883037406275,0.00827152467570723,-0.0665004921050137,-0.0340761153762413,1.24361050298753e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,39919,-0.0290633812977909,0.00478060590421187,-0.0384333688700462,-0.0196933937255356,1.24493604436129e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,42296,-0.0392494761670749,0.00645769449706389,-0.0519065573813201,-0.0265923949528296,1.24967976842811e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BGN,Biglycan,41820,0.0758047394852489,0.0124837226128522,0.0513366431640587,0.100272835806439,1.29558096325527e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,-0.0344337925566149,0.00567664919168317,-0.0455600249723139,-0.0233075601409159,1.3543268365251e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,-0.0338106085163691,0.00557621129535434,-0.0447399826552636,-0.0228812343774746,1.37662747963254e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,42145,-0.0189288151713798,0.00312438887336635,-0.0250526173631778,-0.0128050129795817,1.41120997337172e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,-0.0426773360689421,0.00705813562473204,-0.0565112818934169,-0.0288433902444673,1.51888303813427e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,-0.0505079039020598,0.00836486102315556,-0.0669030315074447,-0.0341127762966749,1.60053325909263e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,39736,-0.0698970650436849,0.0115761852082494,-0.0925863880518537,-0.0472077420355161,1.61006647364729e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,-0.0580289400983492,0.00962363694096344,-0.0768912685026376,-0.0391666116940609,1.69242842536263e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,-0.0542275299060102,0.00899821767864434,-0.0718640365561531,-0.0365910232558673,1.72786009700648e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRL,Prolactin,42249,-0.0467611576428267,0.00776360794108877,-0.0619778292073607,-0.0315444860782927,1.75481327589786e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,41913,-0.0507406609022565,0.00843824306586838,-0.0672796173113585,-0.0342017044931545,1.86684245475593e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,42112,-0.0419119356150419,0.00697736243901487,-0.055587565995511,-0.0282363052345727,1.94027429700489e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.0226061080240763,0.00376370811343765,-0.029982975926414,-0.0152292401217385,1.94710332387013e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,-0.0302794075958675,0.00504880492179087,-0.0401750652425776,-0.0203837499491573,2.06681118426059e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,39934,-0.0162736977821348,0.00271396093773889,-0.021593061220103,-0.0109543343441666,2.08028431661281e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALB2,Calretinin,41839,-0.0186031959842269,0.00310579389716715,-0.0246905520226746,-0.0125158399457793,2.15499923151988e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,39914,-0.06193059445488,0.0103435827005215,-0.0822040165479021,-0.0416571723618578,2.1976834395876e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,-0.0249936093474607,0.00418758255261271,-0.0332012711505816,-0.0167859475443398,2.4660438475753e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,42016,-0.0271180534637709,0.00454470421557907,-0.0360256737263059,-0.0182104332012359,2.47811584003585e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,42296,-0.0399853294419952,0.00670670478795844,-0.0531304708263937,-0.0268401880575967,2.55309536442453e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,-0.0146808030405634,0.00246361553293433,-0.0195094894851147,-0.00985211659601211,2.59934890911645e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,-0.0415308071827076,0.00697351049953876,-0.0551988877618035,-0.0278627266036116,2.67209213175246e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,-0.0418228789319231,0.00702673057928931,-0.0555952708673301,-0.028050486996516,2.72982462390381e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,-0.0247842894519401,0.00416984362292005,-0.0329571829528634,-0.0166113959510168,2.86865816364644e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,-0.0518047888524907,0.00871868880743308,-0.0688934189150595,-0.0347161587899218,2.88812868275183e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,-0.0370621038206124,0.00623849704606493,-0.0492895580308997,-0.0248346496103252,2.90472029446397e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,42082,-0.0549771450943013,0.00925864588448038,-0.0731240910278828,-0.0368301991607197,2.95753198293401e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,-0.0672828001391235,0.0113392309919925,-0.0895076928834287,-0.0450579073948182,3.04972886819071e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,41913,-0.0300504372785816,0.00506641446645377,-0.039980609632831,-0.0201202649243322,3.07996446399798e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,-0.0528746671737789,0.00892002929455726,-0.0703579245911112,-0.0353914097564467,3.16292920552593e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,-0.0249578527013466,0.00421334720633152,-0.0332160132257564,-0.0166996921769368,3.2441826915813e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,-0.0423019698412311,0.00715050563650798,-0.0563169608887867,-0.0282869787936755,3.39847989903234e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.0204692735554922,0.00346079041043475,-0.0272524227599443,-0.0136861243510401,3.4066407544809e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.0185173790593702,0.00313551120386926,-0.0246629810189539,-0.0123717770997864,3.59626763081967e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,0.0201998393578977,0.00342168869744354,0.0134933295109083,0.026906349204887,3.66315870229781e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,41751,-0.0675591076706308,0.0114541605033979,-0.0900092622572907,-0.0451089530839709,3.76481773963966e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,-0.0251720883577187,0.00426886391666353,-0.0335390616343792,-0.0168051150810582,3.81465083508063e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,-0.0728960538867467,0.0123926197860616,-0.0971855886674274,-0.048606519106066,4.14494435211056e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,41913,-0.047744680796527,0.00811702612918502,-0.0636540520097297,-0.0318353095833244,4.14966057474314e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPARC,SPARC,42181,-0.0433989916299941,0.00738050314226405,-0.0578647777888316,-0.0289332054711566,4.19346408093844e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,-0.0464996064471405,0.00790797042925731,-0.0619992284884849,-0.0309999844057962,4.2178781498024e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRELP,Prolargin,42123,-0.0145306790197388,0.00247199497285391,-0.0193757891665324,-0.0096855688729451,4.24735784298213e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,39575,-0.0245038151268752,0.00416933405297128,-0.0326757098706989,-0.0163319203830515,4.29522593334667e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,-0.02952168127807,0.00503185069437415,-0.0393841086390433,-0.0196592539170966,4.56267174349713e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,-0.0653372907291183,0.011141369170196,-0.0871743743027025,-0.0435002071555341,4.63607915867427e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,-0.0617924286363631,0.0105459345487623,-0.0824624603519371,-0.041122396920789,4.75555105514302e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,-0.014462030623696,0.00247447069857436,-0.0193119931929017,-0.00961206805449021,5.19862816855588e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,0.0224810358805207,0.00385348584740594,0.014928203619605,0.0300338681414363,5.53794368873753e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,41900,-0.048448686653276,0.00830537518367308,-0.0647272220132752,-0.0321701512932768,5.55678161538523e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,-0.0304008351073797,0.00521533113798063,-0.0406228841378218,-0.0201787860769377,5.72369909803062e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.038861113810046,0.00667845328868566,-0.0519508822558699,-0.0257713453642221,6.05667147307571e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,-0.0463580563859315,0.00797283550767942,-0.0619848139809832,-0.0307312987908799,6.22213826052738e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,-0.0267337237496157,0.00459912679016403,-0.0357480122583372,-0.0177194352408942,6.30999484510596e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C3,Complement C3,39445,-0.0283757219112725,0.00489320439827906,-0.0379664025318995,-0.0187850412906455,6.85721479869478e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,-0.023802475309221,0.00410875553051275,-0.031855636149026,-0.015749314469416,7.09334579844361e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,39979,-0.0211361947199765,0.00364947028109997,-0.0282891564709325,-0.0139832329690206,7.157341010319e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,41814,-0.0223381353878977,0.00385872110936846,-0.0299012287622599,-0.0147750420135356,7.24153841983911e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0185912246199144,0.00321614709767257,-0.0248948729313526,-0.0122875763084761,7.60841746120085e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,-0.0243951891030576,0.00422704142471342,-0.0326801902954959,-0.0161101879106193,8.07931093146446e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,42199,-0.0156263836866967,0.00271092798912047,-0.0209398025453729,-0.0103129648280206,8.3816817178884e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,-0.0408053946278828,0.00710205504447997,-0.0547254225150635,-0.026885366740702,9.36247901208796e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,-0.0545259525399673,0.00951547979971872,-0.0731762929474159,-0.0358756121325186,1.02437410164273e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,0.0207828249327328,0.0036364248024132,0.0136554323200029,0.0279102175454626,1.11888780627255e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,-0.0259432811550402,0.0045483741670996,-0.0348580945225554,-0.017028467787525,1.19631160603935e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,-0.0233752388311096,0.00409923151792736,-0.0314097326062472,-0.0153407450559719,1.21221158102045e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,-0.0390621537955511,0.00685280971038849,-0.0524936608279125,-0.0256306467631896,1.22679559897311e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,42181,-0.0368912328590918,0.00647286926883216,-0.0495780566260029,-0.0242044090921808,1.22755269297785e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,-0.0321109497006411,0.00563649193932145,-0.0431584739017111,-0.021063425499571,1.2499091203386e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,-0.0386982676660671,0.00679702574077044,-0.0520204381179772,-0.025376097214157,1.27170261911985e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,-0.0138707465811078,0.00243846933975334,-0.0186501464870243,-0.00909134667519123,1.31482376150047e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALB1,Calbindin,42070,-0.0271605097818312,0.00478169749859094,-0.0365326368790694,-0.017788382684593,1.37401715868415e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,39638,-0.0712436759038266,0.0125522092951271,-0.0958460061222758,-0.0466413456853775,1.41532229072628e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,-0.0524343282228451,0.00924965213266055,-0.0705636464028598,-0.0343050100428304,1.4738608158691e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,42166,-0.0343008426554722,0.00605341112029394,-0.0461655284512483,-0.0224361568596961,1.48824498468419e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,42116,-0.02421355108147,0.00428404513670284,-0.0326102795494075,-0.0158168226135324,1.61769157324697e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,-0.0288149863737769,0.00510031742099022,-0.0388116085189177,-0.0188183642286361,1.64654332479432e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,-0.0470646739973448,0.00833410493660799,-0.0633995196730964,-0.0307298283215931,1.66969594991106e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,-0.0686766591189908,0.0121673126197189,-0.0925245918536399,-0.0448287263843418,1.69781300152228e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,39966,-0.0258391556799943,0.00458664046039792,-0.0348289709823742,-0.0168493403776143,1.80713341473633e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,39649,-0.0491788109292015,0.00873471232808835,-0.0662988470922546,-0.0320587747661483,1.84315451291663e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,-0.0292235159614208,0.00519703431154943,-0.0394097032120576,-0.0190373287107839,1.92004170456831e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.0505496661967548,0.00899112658700127,-0.0681722743072773,-0.0329270580862323,1.92303155551456e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,-0.0540572431820264,0.00962077350245278,-0.0729139592468339,-0.035200527117219,1.96934647167407e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0186208376675176,0.00331815441787656,-0.0251244203265556,-0.0121172550084795,2.04226258243793e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,-0.0409408727754712,0.00729530675927851,-0.055239674023657,-0.0266420715272853,2.04835595257337e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,42070,-0.0193898743532364,0.00345897047135909,-0.0261694564771003,-0.0126102922293726,2.11515348362426e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,-0.0209744157279081,0.00374149420622532,-0.0283077443721098,-0.0136410870837065,2.12034473087875e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,0.0184594793959332,0.00329299353519635,0.0120052120669484,0.0249137467249181,2.12044013073936e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,-0.0343912954776777,0.00614367603509749,-0.0464329005064688,-0.0223496904488866,2.21282169615455e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,39908,-0.0508386582601816,0.0090926286657035,-0.0686602104449605,-0.0330171060754028,2.30742887276696e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,-0.0314939042970129,0.00563920832044402,-0.0425467526050832,-0.0204410559889426,2.38562773815382e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,0.0195367185274263,0.00350033744820417,0.0126760571289461,0.0263973799259065,2.44083757251008e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,-0.0449118781037396,0.00805497173341736,-0.0606996227012376,-0.0291241335062416,2.52401004107293e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,41997,0.0269642074307087,0.00484127971133974,0.0174752991964828,0.0364531156649346,2.60174308948049e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,-0.0429241956143449,0.00771758731835048,-0.0580506667583118,-0.0277977244703779,2.72085761661925e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,-0.0597700373794398,0.0107672144249397,-0.0808737776523216,-0.038666297106558,2.89245833430289e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,39919,-0.0234884404015237,0.00423885022202111,-0.0317965868366851,-0.0151802939663624,3.07074715708428e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,39657,-0.0157652024213482,0.00284700405706233,-0.0213453303731904,-0.0101850744695061,3.13880586412918e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,0.0155279398085095,0.00280546834712949,0.0100292218481357,0.0210266577688833,3.18327551769301e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,-0.0385234062290353,0.00696694542840849,-0.0521786192687159,-0.0248681931893546,3.27174470800525e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,0.0245098033880783,0.00443463460622676,0.0158179195598739,0.0332016872162827,3.33182558439047e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.040566738834698,0.00734144987812184,-0.0549559805958169,-0.0261774970735792,3.35405690311072e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,-0.032954427509135,0.00596496201357244,-0.044645753055737,-0.021263101962533,3.37640783928556e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,39657,-0.0337876457460285,0.00611858505333149,-0.0457800724505582,-0.0217952190414988,3.42475012519448e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,39929,-0.017701831453306,0.00321505860765273,-0.0240033463243054,-0.0114003165823067,3.75265937608287e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,-0.0419980356244884,0.00763212854224045,-0.0569570075672797,-0.0270390636816971,3.82074285912477e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,42081,-0.0632477463091465,0.0115177172183521,-0.0858224720571166,-0.0406730205611763,4.06107511138145e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,42087,-0.0384004182156996,0.00699457034230476,-0.0521097760866169,-0.0246910603447823,4.09124404698982e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,-0.037574227829693,0.006846456073545,-0.0509932817338412,-0.0241551739255448,4.15175179979765e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.0356004183025957,0.00648781043580472,-0.048316526756773,-0.0228843098484185,4.15578392854816e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,-0.0390936324523888,0.007128966470272,-0.0530664067341219,-0.0251208581706557,4.25510806013257e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,42119,-0.0287884096208322,0.00525125297017769,-0.0390808654423805,-0.0184959537992839,4.27606684302752e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,39919,-0.0498318496885091,0.00908984195895055,-0.0676479399280522,-0.032015759448966,4.29207902361842e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,-0.052876559184129,0.00965117769908907,-0.0717928674743435,-0.0339602508939144,4.37698703129554e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,-0.0675947854422887,0.0123448998654324,-0.0917907891785363,-0.0433987817060412,4.44035263668172e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,0.038053985949409,0.00695309745085294,0.0244259149457372,0.0516820569530808,4.50453770633372e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,-0.025310163145929,0.00462415995761179,-0.0343735166628481,-0.0162468096290099,4.50977304812743e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,-0.0516549081502521,0.0094404481123467,-0.0701581864504516,-0.0331516298500526,4.53794454153125e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0397935124558116,0.00727453021039784,0.0255354332434319,0.0540515916681914,4.57416677825399e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,41839,-0.04167757387228,0.00762493057472214,-0.0566224377987354,-0.0267327099458246,4.68740827063747e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,-0.0386259205607243,0.00707019553759088,-0.0524835038144024,-0.0247683373070461,4.77498665564325e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,-0.0388305125552694,0.00711310470588086,-0.0527721977787959,-0.0248888273317429,4.89045030873116e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,-0.0270724501307221,0.00495986051936249,-0.0367937767486725,-0.0173511235127716,4.89359003716993e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,42138,-0.0235649020202234,0.00431934832576227,-0.0320308247387174,-0.0150989793017293,4.9648233857963e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,42200,0.0230460730614592,0.00422968746462235,0.0147558856307994,0.031336260492119,5.16377972950415e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,39713,-0.0601465658624258,0.0110384704797222,-0.0817819680026812,-0.0385111637221703,5.17888228252375e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,-0.0420004422044917,0.00771796346032677,-0.0571276505867322,-0.0268732338222512,5.38078169758878e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,39929,-0.0282486013129879,0.00519412613940609,-0.0384290885462239,-0.018068114079752,5.48265595147767e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,41900,-0.0804833894777865,0.0148043279476882,-0.109499872255255,-0.0514669067003176,5.53031864579917e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,-0.030793237856698,0.00566458588754646,-0.041895826196289,-0.0196906495171069,5.53953493652722e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,-0.020930491637566,0.00385183906453758,-0.0284800962040596,-0.0133808870710723,5.63082827087741e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,0.0266919131133806,0.00491630788504691,0.0170559496586887,0.0363278765680725,5.75559392915233e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.0234983693467901,0.00432877920823376,-0.0319827765949283,-0.0150139620986519,5.78444574403782e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.0153459181623753,0.0028275314018817,0.00980395661468719,0.0208878797100635,5.81964484924047e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,-0.0342846280049491,0.00632293288290298,-0.0466775764554389,-0.0218916795544592,6.00529875328013e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,-0.0511171217598807,0.0094316108504762,-0.069603079026814,-0.0326311644929474,6.09304083092042e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0225020330830904,0.00415252473130143,-0.0306409815564412,-0.0143630846097396,6.09993946277621e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,39929,-0.0219240304608077,0.00405218772215811,-0.0298663183962376,-0.0139817425253778,6.41575292983484e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,-0.0638992312186936,0.0118135995241635,-0.0870538862860541,-0.0407445761513331,6.44900303286743e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0677692748180584,0.0125349060351013,-0.092337690646857,-0.0432008589892598,6.53785628846835e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,41900,0.0132479076300719,0.00245415346642941,0.00843776683587029,0.0180580484242736,6.84842287349497e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,42119,-0.0393753403741034,0.00729809369353094,-0.053679604013424,-0.0250710767347827,6.95651639119697e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASN,Vasorin,41975,0.0156294349719608,0.0028981492695963,0.0099490624035521,0.0213098075403696,7.050747262079e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,-0.0360674884408067,0.00668941967292131,-0.0491787509997325,-0.022956225881881,7.09835578334594e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,42027,-0.0263600889791307,0.00489101327703276,-0.0359464750021149,-0.0167737029561464,7.18497919242331e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,-0.0250075804665081,0.00464792065342306,-0.0341175049472173,-0.0158976559857989,7.58571332399367e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,-0.0244137425188195,0.0045436911123003,-0.033319377098928,-0.0155081079387109,7.86940980711655e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,-0.0246838063292984,0.00459534103565467,-0.0336906747591816,-0.0156769378994153,7.96373685465724e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,0.0188683850349314,0.00352086979893756,0.0119674802290138,0.025769289840849,8.50592172200519e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,41949,-0.039648605809844,0.00740923664596162,-0.0541707096359288,-0.0251265019837592,8.87971251687683e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,41913,-0.0164610136541035,0.00307664113261589,-0.0224912302740306,-0.0104307970341764,8.92530253304941e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.013890814817934,0.00259920907110879,0.00879636503856077,0.0189852645973072,9.25472174098969e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,39649,-0.0280629666821483,0.00525569929012781,-0.0383641372907988,-0.0177617960734978,9.50350626485025e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,-0.0421143164287994,0.00790961691331424,-0.0576171655788953,-0.0266114672787035,1.03228114936853e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,-0.0128742807146282,0.00242337930762558,-0.0176241041575744,-0.00812445727168208,1.10161291649924e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,-0.0562393093579286,0.0105962256480733,-0.0770079116281523,-0.035470707087705,1.13246848162912e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,41839,-0.0280617165215131,0.00528876162607804,-0.0384276893086261,-0.0176957437344002,1.13916934745053e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,41814,-0.0514148769112167,0.00969272339139124,-0.0704126147583435,-0.0324171390640898,1.1481655835798e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,0.0131316375807932,0.00247855945204765,0.00827366105477978,0.0179896141068066,1.18829452863201e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,39657,-0.0235776799928956,0.00445272386833128,-0.0323050187748249,-0.0148503412109663,1.21222982587413e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,-0.0254749737420529,0.00481814730313903,-0.0349185424562054,-0.0160314050279004,1.26446685356237e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,39929,-0.0475095176728682,0.00898733405502235,-0.065124692420712,-0.0298943429250244,1.27152892621245e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,-0.0347801017044877,0.00658298644165,-0.0476827551301217,-0.0218774482788537,1.2882127073728e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,-0.0508926986473006,0.00965052344142547,-0.0698077245924945,-0.0319776727021067,1.35839554172132e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.0167819363428799,0.00318298896535082,-0.0230205947149675,-0.0105432779707923,1.36753696824255e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,0.0295501547572435,0.00561073476992082,0.0185531146081987,0.0405471949062883,1.40992199348027e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,-0.0366066175490794,0.00696019032951857,-0.0502485905949358,-0.022964644503223,1.46742965194973e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,-0.0368355712395371,0.00700771325229785,-0.0505706892140409,-0.0231004532650333,1.49546249249322e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,-0.0204805408241438,0.00390520886115905,-0.0281347501920155,-0.012826331456272,1.59131953675233e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,42081,-0.0576206894396538,0.0109933926211495,-0.0791677389771067,-0.0360736399022008,1.61774431339882e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,-0.0416625693880577,0.00795240887783392,-0.0572492907886121,-0.0260758479875032,1.64350766258915e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,-0.0151848253962253,0.00290139207353399,-0.020871553860352,-0.00949809693209871,1.6917919624572e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,41839,-0.0338973866095888,0.00648094003953069,-0.046600029087069,-0.0211947441321087,1.71797101552231e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.0191490833525361,0.00366378026451698,-0.0263300926709894,-0.0119680740340828,1.75273512246407e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,42239,-0.0334688957458636,0.00640374945151153,-0.0460202446708262,-0.020917546820901,1.75341829285368e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.165251638225312,0.0316283509521237,-0.227243206091475,-0.10326007035915,1.76939599704777e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,41877,-0.0236477018398277,0.00453209042585517,-0.0325305990745038,-0.0147648046051515,1.83752532888523e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,-0.0546239665922058,0.0104698392847705,-0.0751448515903559,-0.0341030815940556,1.84779241064317e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,42262,0.0330640835421607,0.00634443670418803,0.0206289876019522,0.0454991794823692,1.90039702512718e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,-0.0353752053061393,0.00678750876615439,-0.0486787224878019,-0.0220716881244767,1.90383785648967e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,-0.0282530738410325,0.00543003086060655,-0.0388959343278213,-0.0176102133542436,1.9888983418311e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FST,Follistatin,42166,0.0267034934421125,0.0051481584562501,0.0166131028678623,0.0367938840163627,2.16787469389275e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,-0.0393451977700577,0.00758992291775738,-0.0542214466888622,-0.0244689488512532,2.20443753496052e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,42070,0.0426803674007437,0.00823544875952728,0.0265388878320703,0.0588218469694172,2.22073952244115e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,-0.0118342385408283,0.00228583365034249,-0.0163144724954996,-0.00735400458615702,2.28445233692234e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,-0.0508862051411512,0.00982922550249506,-0.0701514871260415,-0.0316209231562609,2.28679059730563e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,42070,-0.0191039524426313,0.00369029030339588,-0.0263369214372872,-0.0118709834479753,2.28953953294256e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,39736,-0.0250536270728869,0.00484180706717841,-0.0345435689245566,-0.0155636852212172,2.32576801225549e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,-0.0418291494206639,0.00809251226065264,-0.057690473451543,-0.0259678253897847,2.39659888209508e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,39925,-0.0170631170378734,0.00330131287012309,-0.0235336902633147,-0.0105925438124321,2.39890476575814e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,-0.0166376065050324,0.00321981642690791,-0.0229484467017719,-0.0103267663082929,2.41700578865038e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,-0.0109742003659967,0.00213028601570571,-0.0151495609567799,-0.00679883977521352,2.62736751727797e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,-0.0414034654588151,0.00804276301633186,-0.0571672809708256,-0.0256396499468047,2.67080273721209e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LXN,Latexin,41960,0.037206099455986,0.00722994078945098,0.0230354155086621,0.0513767834033099,2.69709297568462e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,-0.0233280499587077,0.00453423251954867,-0.0322151456970231,-0.0144409542203923,2.71450048008538e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,42070,-0.0408158367731299,0.00794095062159531,-0.0563800999914567,-0.0252515735548031,2.7870593981729e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,-0.0291279749774914,0.00566859931114294,-0.0402384296273315,-0.0180175203276512,2.81704599272644e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,42167,0.0114394216288939,0.00222807732735308,0.00707239006728181,0.0158064531905059,2.8724936396012e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,-0.0457482945014075,0.00891108874476177,-0.0632140284411406,-0.0282825605616744,2.87881050250019e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,42286,-0.016377986555384,0.00319255310182303,-0.0226353906349572,-0.0101205824758109,2.93611943050119e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,-0.0233241941549264,0.00454725341328953,-0.0322368108449738,-0.0144115774648789,2.95796109194685e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,-0.0267481787058662,0.0052174036638908,-0.0369742898870922,-0.0165220675246402,2.98893875130267e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,-0.0133900140275022,0.00261452543871236,-0.0185144838873784,-0.00826554416762593,3.08355842791911e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,-0.0651988082750206,0.0127405568564019,-0.0901702997135684,-0.0402273168364728,3.14902178459656e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,42261,-0.0186849848606471,0.0036528267837054,-0.0258445253567097,-0.0115254443645845,3.17633459821768e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,42137,-0.0393402034747582,0.00769351140621587,-0.0544194858309413,-0.0242609211185751,3.20686560830637e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,-0.0218104556235048,0.00427617505832761,-0.0301917587378269,-0.0134291525091827,3.44309449806243e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,-0.0197024627075732,0.00386860475083816,-0.027284928019216,-0.0121199973959304,3.58467148803066e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,-0.0340659018473945,0.00669716466145848,-0.0471923445838531,-0.0209394591109359,3.70531547349773e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,-0.0112042551339945,0.00220659109950455,-0.0155291736890234,-0.00687933657896553,3.87272891807482e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,-0.039825726895322,0.00784915317870195,-0.0552100671255778,-0.0244413866650662,3.96039817570077e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,42216,-0.0313304546315372,0.00617909422714268,-0.0434414793167368,-0.0192194299463375,4.02203260870145e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,-0.0312713122965154,0.00617125401250026,-0.043366970161016,-0.0191756544320149,4.09957626159333e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,-0.0154762745400292,0.00305475284829053,-0.0214635901226786,-0.00948895895737971,4.12010213339209e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,39819,-0.0324929169416787,0.00641720116098847,-0.0450706312172161,-0.0199152026661413,4.18361395165297e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,39930,-0.0353652485655453,0.00698595568830401,-0.0490577217146211,-0.0216727754164694,4.20656397103112e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNLY,Granulysin,42137,-0.028800567815075,0.00569393970556567,-0.0399606896379837,-0.0176404459921663,4.28976338345249e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,-0.0176289983030221,0.00348614238754619,-0.0244618373826126,-0.0107961592234315,4.33017071675506e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,38503,-0.0574200104002825,0.011366691215197,-0.0796987251820686,-0.0351412956184964,4.45932140072493e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,39958,-0.0286915437893148,0.0056809985229864,-0.0398263008943681,-0.0175567866842614,4.47635396526543e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,42119,-0.0318366532871234,0.00630556081753576,-0.0441955524894935,-0.0194777540847533,4.49954750785099e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,41839,-0.0220550341756692,0.00436980699408175,-0.0306198558840695,-0.013490212467269,4.54421376269715e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,39979,-0.0220800027242182,0.0043781769201137,-0.0306612294876411,-0.0134987759607954,4.64874928435112e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,-0.0545782772550618,0.0108314281943694,-0.0758078765160259,-0.0333486779940977,4.7572254249957e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,-0.0194319119532042,0.00385884591028702,-0.0269952499373668,-0.0118685739690416,4.83496629698529e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,-0.0136637298990068,0.00271468632049561,-0.0189845150871782,-0.00834294471083543,4.89584759801961e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.020238270891915,0.00402165280468413,0.0123558313947341,0.0281207103890959,4.90918810274126e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,42145,-0.0362222350293137,0.00720040102136074,-0.0503350210311808,-0.0221094490274467,4.95245667234591e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,-0.04629945490515,0.00921168743702486,-0.0643543622817187,-0.0282445475285813,5.08026936850469e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,39930,-0.0552221083616137,0.0109992214656085,-0.0767805824342064,-0.033663634289021,5.23080773572336e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,-0.0326451075773195,0.00650444047909866,-0.0453938109163529,-0.0198964042382862,5.26289496628043e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,-0.0165990478702293,0.00331163124900764,-0.0230898451182843,-0.0101082506221743,5.46025744179126e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,-0.0310471982389197,0.00620858289182324,-0.0432160207068933,-0.0188783757709462,5.78569711426765e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,41913,-0.0428488215454755,0.00857427644376226,-0.0596544033752495,-0.0260432397157015,5.88559639765202e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,-0.0249768666928797,0.00500792988760675,-0.034792409272589,-0.0151613241131705,6.21071802933362e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,39560,-0.0295471887892442,0.00593523407051774,-0.0411802475674589,-0.0179141300110294,6.51317997531277e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,-0.0117494377807394,0.0023651451230966,-0.0163851222220087,-0.00711375333947005,6.85569790895378e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,-0.0450399569402544,0.00907472449889232,-0.0628264169580833,-0.0272534969224254,7.03379227432225e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,39657,-0.0188016109388184,0.00378952958817469,-0.0262290889316408,-0.011374132945996,7.10056047608242e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,-0.0217685287984275,0.00438877753960267,-0.0303705327760488,-0.0131665248208063,7.13516141347712e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,-0.0176566819487341,0.00356020372483601,-0.0246346812494127,-0.0106786826480555,7.17152175013394e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,-0.0271764665758552,0.00548082814247997,-0.037918889735116,-0.0164340434165945,7.21111858637521e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,-0.0248891911934237,0.00502955651985065,-0.0347471219723309,-0.0150312604145164,7.58463272919069e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,-0.0381693752674273,0.00771474607614072,-0.0532902775766631,-0.0230484729581915,7.62539068160566e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,41839,-0.0255944967717254,0.0051812314626537,-0.0357497104385267,-0.0154392831049242,7.91381387840246e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,-0.0562432439410216,0.0113881728680693,-0.0785640627624374,-0.0339224251196058,7.97502587395312e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,-0.0435690458571454,0.00883710493939909,-0.0608897715383676,-0.0262483201759232,8.30989456745635e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,39929,-0.0719166166058734,0.0145941931780399,-0.100521235234832,-0.0433119979769152,8.43562986276402e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTD,Biotinidase,39979,-0.0107158589612507,0.00217744794412324,-0.0149836569317323,-0.00644806099076916,8.71791082275641e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,-0.0517599700701465,0.0105217708198836,-0.0723826408771183,-0.0311372992631746,8.806529795729e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,-0.0226340899788167,0.00460465624264852,-0.0316592162144078,-0.0136089637432256,8.96218431137705e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLGN,Calmegin,39649,-0.0238436441373164,0.00485793295762998,-0.0333651927342711,-0.0143220955403616,9.32352396925044e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,42217,-0.0153422299202543,0.00313442636156778,-0.0214857055889272,-0.00919875425158148,9.95590229836068e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,-0.0318341004341712,0.00650613433133143,-0.0445861237235808,-0.0190820771447616,1.00705399779498e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,-0.0224891233649987,0.0045968238722183,-0.0314988981545466,-0.0134793485754509,1.00827193054373e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.0572013784384849,0.0116974129525078,-0.0801283078254002,-0.0342744490515695,1.01947533318452e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,42119,-0.0177797031393105,0.00363662132318962,-0.0249074809327622,-0.0106519253458588,1.02476395890691e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,-0.0318301128909756,0.00651031741375875,-0.0445903350219427,-0.0190698907600084,1.02681832815665e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,-0.051505480265636,0.0105435212267844,-0.0721707818701335,-0.0308401786611386,1.048687647948e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,42145,0.036412746696373,0.00746346024091907,0.0217843646241717,0.0510411287685744,1.07945891240357e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,-0.0419552283322218,0.00860358701880406,-0.0588182588890778,-0.0250921977753658,1.09498490097137e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,39575,-0.0327110237533074,0.00670835271339183,-0.0458593950715553,-0.0195626524350594,1.09685773779172e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,-0.0228925054645748,0.00469532922432959,-0.0320953507442608,-0.0136896601848888,1.10003557125475e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,-0.0368191321940523,0.00755927810489515,-0.0516353172796467,-0.0220029471084578,1.12718870035597e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,0.0145723427969692,0.00299271013881195,0.0087066309248978,0.0204380546690406,1.13270791142215e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,-0.029766007430273,0.00611577474586835,-0.041752925932175,-0.017779088928371,1.14543694434659e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,39919,-0.0232453376354112,0.00477591778967315,-0.0326061365031705,-0.0138845387676518,1.14719341034033e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,42070,-0.0218799146492697,0.00450147104456192,-0.030702797896611,-0.0130570314019283,1.18341208095254e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,39934,-0.0397321770443277,0.00819079365339615,-0.0557861326049841,-0.0236782214836712,1.24579358271917e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,41832,-0.0556472160954327,0.0114769521360159,-0.0781420422820238,-0.0331523899088416,1.25745562034117e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,42230,0.0139560613814916,0.00288546443456137,0.00830055108975132,0.0196115716732319,1.33470234107805e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,-0.0306082241679183,0.00633504639425816,-0.0430249151006643,-0.0181915332351723,1.37266544954206e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,-0.0320074093233287,0.00663820751485737,-0.0450182960524491,-0.0189965225942082,1.44241904540692e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,-0.0104621834845409,0.00217153715034275,-0.0147183962992127,-0.00620597066986913,1.47026471548906e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,41843,-0.0334210097307377,0.00693774356284952,-0.0470189871139227,-0.0198230323475526,1.47145006710333e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,42070,-0.0338222975680739,0.00703065697416584,-0.0476023852374389,-0.0200422098987088,1.5204083323393e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,-0.0206135535358515,0.00428549097215924,-0.0290131158412836,-0.0122139912304194,1.52816811266404e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,-0.027191689114612,0.00565423233171387,-0.0382739844847712,-0.0161093937444528,1.53281680426147e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,42165,-0.0270873076204921,0.00566403639561391,-0.0381888189558953,-0.0159857962850888,1.75093988489675e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,41843,-0.0287683538949127,0.00603571252820479,-0.0405983504501941,-0.0169383573396313,1.89582094555088e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,0.0143337172359393,0.00300801918682235,0.00843799962976749,0.0202294348421111,1.91081441372081e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,39575,-0.038424091084029,0.00806480475636003,-0.0542311084064947,-0.0226170737615634,1.91828614773111e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,-0.0285219413587137,0.00600293568731367,-0.0402876953058485,-0.0167561874115789,2.04167303294377e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,-0.0356850573608877,0.00751203048712517,-0.050408637115653,-0.0209614776061224,2.05557963001198e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,-0.0242395599603662,0.00510336759717011,-0.0342421604508196,-0.0142369594699128,2.05836459412213e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,-0.0240966338305515,0.00508139984641325,-0.0340561775295215,-0.0141370901315815,2.14066759879303e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,-0.0569147208938691,0.0120142608640379,-0.0804626721873833,-0.0333667696003549,2.18812900857198e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,-0.0190982931131654,0.00403221215447285,-0.0270014289359322,-0.0111951572903986,2.1972205568515e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,0.0318302373488146,0.00672803334510897,0.018643291992401,0.0450171827052282,2.26218572474884e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,39649,-0.0329055416144865,0.00695961718994628,-0.0465463913067812,-0.0192646919221918,2.29468535071164e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,42189,-0.0226202483342097,0.00480280643028019,-0.0320337489375589,-0.0132067477308605,2.50415509751622e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,0.0233064983052843,0.00495193848960548,0.0136006988656576,0.0330122977449111,2.55037082307955e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,-0.0202758221348231,0.00430907597655905,-0.0287216110488788,-0.0118300332207673,2.55966503804209e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,39638,-0.0148405997150807,0.00316676362127048,-0.0210474564127708,-0.0086337430173905,2.81430205843713e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,39958,-0.03281727562021,0.00703086513123616,-0.0465977712774329,-0.0190367799629872,3.08223008896587e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,41839,-0.0360668727548064,0.00775057892949583,-0.0512580074566182,-0.0208757380529945,3.29603741234417e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,42224,-0.0340862678183537,0.00733643392496429,-0.0484656783112837,-0.0197068573254237,3.41332356784895e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,-0.0346106209290919,0.00745182926651185,-0.0492162062914552,-0.0200050355667287,3.44669971492725e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,39934,-0.0299547348886579,0.00645919222388154,-0.0426147516474657,-0.0172947181298501,3.56530814525169e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,-0.0171907632098329,0.00371220592003432,-0.0244666868131002,-0.00991483960656562,3.67571775838518e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,-0.0188100491188217,0.00407171922811193,-0.0267906188059211,-0.0108294794317224,3.88573419984722e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,-0.0434428937853179,0.00940840210612902,-0.0618833619133308,-0.025002425657305,3.9274480243344e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,-0.0224414030332802,0.00486905581687026,-0.0319847524343459,-0.0128980536322145,4.08335472093812e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,42249,-0.0146292956808845,0.00317484023728969,-0.0208519825459723,-0.00840660881579667,4.10470284020275e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,-0.0385648825698173,0.00837671799644805,-0.0549832498428555,-0.0221465152967791,4.19447614705743e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,39934,-0.014345360584407,0.00311768318409981,-0.0204560196252426,-0.00823470154357137,4.24440855499065e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,41839,-0.0334895381012129,0.00728022637238987,-0.047758781791097,-0.0192202944113287,4.2626955187506e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,-0.0618082801494309,0.0134381308115892,-0.0881470165401457,-0.0354695437587161,4.28237992275903e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,-0.0382028414674408,0.00830830351229103,-0.0544871163515312,-0.0219185665833504,4.30200858565037e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,-0.0474742503466545,0.0103395036382648,-0.0677396774776536,-0.0272088232156554,4.44036376959609e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSPN,Persephin,42119,-0.041925946600583,0.0091332472283427,-0.0598271111681347,-0.0240247820330313,4.46221646967829e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,-0.0124341640179612,0.00271343193345012,-0.0177524906075234,-0.00711583742839895,4.63666067641425e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNC,Tenascin,42217,0.0233578603475318,0.00510411023356995,0.0133538042897347,0.0333619164053289,4.77489905577862e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0230150823432491,0.00503309007790542,-0.0328799388959438,-0.0131502257905545,4.86592095968433e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,-0.0237067539098242,0.00520031626283589,-0.0338993737849826,-0.0135141340346659,5.2021173030093e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,39649,-0.0331898598477176,0.00728980730020325,-0.047477882156116,-0.0189018375393192,5.34735867043244e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,-0.0180133034969982,0.00395651025522065,-0.0257680635972306,-0.0102585433967657,5.34821265855716e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,39726,0.0101509184302606,0.0022301474541385,0.00577982942014912,0.014522007440372,5.37834024260727e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,-0.0155732185095059,0.00344203325637313,-0.0223196036919972,-0.00882683332701452,6.11747269430047e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,-0.0508317224122424,0.0112488336421359,-0.0728794363508288,-0.0287840084736559,6.28176005934431e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,42200,-0.0178544697308205,0.00396233862325927,-0.0256206534324086,-0.0100882860292323,6.65983182796506e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,-0.0167586758359051,0.00372215941534312,-0.0240541082899776,-0.00946324338183257,6.77428019570231e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,-0.0210480962394114,0.00468365162771183,-0.0302280534297266,-0.0118681390490962,7.04937284469949e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,0.00882533524982168,0.00196482173235441,0.00497428465440704,0.0126763858452363,7.13634362051776e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,0.0111102587419215,0.00247554371690817,0.00625819305678152,0.0159623244270615,7.24835361444002e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,0.0528481971863297,0.0117769241962464,0.0297654257616867,0.0759309686109726,7.28392757720609e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,0.0132416013786995,0.00295124679001973,0.0074571576702608,0.0190260450871381,7.29112658115692e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,-0.0341374392659372,0.00761335895554124,-0.049059622818798,-0.0192152557130764,7.3911690301508e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,0.0239917731518813,0.00535085668669328,0.0135040940459624,0.0344794522578001,7.4071728871766e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,-0.0140150643793087,0.00313120287188439,-0.0201522220082021,-0.00787790675041532,7.67058207714859e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,42107,-0.019012781605851,0.00424887271937584,-0.0273405721358277,-0.0106849910758744,7.711437316063e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,-0.0324357416472451,0.00726700047836504,-0.0466790625848406,-0.0181924207096496,8.13076656066096e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.0176821112276804,0.0039614303737278,-0.0254465147601869,-0.00991770769517392,8.13968278066492e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,-0.0450036659634595,0.0100841059284897,-0.0647685135832993,-0.0252388183436196,8.16650509369511e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,-0.0589342069972795,0.0132155062828348,-0.0848365993116358,-0.0330318146829232,8.29773890693743e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,-0.0307639054768543,0.00689887311127223,-0.0442856967749479,-0.0172421141787607,8.30282055296741e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,-0.026579189897287,0.00596355500261895,-0.0382677577024202,-0.0148906220921539,8.39463980176581e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,41800,-0.0226401716648415,0.00508120118889836,-0.0325993259950823,-0.0126810173346007,8.43185676814841e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,39757,-0.013714456892623,0.00307901702175586,-0.0197493302552645,-0.00767958352998149,8.50387754183083e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,41913,-0.0160282763764371,0.00359983411152847,-0.0230839512350329,-0.00897260151784134,8.55651973598383e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,0.012897063626506,0.00290027605696867,0.0072125225548474,0.0185816046981646,8.79752589582775e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.0328123012765797,0.00738819130086189,0.0183314463268904,0.047293156226269,9.01954912505745e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,-0.0126249868859217,0.00284525191578573,-0.0182016806408617,-0.00704829313098168,9.19871746142151e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,39586,-0.0387213883820913,0.00873194373235142,-0.0558359980975,-0.0216067786666825,9.3203305166569e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,42310,-0.0411974856714086,0.00929378125307891,-0.0594132969274433,-0.022981674415374,9.37390608999786e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,-0.0392032970069425,0.00884562649350875,-0.0565407249342196,-0.0218658690796653,9.42814374346831e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,0.0111856339758464,0.00252515392880249,0.00623633227539358,0.0161349356762993,9.5111278075115e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,-0.0433529229511495,0.00978683215867458,-0.0625351139821516,-0.0241707319201473,9.52641703600855e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,-0.0171886227663213,0.00388201327711208,-0.024797368789461,-0.00957987674318162,9.61385884505198e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,39966,0.0233563515739359,0.00528196633020917,0.0130036975667259,0.0337090055811458,9.87431795144365e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,39919,-0.018785405539063,0.00425078980919503,-0.0271169535650852,-0.0104538575130407,9.99543643198968e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,-0.0136868884447461,0.00310164784169208,-0.0197661182144626,-0.00760765867502964,1.02994759339191e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,42137,-0.0567192088498512,0.0128602969509959,-0.0819253908738032,-0.0315130268258992,1.03970145856647e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,-0.0412650117215865,0.00935951777108585,-0.0596096665529148,-0.0229203568902582,1.04862623410042e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,-0.0332766690195078,0.00755068392210112,-0.048076009506826,-0.0184773285321896,1.05721761271683e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,-0.0259652746410023,0.00589551163593731,-0.0375204774474394,-0.0144100718345651,1.07151193925447e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,42119,-0.0317424355369143,0.00721982582699017,-0.045893294157815,-0.0175915769160135,1.10816794993074e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,-0.05363773733681,0.012205170742784,-0.0775598719926666,-0.0297156026809534,1.11948848086608e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,-0.0185278545236602,0.00422446372552798,-0.026807803425695,-0.0102479056216253,1.16579051179485e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,-0.0190104395616233,0.00433734604757051,-0.0275116378148615,-0.0105092413083851,1.17950847643637e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,-0.0364038283236127,0.00830960959734249,-0.052690663134404,-0.0201169935128214,1.19235119439628e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGN,Cingulin,39649,-0.0174234744047853,0.00398135309677277,-0.0252269264744599,-0.00962002233511065,1.21836159442564e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,39854,-0.020045822435641,0.00458086394814232,-0.029024315774,-0.0110673290972821,1.2197096548197e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0122627224770174,0.00280452348083514,0.00676585645458049,0.0177595884994542,1.23751694817912e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIM,Vimentin,41900,-0.0529413605349218,0.0121268190116341,-0.0767099257977247,-0.0291727952721189,1.27706720878627e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,-0.0147274637704087,0.00337957315163904,-0.0213514271476212,-0.00810350039319619,1.32577208059277e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,-0.0344906645320027,0.00791688094682489,-0.0500077511877795,-0.0189735778762259,1.33280352972219e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,39733,-0.0177886587505484,0.00409105885161362,-0.0258071340997111,-0.00977018340138571,1.3849251215464e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,41714,-0.0121014964848711,0.00278969254856237,-0.0175692938800533,-0.00663369908968884,1.4490486162245e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,42210,-0.0192989233365059,0.004463390501368,-0.0280471687191872,-0.0105506779538247,1.54437129473623e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,-0.0116509408740871,0.00269572658442062,-0.0169345649795515,-0.00636731676862265,1.55932469115586e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0225753730348157,0.00522561474352838,0.0123331681375001,0.0328175779321313,1.57286945749768e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTG,Protogenin,42262,-0.0112020532313243,0.00259679882614344,-0.0162917789305654,-0.00611232753208314,1.61604128564919e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,42070,-0.037572431347385,0.00872641472533379,-0.0546762042090392,-0.0204686584857307,1.67713219801726e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,-0.0263985942010962,0.0061361174700561,-0.0384253844424062,-0.0143718039597863,1.70349751280153e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,-0.0261762874408715,0.00609204913745103,-0.0381167037502755,-0.0142358711314675,1.74769875119728e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,42016,0.0055111036160455,0.00128513526714987,0.00299223849243177,0.00802996873965924,1.81267937213536e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,42264,-0.00933571449746515,0.00217747775154246,-0.0136035708904884,-0.00506785810444192,1.82018000064531e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,0.027672210114409,0.00646413211291691,0.0150025111730919,0.0403419090557261,1.87674776659514e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,-0.02355880343938,0.00550590790097137,-0.0343503829252839,-0.0127672239534761,1.89161875767422e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,-0.0385339417201435,0.00901278569944788,-0.0561990016910613,-0.0208688817492256,1.92065769498848e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,-0.0182076268649518,0.00425928315650903,-0.0265558218517095,-0.00985943187819406,1.92621857100994e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,39575,-0.0255645104517601,0.00598105725372963,-0.0372873826690702,-0.01384163823445,1.93404908462626e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,-0.019905198148896,0.00465954674328535,-0.0290379097657353,-0.0107724865320567,1.95381533155579e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,-0.0220058501340522,0.00515198312557892,-0.0321037370601869,-0.0119079632079176,1.95892434722607e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,-0.0209678911222913,0.0049104931246562,-0.0305924576466174,-0.0113433245979651,1.97102265236857e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,39919,-0.0319677048256691,0.00749430379871295,-0.0466565402711465,-0.0172788693801917,2.00985267902514e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,-0.0261032979109522,0.00612232525512894,-0.0381030554110049,-0.0141035404108995,2.02810406394712e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFP,Properdin,39979,-0.0106947612588227,0.00251361533631296,-0.0156214473179961,-0.00576807519964935,2.10974125712715e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,0.0147154948157504,0.0034593358700948,0.00793519651036462,0.0214957931211362,2.11529986453468e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,0.02044592229529,0.00481785158963204,0.0110029331796112,0.0298889114109688,2.21280436804748e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,-0.0341658821097886,0.00805176047422961,-0.0499473326392786,-0.0183844315802985,2.21774105360132e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0157695860644922,0.00372775486653186,-0.0230759856028946,-0.00846318652608975,2.34887238863814e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,-0.0101965629211285,0.00241292831135553,-0.0149259024113853,-0.00546722343087167,2.39629004854989e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,-0.027190953646446,0.00643628479873458,-0.0398060718519658,-0.0145758354409262,2.40922793393719e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.0128241232347824,0.0030454361026109,-0.0187931779958998,-0.00685506847366501,2.55978580921059e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.0325458903749404,0.00773973691856677,-0.0477157747353313,-0.0173760060145496,2.62718488672285e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,-0.0237355667584483,0.00564592755587686,-0.034801584767967,-0.0126695487489297,2.6391390611249e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,-0.0320791702812754,0.00763432394484515,-0.0470424452131719,-0.0171158953493789,2.66636854323571e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,41992,0.0145906827041545,0.00348174077567657,0.00776647078382844,0.0214148946244806,2.79967205715227e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,42310,0.0117982108300776,0.00282029189295205,0.00627043871989154,0.0173259829402636,2.89058438203662e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,39930,-0.0194447644854546,0.00465613550394519,-0.0285707900731872,-0.0103187388977221,2.9869154391448e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,-0.0124872063983586,0.0029948032284427,-0.0183570207261063,-0.00661739207061092,3.0703282666335e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,42287,-0.0258815140895843,0.00620937384009284,-0.0380518868161662,-0.0137111413630023,3.08989233583239e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,-0.0173641023402817,0.00417913152784106,-0.0255552001348501,-0.0091730045457132,3.27801828294364e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,39575,0.0153004002768469,0.0036840805038498,0.00807960248930128,0.0225211980643925,3.3046579269971e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,-0.0124204540168052,0.00300270693477549,-0.0183057596089651,-0.0065351484246452,3.54880720728766e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,-0.0205475707879393,0.00497482936876632,-0.0302982363507213,-0.0107969052251573,3.64503699369519e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.0131874916446386,0.00319707908824064,-0.0194537666575902,-0.00692121663168692,3.73614946522179e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,-0.0423227409042064,0.0102693809014424,-0.0624507274710336,-0.0221947543373792,3.79495822197968e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,-0.0070148507493326,0.00170384849878066,-0.0103543938069427,-0.0036753076917225,3.85979699549022e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.0378096248214589,0.00919139162853826,-0.0558247524133939,-0.0197944972295239,3.92403665391712e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,-0.0126698033213772,0.00308125837986455,-0.0187090697459117,-0.00663053689684265,3.94804820637659e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,42070,-0.0412014441568257,0.0100309218449405,-0.0608620509729091,-0.0215408373407424,4.02426713651068e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,42145,-0.0168845749556009,0.00411774951181118,-0.0249553639987508,-0.008813785912451,4.14777142423797e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,-0.0414002534139928,0.0101218266179001,-0.0612390335850769,-0.0215614732429087,4.33499744331892e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F3,Tissue factor,42174,0.0113042736456547,0.00276471189733693,0.00588543832687436,0.0167231089644351,4.36164045232191e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,-0.0321390004925615,0.00787173599331503,-0.047567603039459,-0.0167103979456641,4.47479384632556e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBN1,Drebrin,39657,-0.0220885085440428,0.00543376134466563,-0.0327386807795874,-0.0114383363084981,4.83547537614263e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,39575,0.013438698458637,0.0033121931196612,0.006946799944101,0.0199305969731729,4.99782095839049e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.0247563285472277,0.00610797322985237,-0.0367279560777383,-0.012784701016717,5.08213885751458e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,-0.0253792762177105,0.00627412861755344,-0.0376765683081152,-0.0130819841273057,5.26636466812236e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,41913,-0.0205835834370778,0.00508891995534208,-0.0305578665495482,-0.0106093003246073,5.26666777677084e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,-0.0353571338141856,0.00874513822851911,-0.052497604742083,-0.0182166628862881,5.30502363759043e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,-0.0123619333544749,0.00306127842977174,-0.0183620390768275,-0.00636182763212231,5.41678851513065e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,39990,-0.0314182880970726,0.00779160617148554,-0.0466898361931842,-0.0161467400009609,5.55876738964785e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRNN,Cornulin,41749,0.0286949199514731,0.007119103733974,0.014741476632884,0.0426483632700621,5.5926069227723e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,-0.0145716735814265,0.00361580151275675,-0.0216586445464297,-0.00748470261642325,5.60812743511238e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,0.0254028894752922,0.00630765907941389,0.0130398776796409,0.0377659012709434,5.6786900410215e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.0116971514988479,0.00291212470197847,-0.0174049159147257,-0.00598938708297015,5.93415037691371e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,-0.0141946325134289,0.00353450719435943,-0.0211222666143733,-0.00726699841248437,5.95105152608266e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.0112671957196245,0.00280959347163767,-0.0167739989240344,-0.00576039251521469,6.10394730527395e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,-0.0159245474155121,0.00397428641185627,-0.0237141487827504,-0.00813494604827382,6.19156298413012e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,-0.0459781381821813,0.0114940657758653,-0.0685065071028772,-0.0234497692614853,6.37015241813288e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,-0.0133876818430324,0.00335076518376531,-0.0199551816032124,-0.00682018208285234,6.49239613190134e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,39575,-0.016531893419466,0.00413951806810598,-0.0246453488329538,-0.00841843800597832,6.54810394223023e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,-0.019932324952351,0.00499441519574527,-0.0297213787360117,-0.0101432711686902,6.62312331725315e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCT,Secretin,39649,-0.0204427096450877,0.00512267207740963,-0.0304831469168106,-0.0104022723733649,6.63225073792039e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,39958,-0.0305397633483068,0.007656304551506,-0.0455461202692585,-0.015533406427355,6.68140158168093e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,-0.015867192220359,0.00398320287827203,-0.0236742698617722,-0.00806011457894579,6.83254266605793e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,-0.0116056354434219,0.00291389890954565,-0.0173168773061314,-0.00589439358071242,6.85181818546313e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,-0.0352045747759205,0.00884302135987325,-0.0525368966412721,-0.017872252910569,6.89656886310265e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFB,Complement factor B,39794,-0.013804387795739,0.00347790184582195,-0.0206210754135501,-0.00698770017792799,7.25735302031129e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,39649,-0.0208092964958445,0.00524809609707075,-0.0310955648461032,-0.0105230281455858,7.38234793198731e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,-0.0247621186136175,0.00626856350781962,-0.037048503088944,-0.0124757341382911,7.85723927232313e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,0.0160556445647487,0.00406502815509119,0.00808818938076995,0.0240230997487274,7.86511941469348e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,42137,-0.0371671282932128,0.00941939475336463,-0.0556291420098074,-0.0187051145766181,7.99326744222767e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,39930,-0.0128784599347597,0.0032908033456149,-0.0193284344921649,-0.00642848537735448,9.15113780022271e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,-0.0417119162159324,0.0106660970163371,-0.0626174663679531,-0.0208063660639118,9.25652920861567e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.00898573469263092,0.00229837676097926,0.00448091624111157,0.0134905531441503,9.30019267071452e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,39721,-0.0239853915618929,0.00617355488775888,-0.0360855591419003,-0.0118852239818855,0.000102845609498897
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,39897,-0.0382347551832086,0.00984897223560133,-0.0575387407649872,-0.01893076960143,0.000104144933093249
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,-0.0229545838779043,0.00591782936640136,-0.0345535294360509,-0.0113556383197576,0.000105529588444303
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,-0.0236800734356554,0.00610791129240207,-0.0356515795687635,-0.0117085673025473,0.000106284319220795
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,-0.0153865018010285,0.00397642274352806,-0.0231802903783435,-0.00759271322371354,0.000109602752232203
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,-0.0348186730957792,0.00900029272323437,-0.0524592468333186,-0.0171780993582399,0.000109970387804148
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,-0.0401080283449599,0.0103901428589556,-0.060472708348513,-0.0197433483414069,0.000113943885611287
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,-0.0118906480322399,0.00308216779167835,-0.0179316969039294,-0.0058495991605503,0.000115006918131828
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,-0.0229467719067818,0.00595600871813743,-0.0346205489943312,-0.0112729948192324,0.000117477851639091
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,0.00984014120370925,0.00255818869704801,0.00482609135749515,0.0148541910499233,0.000120356081373492
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,-0.0357160311526813,0.00930816109504262,-0.0539600268989648,-0.0174720354063977,0.000125200629662192
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,39586,-0.0432980322922679,0.0112938754483919,-0.065434028171116,-0.0211620364134198,0.000126902478182325
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.0233987872706239,0.0061151650290945,-0.0353845107276491,-0.0114130638135987,0.000130640034226876
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,41780,-0.0122634078312243,0.00321384104818271,-0.0185625362856624,-0.00596427937678621,0.000136356902587364
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,-0.00798120801786991,0.00210714001481832,-0.0121112024469138,-0.003851213588826,0.000152711097146253
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,-0.031151515174959,0.00824116915694428,-0.0473042067225698,-0.0149988236273482,0.000157510471445813
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,-0.0343497975445816,0.00908704474440221,-0.0521604052436099,-0.0165391898455532,0.000157599384302429
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,-0.0445048214243048,0.0117821497835813,-0.0675978350001242,-0.0214118078484855,0.000159225953233752
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,-0.0293718780663993,0.00777612521655503,-0.0446130834908472,-0.0141306726419515,0.000159303994180524
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,42070,-0.0532893704271415,0.0141416906217783,-0.0810070840458271,-0.0255716568084559,0.000165099548551124
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,42016,0.0166507288862829,0.00441875088955911,0.00798997714274703,0.0253114806298187,0.000165134051914181
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.010301494835182,0.00273574520390553,0.00493943423552714,0.0156635554348368,0.000167045018639503
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,-0.0125905359613911,0.0033464921245225,-0.0191496605254552,-0.00603141139732696,0.000169200437182107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,0.0117761588990871,0.0031374549818713,0.00562674713461934,0.0179255706635548,0.000175171119338841
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,-0.0192860833314359,0.00513924866329349,-0.0293590107114912,-0.0092131559513807,0.000175680554113813
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,-0.0291924174770108,0.00778273270932531,-0.0444465735872884,-0.0139382613667332,0.000176912127676529
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,-0.0294382241307121,0.00785258819430552,-0.0448292969915509,-0.0140471512698733,0.000178398488591543
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,39966,-0.0334987960994267,0.00894266455869977,-0.0510264186344782,-0.0159711735643751,0.000180598890673459
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,-0.0480405421730363,0.0128499766622873,-0.0732264964311193,-0.0228545879149533,0.000185832848856159
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,39919,-0.0207509735929745,0.005550332987162,-0.0316296262478121,-0.00987232093813701,0.000185893193409369
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,39925,-0.0190120226056265,0.0050956036488482,-0.0289994057573689,-0.00902463945388399,0.000191604652974246
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,0.0084326592048223,0.00226202507746516,0.00399909005299058,0.012866228356654,0.000194019479686491
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,-0.0134164356952931,0.0035993791440613,-0.0204712188176532,-0.00636165257293292,0.000194243648133364
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,-0.0255747663269722,0.00686562796563796,-0.0390313971396226,-0.0121181355143218,0.000196252686846774
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,-0.0144410297972632,0.00387703242618144,-0.0220400133525788,-0.00684204624194757,0.000196293252360003
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,-0.0249907497384529,0.00672476069733146,-0.0381712807052226,-0.0118102187716833,0.000203206601312494
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELL,L-selectin,39979,0.0091852056208763,0.00247274151188272,0.00433863225758618,0.0140317789841664,0.000204511952907942
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,42119,-0.0217137411864719,0.00584994080123652,-0.0331796251568955,-0.0102478572160484,0.000206626174410089
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,39960,-0.0147478296619734,0.00397514564578873,-0.0225391151277194,-0.00695654419622753,0.000208239536673394
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,41843,-0.0313446625456204,0.00844965322810931,-0.0479059828727146,-0.0147833422185261,0.000208452282176943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,-0.0112325425707828,0.00303360990365051,-0.0171784179819378,-0.00528666715962781,0.000214328390209803
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,-0.0377438722810019,0.0101965074322364,-0.0577290268481852,-0.0177587177138187,0.000215237721390962
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,-0.0225272279198687,0.00611051723790299,-0.0345038417061586,-0.0105506141335789,0.000228319212358628
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,-0.0340773526432272,0.00924559314966585,-0.0521987152165722,-0.0159559900698821,0.000228880123072277
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,-0.0304763807083365,0.00827831960944329,-0.0467018871428454,-0.0142508742738277,0.000232970685276964
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,-0.0158539728561089,0.00431483709861488,-0.0243110535693941,-0.00739689214282376,0.000239636473663432
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0573273436193475,0.015615858341065,-0.0879344259678349,-0.0267202612708601,0.000242658345436571
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,-0.0154255131076357,0.00421380145616066,-0.0236845639617106,-0.00716646225356084,0.000252494011236967
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,0.0149305246256368,0.00407991367707996,0.00693389381856004,0.0229271554327135,0.000253638957469451
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,-0.0196949017435572,0.00539450863773783,-0.0302681386735233,-0.00912166481359103,0.000262520390426247
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,-0.0372267854407234,0.0102345900529626,-0.0572865819445302,-0.0171669889369167,0.000276712786885616
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,-0.0338641886210912,0.00932488021738057,-0.0521409538471571,-0.0155874233950253,0.000282711321793563
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,-0.0254556882630176,0.0070478785728732,-0.039269530265849,-0.0116418462601861,0.000305178738208416
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPTC,Opticin,42070,0.0172473549669534,0.0047991983584883,0.00784092618431637,0.0266537837495905,0.000327053945369755
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,-0.0454672929139553,0.0127282212904941,-0.0704146066433238,-0.0205199791845868,0.000355268269987538
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFD,Complement factor D,39979,-0.00766902055300775,0.0021495569175931,-0.0118821521114902,-0.00345588899452528,0.000361579278501904
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,42016,0.0125781479409834,0.00352652205354377,0.00566616471603765,0.0194901311659292,0.000362723989833399
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.0224582469694495,0.00629663690154515,-0.0347996552964779,-0.010116838642421,0.000363037199338504
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,41668,-0.0138088852791911,0.00387320427926267,-0.0214003656665459,-0.00621740489183622,0.000364827403512006
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,-0.0146907292867908,0.00412207525442678,-0.0227699967854672,-0.00661146178811429,0.000366905492325761
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,-0.0278420609310553,0.00782101156145285,-0.0431712435915029,-0.0125128782706077,0.000372547986253476
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,-0.0102061942964262,0.00286820646901708,-0.0158278789756997,-0.00458450961715276,0.000374657230728793
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,-0.0160153143939923,0.00450144740247265,-0.0248381513028386,-0.00719247748514586,0.000375253561293163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,0.014063219716313,0.00395415075276259,0.00631308424089834,0.0218133551917277,0.000377309254040976
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,-0.0220530088113722,0.00622479168504706,-0.0342536005140645,-0.00985241710868001,0.000397281042353988
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TF,Serotransferrin,39979,-0.00805879953456107,0.00227578541646582,-0.0125193389508341,-0.00359826011828806,0.000400044872547822
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,39649,-0.0264594832832728,0.0074738379789273,-0.0411082057219703,-0.0118107608445752,0.000401346054146847
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,39657,-0.0462965124174299,0.0130874523578432,-0.0719479190388027,-0.0206451057960572,0.00040563075692283
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,41839,-0.0246373441828942,0.00697853915501324,-0.0383152809267202,-0.0109594074390683,0.00041627146110261
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,42070,-0.0107265595502815,0.00304095435651876,-0.0166868300890582,-0.00476628901150471,0.000421112508545292
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,-0.0180655891071761,0.00512503882548814,-0.0281106652051328,-0.00802051300921932,0.000425209942655158
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,-0.0276831682914309,0.00785422761282647,-0.0430774544125707,-0.012288882170291,0.000425521811088912
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_A,,39934,-0.0123226248727063,0.00349683404805533,-0.0191764196068947,-0.00546883013851783,0.000426860134188541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,39990,-0.0346084687754272,0.00983900844464615,-0.0538929253269336,-0.0153240122239207,0.000437369882348201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,-0.0167664115124495,0.00476801374520856,-0.0261117184530583,-0.00742110457184071,0.000439095747024767
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,-0.0406842570381743,0.0115834479612355,-0.0633878150421958,-0.0179806990341527,0.000445738605688119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FN1,Fibronectin,39979,-0.0101619024030189,0.0028938504812506,-0.0158338493462701,-0.00448995545976775,0.000447226609988115
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,39736,0.0362464653884754,0.0103233158039964,0.0160127664126426,0.0564801643643083,0.00044797808341965
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,39699,-0.0165950255458557,0.00472937900432789,-0.0258646083943383,-0.00732544269737301,0.000451707730844925
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,42015,-0.0187342985103184,0.00534411528880451,-0.0292087644763752,-0.00825983254426153,0.000457077020110089
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,-0.0221849671668895,0.00635837744044854,-0.0346473869501686,-0.00972254738361036,0.000486186494794773
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,0.0210879752436343,0.00604593972870679,0.009237933375369,0.0329380171118996,0.000488290766686799
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,0.00985447359804913,0.00282557380548504,0.00431634893929846,0.0153925982567998,0.000489215637711872
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,42249,-0.00829381601539982,0.0023898668158666,-0.0129779549744984,-0.00360967705630128,0.000521271729577035
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,-0.0322410462767735,0.00929065948184934,-0.0504507388611982,-0.0140313536923488,0.000521911746070873
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,-0.0342235967095767,0.00991573777812096,-0.0536584427546938,-0.0147887506644597,0.00055930972324275
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,-0.0223643064727575,0.00650353394074204,-0.0351112329966119,-0.00961737994890316,0.000586472420063521
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0431640223093267,0.0125623505694704,-0.0677862294254886,-0.0185418151931647,0.000592525576269051
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,-0.0466441957038992,0.0136205105810096,-0.0733403964426781,-0.0199479949651203,0.000617987126945993
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,42016,-0.01184252369463,0.0034642438914497,-0.0186324417218714,-0.00505260566738858,0.000631540778970844
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,-0.0431012255339494,0.0126162155424029,-0.0678290079970591,-0.0183734430708397,0.000636561138375872
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,42137,0.0101374787737415,0.00296948799965864,0.00431728229441053,0.0159576752530724,0.000642322435904279
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,39979,0.00817944483314904,0.00240100750428893,0.00347347012474275,0.0128854195415553,0.000659876551946997
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,39930,-0.0226195329389054,0.00664044098803213,-0.0356347972754483,-0.00960426860236241,0.000660712753615849
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,0.0112961805777739,0.00331973516193586,0.00478949966037963,0.0178028614951682,0.000669534823841354
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,39638,-0.0112513637863843,0.00331227684686747,-0.0177434264062446,-0.00475930116652411,0.000684026416776148
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,-0.0119723471173464,0.00352528350833138,-0.0188819027936759,-0.00506279144101686,0.000685408032395496
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,-0.0194899466701067,0.00574237814148453,-0.0307450078274164,-0.00823488551279705,0.000691021450577462
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,-0.0137324087335675,0.00405249250358279,-0.0216752940405897,-0.00578952342654518,0.000704872586057621
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,39586,-0.0155453962052024,0.00458892954222897,-0.0245396981079712,-0.00655109430243367,0.000707579347261035
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.012143702619545,0.00358627157541373,-0.0191727949073559,-0.00511461033173407,0.000711242975782557
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,-0.0146232840386044,0.00433334337045333,-0.0231166370446929,-0.00612993103251584,0.000741782128852327
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRTN,Neurturin,41913,-0.0176468790274659,0.00523461633102252,-0.0279067270362701,-0.0073870310186618,0.00075057454716152
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,-0.0203891186861932,0.00605458215797363,-0.0322560997158215,-0.0085221376565649,0.000760918386747232
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,-0.0156791023183484,0.00467284331601981,-0.0248378752177472,-0.00652032941894955,0.000795204533745283
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,39575,-0.0398827259027502,0.0119182486306731,-0.0632424932188694,-0.016522958586631,0.000821555050222395
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,0.0397535740465059,0.0118944617182908,0.016440429078656,0.0630667190143558,0.000833467376430608
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,-0.0170198144139078,0.00511058362735354,-0.0270365583235207,-0.00700307050429488,0.000869876148627334
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.0275260741659949,0.00828907964726321,-0.0437726702746308,-0.011279478057359,0.000900142357502616
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,-0.0175779933918135,0.00530024409731312,-0.0279664718225472,-0.00718951496107976,0.000914142657046677
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,-0.0314523615217277,0.00949872237080595,-0.0500698573685074,-0.012834865674948,0.000931856032236915
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,-0.0293539537791976,0.00886892908314481,-0.0467370547821615,-0.0119708527762338,0.000936270381304929
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.0141787642225147,0.00429027994107941,-0.0225877129070303,-0.00576981553799901,0.000953242742260889
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,-0.0167055487665106,0.00505745071405778,-0.0266181521660639,-0.00679294536695739,0.000958984965046701
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,-0.0226838104987484,0.00687675918964278,-0.0361622585104482,-0.00920536248704852,0.000974164887294538
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,0.0111656394568966,0.00338771167903994,0.00452572456597828,0.0178055543478148,0.000983477741592732
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,42119,-0.0110993316964081,0.00336796601194115,-0.0177005450798128,-0.00449811831300349,0.000984788645780273
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,39657,-0.0223786657254254,0.00680003676326196,-0.0357067377814189,-0.00905059366943198,0.00100157968477351
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,-0.0417486294378896,0.0126894356190272,-0.0666199232511829,-0.0168773356245964,0.00100432861130033
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,-0.0188764763959906,0.00574307391657247,-0.0301329012724726,-0.00762005151950854,0.00101640055423587
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,-0.0139608397285822,0.00425102319752724,-0.0222928451957356,-0.00562883426142882,0.00102622165632862
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.00764166772465338,0.00233604028820122,0.003063028759779,0.0122203066895278,0.00107409184423197
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,-0.0298139254684171,0.00911588387246467,-0.0476810578584478,-0.0119467930783863,0.00107668540919321
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",42262,-0.0251183500176618,0.00768388718214793,-0.0401787688946717,-0.0100579311406519,0.00108208933222676
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.051772427120648,0.0158562658946453,-0.0828507082741529,-0.0206941459671432,0.00109694391629137
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,-0.0191740495305115,0.00587380824657275,-0.030686713693794,-0.00766138536722887,0.00110059200078529
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,-0.0193972200066932,0.00595225941535049,-0.0310636484607802,-0.00773079155260626,0.00112214522083622
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,-0.0321440651900482,0.00987317620436352,-0.0514954905506007,-0.0127926398294957,0.00113446713023155
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,-0.00953562786612537,0.00293643903371593,-0.0152910483722086,-0.00378020736004214,0.0011677748018216
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,42310,0.0104088612080907,0.00320870686098227,0.00411979576056547,0.016697926655616,0.00118169761259513
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,42145,0.0162130761585769,0.00500925036980186,0.0063949454337653,0.0260312068833886,0.00121242030924807
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,0.0152352294025842,0.0047151547101066,0.00599352617077528,0.0244769326343932,0.00123600359862603
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,-0.0116514136861309,0.0036089790143008,-0.0187250125541605,-0.00457781481810136,0.00124759439602731
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0264173999543352,0.00819549100161969,-0.0424805623175098,-0.0103542375911606,0.00127033319737154
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,-0.0157022181299778,0.0048742419020003,-0.0252557322578984,-0.00614870400205722,0.0012789547255559
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.0318391820978962,0.00988741931952978,-0.0512185239641746,-0.0124598402316179,0.00128416759084922
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,41960,-0.0137043236810947,0.00426858380232528,-0.0220707479336522,-0.00533789942853716,0.00132813841140223
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,-0.0106860033815721,0.00334653462885083,-0.0172452112541197,-0.00412679550902449,0.00141122399836564
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,39934,-0.0235438105026792,0.00738025903573076,-0.0380091182127115,-0.00907850279264693,0.00142607840739465
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,-0.0198912385730741,0.00623966186855136,-0.0321209758354348,-0.00766150131071346,0.00143723454375648
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,39657,-0.00581081682341094,0.00182480588586505,-0.00938743635970643,-0.00223419728711545,0.00145482877120063
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,-0.0242122587250017,0.00765837333628094,-0.0392226704641124,-0.00920184698589107,0.00157284787743245
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,-0.00927532411176866,0.00293613903770709,-0.0150301566256746,-0.00352049159786276,0.00158652220189648
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,42262,-0.0105956960562933,0.00335552164054871,-0.0171725184717688,-0.00401887364081783,0.00159370740898676
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.0334632573686122,0.0106180033277989,-0.0542745438910981,-0.0126519708461263,0.00162838479345181
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,39934,-0.0101039470405743,0.00321648798528664,-0.0164082634917361,-0.00379963058941253,0.00168633653382295
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,-0.0235138852634197,0.00748604078320401,-0.0381865251984996,-0.00884124532833988,0.00168801535827692
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,41913,-0.0160157020331883,0.00510029371791825,-0.026012277720308,-0.00601912634606849,0.00169229073211076
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,-0.025030768913204,0.00797299427879421,-0.0406578376996406,-0.00940370012676731,0.00169711128991366
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.0140109908198764,0.00446814778182407,0.00525342116750118,0.0227685604722515,0.00171853960405105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,-0.0279457251787195,0.00891920738205729,-0.0454273716475518,-0.0104640787098872,0.00173346797525406
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,-0.011793525922134,0.00376903654984739,-0.0191808375598349,-0.00440621428443315,0.00175820855679826
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,-0.0491809403017385,0.0157239314208355,-0.0799998458865761,-0.0183620347169009,0.00176516042055022
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,-0.0174132485087998,0.00558592797566362,-0.0283616673411005,-0.00646482967649914,0.00182945257408466
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0169918789224098,0.00546124965140648,0.00628782960565306,0.0276959282391665,0.00186693107521001
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,39575,-0.0198433698243722,0.00638580262625221,-0.0323595429718266,-0.0073271966769179,0.00189210097224808
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,-0.0215756608962808,0.00694524034671508,-0.0351883319758424,-0.00796298981671929,0.00189759446600593
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,0.0234905746069216,0.00756494390623315,0.00866328455070464,0.0383178646631386,0.00190627154634841
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,-0.0187458080477903,0.00604725983357202,-0.0305984373215914,-0.00689317877398909,0.00194086665141067
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,-0.011850563788266,0.00383602062672155,-0.0193691642166402,-0.00433196335989173,0.00201123944571741
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,39649,-0.0299122339706043,0.0097109836917363,-0.0489457620064074,-0.0108787059348011,0.00207336574982808
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,-0.00720178433884615,0.00234076748380034,-0.0117896886070948,-0.00261388007059747,0.00209833883499297
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,41900,0.0126204613389087,0.00411741214870112,0.00455033352745454,0.0206905891503629,0.0021800112090955
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,-0.0107338487305355,0.00350559562605559,-0.0176048161576045,-0.00386288130346654,0.00220455211656492
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,-0.0118259911229534,0.00386523308819125,-0.0194018479758082,-0.00425013427009854,0.00222178063575787
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,42124,0.0186056903981358,0.00609022451462482,0.00666885034947116,0.0305425304468004,0.00225491928204638
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,39970,-0.0114788350658734,0.00377757280793373,-0.0188828777694235,-0.00407479236232329,0.00238156655999334
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.03522688514834,0.0116036586381418,0.012483714217582,0.057970056079098,0.00240318679141683
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,0.0143039751069397,0.00471314569764261,0.00506620953956015,0.0235417406743192,0.00241064507783117
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,41913,-0.0194119817322,0.00640710651461531,-0.031969910500846,-0.00685405296355399,0.00245219362492785
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,39736,-0.0168358471376184,0.00555919778264883,-0.0277318747916102,-0.00593981948362674,0.00246360817906463
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,-0.0328120031184388,0.0108403375009107,-0.0540590646202238,-0.0115649416166538,0.00247691869377278
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.0322752244815053,0.0106774371948985,-0.0532030013835063,-0.0113474475795043,0.00251049480887586
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,42070,0.00483073860008378,0.00160066144872313,0.00169344216058645,0.00796803503958112,0.00254954826874988
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,42296,-0.0251924950285746,0.00837914093662765,-0.0416156112643647,-0.00876937879278438,0.00264690058909707
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,39990,-0.00696591776171844,0.00231853361863503,-0.0115102436542431,-0.00242159186919378,0.00266640335378529
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0151262499306524,0.00503795473581448,-0.0250006412128488,-0.00525185864845607,0.00268292499785152
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,39990,0.00770356924955498,0.00257057949469749,0.0026652334399479,0.0127419050591621,0.00273397760002329
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,-0.0240639507969207,0.00803490439718928,-0.0398123634154117,-0.0083155381784297,0.00275122521619063
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,-0.0221096399708441,0.00738611226536823,-0.0365864200109659,-0.00763285993072237,0.00276495971888462
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,0.010761143811562,0.00359778606757539,0.00370948311911425,0.0178128045040098,0.00278637400365707
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,-0.0135647483515646,0.00453886775932861,-0.0224609291598486,-0.00466856754328049,0.00280790744031662
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,39649,-0.0190213072989871,0.00639351903791241,-0.0315526046132954,-0.00649000998467875,0.00293534251784919
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEO1,Neogenin,39934,-0.00714768429575754,0.00240736599689312,-0.0118661216496681,-0.00242924694184703,0.00299309102650513
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.01074999772242,0.00362082652881046,-0.0178468177188885,-0.00365317772595148,0.00299360207950726
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,-0.0113012989965925,0.00381510113971622,-0.0187788972304363,-0.00382370076274873,0.0030593525352558
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.0143177327575132,0.00483360330280662,0.00484387028401223,0.0237915952310142,0.00306053732059227
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,39934,-0.0115312326595962,0.00389662509261371,-0.0191686178411191,-0.00389384747807332,0.00308989298168187
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,0.0125087916911257,0.00424571759009508,0.00418718521453938,0.0208303981677121,0.00322362174230512
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,-0.0309219268554633,0.0104985567669319,-0.0514990981186499,-0.0103447555922767,0.00323138982895869
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,-0.0180963568414679,0.00614423116193111,-0.0301390499188528,-0.00605366376408291,0.00323247126784537
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,39966,0.0357563043928008,0.0121611201239827,0.0119205089497946,0.0595920998358069,0.00328645513770831
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,0.00540458177379383,0.00184082546936388,0.00179656385384062,0.00901259969374703,0.00333082846189984
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,-0.00976253320641049,0.00332659696831952,-0.0162826632643167,-0.00324240314850423,0.00334451071255232
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,-0.0218735670636839,0.0074755174788815,-0.0365255813222917,-0.00722155280507618,0.00344003751580351
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,-0.00568729969721117,0.00194940765347822,-0.00950813869802847,-0.00186646069639386,0.00353596257486576
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,41976,-0.0171605748934717,0.005897857925084,-0.0287203764266363,-0.00560077336030701,0.00362454905208274
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,-0.032879809919144,0.0113183872816785,-0.0550638489912338,-0.0106957708470542,0.00367991831415974
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,39575,0.012201628597817,0.0042002553224654,0.00396912816578481,0.0204341290298492,0.00368017998107969
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,-0.0112142024132394,0.00386797446790723,-0.0187954323703376,-0.00363297245614123,0.00374799465469054
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,-0.0271631720494603,0.00939564065644073,-0.0455786277360841,-0.00874771636283646,0.00384590958572212
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,-0.0225557374726101,0.00780518243395438,-0.0378538950431606,-0.00725757990205949,0.0038616408036954
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,-0.0116185064241349,0.00402046978275924,-0.019498627198343,-0.00373838564992678,0.00386196499375401
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,39757,-0.0122936267640434,0.00426379214919644,-0.0206506593764684,-0.0039365941516184,0.0039433305416943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,42119,0.0134543234452949,0.00467254808784521,0.00429612919311825,0.0226125176974715,0.00399006953245242
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,0.00635509340018083,0.00221545413991749,0.00201280328594256,0.0106973835144191,0.0041317248065484
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,-0.00820069900308656,0.00286033628002003,-0.0138069581119258,-0.0025944398942473,0.00414961723175661
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,39822,0.00956959048977155,0.00333858704696888,0.00302595987771255,0.0161132211018306,0.00415994829845732
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,39575,0.01273448483079,0.00444305582672501,0.00402609541040901,0.021442874251171,0.00416281322151389
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,-0.0172254263365537,0.00602404327913458,-0.0290325511636575,-0.00541830150944991,0.00425041225083152
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.00612407033366368,0.00215472496014133,-0.0103473312555407,-0.00190080941178668,0.00448759386430471
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,-0.0287907536373039,0.0101317852390576,-0.0486490527058568,-0.00893245456875105,0.00449668232361157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.0110817334962512,0.00391091015743932,-0.0187471174048322,-0.00341634958767009,0.00461042876460082
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,-0.0128083816118492,0.00452864971246037,-0.0216845350482716,-0.00393222817542693,0.00468806747745464
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,-0.0243366484886881,0.0086159370991433,-0.041223885203009,-0.00744941177436726,0.00474232328514424
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,39713,0.00869453097087943,0.00308254942761699,0.00265273409275012,0.0147363278490087,0.00480241067951215
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,42158,-0.00920431538174742,0.00326556204656247,-0.0156048169930099,-0.00280381377048497,0.00483033540983918
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,39958,-0.0159876118783282,0.00567382338660522,-0.0271083057160744,-0.00486691804058197,0.00484397811558092
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,-0.0144382486457726,0.00512931429091508,-0.0244917046559662,-0.00438479263557906,0.00488842486425307
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.012231542016844,0.004347636156413,0.00371017515027453,0.0207529088834135,0.0049108553223262
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,-0.0283467876538873,0.0100787087973167,-0.048101056896628,-0.00859251841114667,0.00492224682623157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,42119,-0.0184478151877586,0.00656050631287329,-0.0313064075609903,-0.005589222814527,0.00493131000381499
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,-0.0186501691740635,0.00664169355667353,-0.0316678885451437,-0.00563244980298343,0.00499287098908581
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,0.00951323989698443,0.00339132958454257,0.00286623391128098,0.0161602458826879,0.00503621572878818
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,-0.0187423709585432,0.00669299466854972,-0.0318606405089007,-0.0056241014081858,0.00511418308740301
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,39638,-0.0218191429196176,0.00781148966405862,-0.0371296626611725,-0.00650862317806268,0.00522774349361686
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIT,Vitrin,39958,-0.0113962940072875,0.00408790661382106,-0.0194085909703768,-0.0033839970441982,0.00531543736360727
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,-0.0190163485516333,0.00683049911885945,-0.0324041268245979,-0.00562857027866884,0.00537759763196692
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.020156185218411,0.00724413391997687,-0.0343546877015657,-0.00595768273525635,0.00540302725746303
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,42145,-0.0197749026690817,0.00711665826175429,-0.0337235528621201,-0.00582625247604326,0.00546557482521766
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,0.0118210422999486,0.004266431724704,0.00345883611952876,0.0201832484803684,0.00560252565193015
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,41839,-0.0113653364480136,0.00410411926805297,-0.0194094102133974,-0.00332126268262974,0.00562635353355876
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,-0.0114661713227587,0.00416101437594685,-0.0196217594996146,-0.0033105831459029,0.00586598754230812
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,-0.0162824631051143,0.00592090927404284,-0.0278874452822383,-0.00467748092799037,0.00596768590360314
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,-0.0134301154052678,0.00489465433006869,-0.0230236378922024,-0.00383659291833314,0.00608081140725937
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,42166,-0.0238654304315432,0.00870768055583901,-0.0409324843209877,-0.00679837654209878,0.00613824615566467
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,-0.0305346706582464,0.0111433544753576,-0.0523756454299473,-0.00869369588654556,0.00615061967823675
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,41839,-0.0129903374026774,0.00474716808078006,-0.0222947868410063,-0.00368588796434843,0.00621908676862699
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,41839,-0.0111137723665258,0.00406669794514715,-0.0190845003390143,-0.00314304439403742,0.00628677091631337
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,0.00921540549946112,0.00337534851476567,0.00259972241052042,0.0158310885884018,0.00633952521473264
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NENF,Neudesin,39919,-0.032664491528812,0.0119699425858567,-0.056125578997091,-0.00920340406053291,0.00636486974899095
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-0.0146293681598012,0.00536689598619857,-0.0251484842927504,-0.00411025202685202,0.00642366677934467
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,-0.0148542239813088,0.00544985613397288,-0.0255359420038956,-0.00417250595872191,0.00642824057315741
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,39560,-0.0179694862424744,0.00660863480134779,-0.0309224104531161,-0.00501656203183273,0.00655644584145186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.0209077921497546,0.00769856972917581,0.00581859548057002,0.0359969888189392,0.00662156771429337
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-0.00813777075918617,0.00299712276902971,-0.0140121313864844,-0.00226341013188794,0.00663208359755627
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.0142767402903689,0.00528916180859621,-0.0246434974352175,-0.00390998314552035,0.00696027687578537
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,-0.0102799556085822,0.00382393267406329,-0.0177748636497462,-0.00278504756741811,0.00719023153234249
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,-0.0148515001755682,0.00553786232007792,-0.0257057103229209,-0.00399729002821545,0.00733310529850413
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,-0.0178335666779824,0.0066526762936936,-0.0308728122136219,-0.00479432114234297,0.0073566561823648
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,39575,0.0100605692791123,0.00375484899973065,0.00270106523964026,0.0174200733185844,0.00738744044326205
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,-0.00796489824059485,0.00297550660237225,-0.0137968911812445,-0.00213290529994524,0.0074431105543269
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.00806745416207045,0.00301586057385475,-0.0139785408868258,-0.00215636743731515,0.00748170225188018
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',39575,-0.0122257291014308,0.00457926028314564,-0.0212010792563962,-0.00325037894646531,0.00760072099206852
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,39966,-0.0262959723195214,0.00985284671630605,-0.0456075518834813,-0.00698439275556157,0.00762148560518394
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,42137,-0.0068958648919258,0.0025925157488708,-0.0119771957597126,-0.00181453402413903,0.00782530426748391
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.0111427754790879,0.00419164114193283,-0.0193583921172762,-0.00292715884089952,0.00786422642447851
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0158280317436236,0.00598429999333421,0.00409880375668859,0.0275572597305587,0.00818035387063689
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,-0.00974281973171655,0.00368849775767786,-0.0169722753367652,-0.00251336412666794,0.00826761971123017
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,0.0171320121172184,0.00650093455190882,0.00439018039547714,0.0298738438389597,0.0084154079745321
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,39575,0.00946300027845067,0.00359277992561171,0.00242115162425172,0.0165048489326496,0.0084530345402189
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,42145,-0.0212514712699876,0.00807366698380018,-0.0370758585582359,-0.0054270839817392,0.00849311982080374
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,39560,-0.0210281296335828,0.00799960899517137,-0.0367073632641187,-0.00534889600304692,0.00858454598300613
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,-0.0149505552303897,0.00569138200353832,-0.0261056639573248,-0.00379544650345455,0.00862721650660484
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.0176601485013406,0.00673345444739253,-0.0308577192182299,-0.00446257778445119,0.00873210759645392
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,42048,-0.0160984296495762,0.00615078082703698,-0.0281539600705686,-0.00404289922858367,0.00887279978748982
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,-0.0198003245019452,0.00757032239965118,-0.0346381564052615,-0.00496249259862893,0.00891929063248933
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,0.0159981830987304,0.0061237055806493,0.00399572016065774,0.028000646036803,0.00900049578293583
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0152568188984453,0.00585231086063883,-0.0267273481852974,-0.00378628961159322,0.00914698700300327
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,42137,-0.00936957514954125,0.00360343789049011,-0.0164323134149019,-0.00230683688418064,0.00932769941343525
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,-0.013628010762886,0.00525107366548648,-0.0239201151472395,-0.00333590637853244,0.00946354756949966
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,-0.00924875114246625,0.00356683454892804,-0.0162397468583652,-0.00225775542656729,0.00952686989375799
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,-0.0212539592209405,0.00822069812716799,-0.0373665275501898,-0.00514139089169124,0.00973873602782123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,0.0126242305954775,0.00492680624856968,0.00296769034828095,0.0222807708426741,0.0104096986835228
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,39690,-0.0229111352629014,0.00908633356425402,-0.0407203490488393,-0.00510192147696351,0.0116996628343475
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,-0.0166876045537683,0.00661883452848964,-0.029660520229608,-0.00371468887792865,0.0117084883632471
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,42310,-0.00821381378257592,0.00326459152249133,-0.0146124131666589,-0.00181521439849291,0.0118797986618023
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,42119,-0.0238255320696135,0.00949218031300102,-0.0424302054830955,-0.00522085865613154,0.0120841284050098
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,39649,-0.0107235875467146,0.00427368848825538,-0.0191000169836952,-0.00234715810973406,0.0121143009108814
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,-0.00896239877551211,0.00357504143940035,-0.0159694799967368,-0.00195531755428743,0.0121925282945521
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,39929,0.0239832966871163,0.00958096391097476,0.00520460742160581,0.0427619859526268,0.0123207311935644
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTN,Titin,39575,-0.0184283626532682,0.00736973231566465,-0.032873037991971,-0.00398368731456551,0.0124146307279978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,41881,-0.0149718321147118,0.00600349208348007,-0.0267386765983327,-0.00320498763109087,0.0126485213751893
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,41864,-0.0130847010914771,0.00525156484686078,-0.0233777681913242,-0.00279163399162994,0.0127297042758038
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00885787445756509,0.00356079350169534,-0.015837029720888,-0.00187871919424222,0.012872448353645
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLU,Clusterin,39979,0.00794437961179411,0.00319670266143187,0.00167884239538765,0.0142099168282006,0.0129628716983596
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,-0.0147316259801455,0.00594075649289431,-0.0263755087062184,-0.00308774325407269,0.0131595234181508
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,42262,-0.0120944173868442,0.0048782694156013,-0.0216558254414228,-0.00253300933226565,0.0131781126588682
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,-0.0121514671433209,0.00491518232168528,-0.0217852244938241,-0.00251770979281777,0.0134418540900983
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,0.00693800195619205,0.00281087561849088,0.00142868574394992,0.0124473181684342,0.0135918890798447
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,39649,-0.02040976917771,0.00827017767702866,-0.0366193174246861,-0.0042002209307338,0.0136067926539716
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,-0.00985398041190304,0.00399587216797445,-0.017685889861133,-0.00202207096267313,0.0136767281383775
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,-0.00996041833735323,0.00403934274496685,-0.0178775301174883,-0.0020433065572182,0.0136816041470033
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0276459793551286,0.0112331646148581,-0.0496629820002505,-0.00562897671000675,0.0138662200157543
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,39575,0.0152094861476911,0.00618105778133367,0.00309461289627707,0.0273243593991051,0.0138834303639383
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,42249,-0.0169046408561619,0.00687548003210935,-0.0303805817190962,-0.00342869999322758,0.0139570082031933
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,0.00705842409069534,0.00287480180235958,0.00142381255807055,0.0126930356233201,0.0140902519195994
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,39966,-0.0221372109369236,0.00903155111772889,-0.0398390511276723,-0.00443537074617503,0.0142570955421242
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,0.00640810301216181,0.00261512393223259,0.00128246010498594,0.0115337459193377,0.0142822338760388
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,0.00808103941647731,0.00333327131197661,0.00154782764500315,0.0146142511879515,0.015351567955271
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,-0.0121519567506153,0.00502071580254585,-0.0219925597236052,-0.00231135377762546,0.0155183685211495
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,-0.0124270273538028,0.00514832771206754,-0.0225177496694552,-0.00233630503815045,0.015802947247418
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,42018,0.0122274011708894,0.00506893628023726,0.00229228606162434,0.0221625162801544,0.0158689409135255
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,-0.0221914264220892,0.00920243455950874,-0.0402281981587263,-0.00415465468545206,0.0159044024453594
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,0.00804690883287525,0.00335318094906071,0.00147467417271626,0.0146191434930342,0.0164212133392738
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,39657,-0.00757079736746635,0.00315810001832792,-0.0137606734033891,-0.00138092133154363,0.0165345378695384
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.00705973831507842,0.00294865395307704,0.00128037656704743,0.0128391000631094,0.0166689330225184
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,39919,-0.00874625116668385,0.00366444635998388,-0.0159285660322523,-0.00156393630111545,0.0170126801613457
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,39560,0.0101482151882444,0.00425422419953108,0.00180993575716345,0.0184864946193253,0.017075387514198
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,0.0150165851071342,0.00629868160640044,0.00267116915858931,0.027362001055679,0.0171352693031064
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0350458533416342,0.0147244390388208,-0.0639057538577229,-0.00618595282554551,0.0173236425562652
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,-0.0177369995440689,0.00745956962545804,-0.0323577560099667,-0.00311624307817113,0.0174350669215922
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,-0.00698490452934346,0.00294570165738392,-0.0127584797778159,-0.00121132928087098,0.017746574884641
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,-0.0180355595051787,0.00761027274001937,-0.0329516940756167,-0.00311942493474077,0.0178071434218491
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,42224,-0.0153078241625169,0.0064629085061195,-0.0279751248345111,-0.00264052349052267,0.017871073812492
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,39958,-0.0248010925339727,0.0105123623701353,-0.0454053227794379,-0.00419686228850747,0.0183296757744908
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,0.00864459028933979,0.0036653307376786,0.00146054204348973,0.0158286385351898,0.018367448748491
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,0.00759656744428321,0.00323546251153749,0.00125506092166973,0.0139380739668967,0.0188963012458205
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,-0.00960999316774879,0.00409890013580945,-0.0176438374339353,-0.00157614890156227,0.019068223207899
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.0146951373424943,0.00627042128790275,-0.0269851630667836,-0.00240511161820487,0.0191181857705887
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,42119,-0.0159730483803828,0.00682676425947171,-0.0293535063289473,-0.00259259043181821,0.0193101672089131
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,39657,0.0136113866350817,0.00582412459260471,0.00219610243357647,0.0250266708365869,0.0194533008724182
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,-0.0169390501307169,0.00725829023061838,-0.0311652989827289,-0.00271280127870482,0.0196235918463709
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,-0.00883220202305656,0.00378900506209576,-0.0162586519447642,-0.00140575210134888,0.0197703930141412
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,0.00921042643614644,0.00396127473348651,0.00144632795851288,0.01697452491378,0.0200835599037842
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,39908,-0.0151004381298548,0.00650556446739474,-0.0278513444859485,-0.00234953177376112,0.0202960460302555
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,42007,0.0120821009414484,0.00521366549107042,0.00186331657895038,0.0223008853039464,0.0204974312742942
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,-0.0594324788227609,0.0256651232726649,-0.109736120437184,-0.00912883720833769,0.0205929475671372
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERVV_1,,39575,0.0107398148618729,0.00463790188030015,0.00164952717648459,0.0198301025472612,0.0205950512765074
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00718169429095681,0.00311123816788064,0.00108366748191075,0.0132797211000029,0.0209973043008471
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00592584824318666,0.00257420210779452,-0.0109712843744639,-0.000880412111909389,0.0213524453341039
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.0214111786071558,0.00930532757712704,0.00317273655598682,0.0396496206583248,0.0214124541942137
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,0.00638798713943061,0.0027765276446405,0.00094599295593523,0.011829981322926,0.0214266662029937
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,42262,-0.0152227039005924,0.00661953243754829,-0.028196987478187,-0.00224842032299771,0.0214822389229804
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,-0.024079948351183,0.0105383163327868,-0.0447350483634452,-0.00342484833892093,0.0223318038657144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,-0.00889053792484558,0.00389354124796457,-0.0165218787708561,-0.00125919707883502,0.0224254500598861
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,42115,-0.0212376103005777,0.00930122403056555,-0.0394680094004862,-0.0030072112006692,0.0224273583159576
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0123348841807493,0.00541433555888915,-0.022946981876172,-0.00172278648532654,0.0227309220763637
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,0.00197182883199092,0.000866406998353283,0.000273671115218488,0.00366998654876336,0.0228726566141322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,0.00589279964701845,0.00258941208593262,0.000817551958590524,0.0109680473354464,0.0228776045136915
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,-0.0054993740588642,0.00241705938665759,-0.0102368104567131,-0.000761937661015327,0.0229074741414554
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,-0.00963924444323839,0.00424999563734589,-0.0179692358924363,-0.00130925299404045,0.0233415927369677
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,39586,-0.0137521797644693,0.00607432385496237,-0.0256578545201955,-0.00184650500874302,0.0235944337667942
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,39929,0.00919443149219024,0.00406292908716213,0.00123109048135247,0.017157772503028,0.023654186274019
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.0166485550839909,0.00738162232222672,-0.0311165348355553,-0.00218057533242658,0.0241271512518388
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,-0.0142820630193174,0.00633500693820489,-0.026698676618199,-0.00186544942043582,0.0241864747429209
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,-0.0126649039302306,0.0056256778061806,-0.0236912324303446,-0.00163857543011662,0.0243846695264103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0115978415576751,0.005154630071179,-0.0217009164971859,-0.00149476661816424,0.024465827264382
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,-0.0188944880144122,0.00840014089921982,-0.035358764176883,-0.00243021185194135,0.0245089818634683
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,-0.00627938427054453,0.00281498047670747,-0.0117967460048912,-0.000762022536197897,0.0257202317717848
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,39757,-0.0205537307926839,0.00921816859407936,-0.0386213412370794,-0.00248612034828835,0.0257873302512147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,-0.0110038400436556,0.00494434375654323,-0.0206947538064803,-0.00131292628083083,0.0260651754609858
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,-0.0119458694960921,0.00537568975348338,-0.0224822214129196,-0.00140951757926472,0.0262898160759051
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00710105647837667,0.00320117301072396,-0.0133753555793956,-0.000826757377357707,0.0265563333451803
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,0.0342275217000235,0.0154382764918862,0.00396849977592648,0.0644865436241206,0.0266389430604692
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,39649,-0.0135521207671398,0.00615764758762106,-0.0256211100388771,-0.00148313149540255,0.0277665403709291
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,-0.00945989374944502,0.00429883455248343,-0.0178856094723125,-0.0010341780265775,0.0277832673756244
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,42103,-0.0162069601000683,0.00737586924277247,-0.0306636638159024,-0.00175025638423427,0.0280163129187876
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,39925,-0.00596245555153203,0.00272067346434501,-0.0112949755416482,-0.000629935561415808,0.0284332752182369
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,41825,-0.013042091002267,0.00595817446909504,-0.0247201129616933,-0.00136406904284071,0.0286185669699201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,-0.0105364901209481,0.00481468349737519,-0.0199732697758035,-0.00109971046609276,0.0286605844903318
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,-0.0141210860921343,0.00647588559760364,-0.0268138218634375,-0.00142835032083118,0.0292330925440148
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,39657,-0.0101666365486956,0.00466723079761718,-0.0193144089120253,-0.00101886418536597,0.0294046399883458
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,-0.0261806967836851,0.012024981590099,-0.0497496607002792,-0.00261173286709108,0.0294871524374596
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,-0.0142243862019874,0.00653391511429462,-0.0270308598260049,-0.00141791257796994,0.0294971798714411
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,-0.00899011563259033,0.00413361454785709,-0.0170920001463902,-0.000888231118790425,0.0296567453600305
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,-0.0155808165922146,0.00717207233181732,-0.0296380783625765,-0.00152355482185261,0.0298441351079879
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,-0.0240521966322393,0.0110786926540639,-0.0457664342342046,-0.00233795903027413,0.0299494405135069
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.0064047298618886,0.0029517510614479,-0.0121901619423265,-0.000619297781450714,0.030038670368186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),39775,0.0419966536105424,0.0193776280225633,0.00401650268631833,0.0799768045347664,0.0302349237868618
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-0.0177694461755111,0.00821032042501175,-0.0338616742085341,-0.00167721814248808,0.0304640884765355
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,41865,-0.0170549511625259,0.0078871982488417,-0.0325138597302557,-0.0015960425947962,0.0306083606025913
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,-0.0088778745441328,0.0041174511138456,-0.0169480787272702,-0.000807670360995423,0.0310928771490937
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,39560,0.0070286276957685,0.00326395019357401,0.000631285316363448,0.0134259700751736,0.0313081012725012
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,0.00866089569071408,0.00403821463493236,0.000745995006246667,0.0165757963751815,0.0319918193621039
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,41830,-0.0193729669065725,0.00907286721849832,-0.0371557866548292,-0.00159014715831581,0.0327577639140532
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,-0.00990009139938781,0.00464563898088014,-0.0190055438019129,-0.000794638996862733,0.0331071702819528
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00675214777739081,0.00318144872474122,0.000516508276898022,0.0129877872778836,0.0338305216222307
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,0.0129484038626476,0.00610153542199139,0.000989394435544444,0.0249074132897507,0.0338470600559176
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,0.00589895128100243,0.002781016504216,0.000448158932739064,0.0113497436292658,0.0339314275911523
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,0.0105733138376481,0.00498586354596268,0.000801021287561281,0.020345606387735,0.0339729479413176
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,0.00593447175338131,0.00280402660700063,0.000438579603660086,0.0114303639031025,0.0343323764827666
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLG,Plasminogen,39742,-0.0049146995051023,0.00232243544027631,-0.00946667296804387,-0.000362726042160719,0.0343513218839432
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,-0.0138834334978158,0.0065625878810015,-0.0267461057445787,-0.00102076125105287,0.034406233394105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,-0.0127358328115148,0.00604027385557222,-0.0245747695684364,-0.000896896054593282,0.0350076060789207
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0097221057922607,0.00462042706733844,0.000666068740277357,0.0187781428442441,0.0353830470358005
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,41843,-0.00696827471520883,0.00331875143700808,-0.0134730275317447,-0.000463521898672991,0.0357769684432857
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,-0.0194688195777535,0.00929091992276759,-0.037679022626378,-0.00125861652912904,0.0361523197945933
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,-0.013979425927426,0.00668657034705075,-0.0270851038076455,-0.000873748047206507,0.0365802845596879
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,-0.00980694292378334,0.00469804314440468,-0.0190151074868165,-0.000598778360750167,0.0368701070980143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,39966,-0.00710973179727912,0.00341308619701191,-0.0137993807434225,-0.000420082851135787,0.03726622296934
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,39575,0.00889584591918666,0.00428373451775767,0.00049972626438163,0.0172919655739917,0.0378564694491352
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.0137135400482365,0.00660638627943056,0.00076502294055259,0.0266620571559204,0.0379356098086896
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00618685348313167,0.00298620060725137,-0.0120398066733443,-0.000333900292918995,0.0383053264973593
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,-0.0104828784520555,0.00507158704152449,-0.0204231890534435,-0.000542567850667506,0.0387551480159746
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,-0.00973050872799865,0.00472002206799481,-0.0189817519812685,-0.000479265474728824,0.0392749850135131
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C5,Complement C5,39979,-0.00328895846116441,0.00159601559073316,-0.00641714901900141,-0.000160767903327418,0.03935140663407
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,-0.00902344050051218,0.0044105609736685,-0.0176681400089024,-0.000378740992121923,0.0407883085850608
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,-0.00972318695198357,0.00476041110575969,-0.0190535927192726,-0.000392781184694581,0.0411246439705144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,41900,-0.0104883706327876,0.00514443046402131,-0.0205714543422694,-0.00040528692330581,0.0414915530987893
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,42122,0.0140766620393573,0.00691166102015365,0.000529806439856175,0.0276235176388585,0.041704167428671
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0116617883605861,0.00573061623204386,0.000429780545780146,0.0228937961753921,0.0418710222930899
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,-0.00766092501324182,0.00378328077917147,-0.0150761553404179,-0.00024569468606574,0.0428966434598469
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,39475,-0.00853717178509045,0.00422319665411544,-0.0168146372271567,-0.000259706343024191,0.0432529737399484
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARTN,Artemin,41913,-0.00963525519797969,0.00477643667207928,-0.0189970710752551,-0.000273439320704297,0.0436897161642168
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.011228227496352,0.00560152357222552,0.000249241294789947,0.022207213697914,0.0450369159600637
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,39657,-0.00849154390401713,0.00423642437839198,-0.0167949356856654,-0.000188152122368852,0.0450501830288227
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,0.00967027643089504,0.0048251645598963,0.000212953893498295,0.0191275989682918,0.0450800514290927
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,-0.00521110241299238,0.00260603523320531,-0.0103189314700748,-0.000103273355909973,0.0455605829339785
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,0.017995542618004,0.00900365295640438,0.000348382823451461,0.0356427024125566,0.0456661231290528
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,42145,-0.0175656318092241,0.00879095208839133,-0.0347958979024711,-0.000335365715977056,0.0457204693545034
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,39575,0.00972570887792801,0.00487685004545672,0.000167082788832835,0.0192843349670232,0.0461483021696411
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,-0.0082264870177709,0.00412613007463677,-0.016313701964059,-0.000139272071482828,0.0462036852794605
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,0.0106385008035099,0.00538019152322634,9.33254179863053e-05,0.0211836761890336,0.0480271432846446
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,39757,-0.00908079983040749,0.00461566904808908,-0.0181275111646621,-3.40884961528946e-05,0.0491635338772921
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,42137,0.00413146240722208,0.00210510033550479,5.46574963268889e-06,0.00825745906481148,0.0497135358919257
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,-0.0174971130369488,0.00891610822987307,-0.0349726851675,-2.15409063976033e-05,0.0497393385908985
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,39649,0.00791498233974478,0.00403642056043065,3.5980413007012e-06,0.0158263666381889,0.0499167762678442
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,0.0110483737951821,0.00564495025913249,-1.5728712717572e-05,0.0221124763030818,0.0503467417261951
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,39657,-0.0179174597747714,0.00915857266308852,-0.0358682621944249,3.33426448820597e-05,0.0504479678665402
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,41913,0.00564828604942716,0.0028907077016735,-1.75010458528966e-05,0.0113140731447072,0.050728541696893
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,39649,-0.0074700837785285,0.00382802922312082,-0.0149730210558453,3.28534987883078e-05,0.051032617909541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,-0.00956381958500911,0.00492963711976686,-0.0192259083397522,9.82691697339385e-05,0.0523929149767781
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,-0.0169331896029452,0.00874139526888066,-0.0340663243299513,0.000199945124060869,0.0527553226908852
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,-0.0189942150671884,0.0098268171416964,-0.0382547766649133,0.00026634653053656,0.0532747109747745
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.0100107557805782,0.00518531323899133,-0.0201739697290012,0.000152458167844779,0.0535541049820995
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,39649,-0.0126192433265235,0.00655634988747654,-0.0254696891059775,0.000231202452930518,0.0542880274343601
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.0116447610288002,0.00608149368645915,-0.0235644886542601,0.000274966596659782,0.0555455329152159
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,-0.0157817283416496,0.00824261915012021,-0.0319372618758852,0.00037380519258606,0.0555629876067753
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,0.00533528557992206,0.00279237971542386,-0.000137778662308696,0.0108083498221528,0.0560740630109022
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,39560,0.00694944190695026,0.0036448559111361,-0.000194475678876501,0.014093359492777,0.0565928534181787
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,0.00700548059367812,0.00368335569660067,-0.000213896571659197,0.0142248577590154,0.0572065825104993
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,-0.00980631232827741,0.00517025565727708,-0.0199400134165405,0.000327388759985661,0.0578965991191856
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00536826400484498,0.00283105737274222,-0.00018060844572977,0.0109171364554197,0.0579593156063822
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,-0.00957981585864659,0.00505287577755144,-0.0194834523826474,0.000323820665354239,0.057993126565325
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,39750,-0.0199843714098158,0.0105743475583951,-0.0407100926242703,0.000741349804638594,0.0587983639696147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.0102080157403234,0.00540495244592451,-0.000385691053688656,0.0208017225343354,0.0589662711958492
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,-0.00395459960013542,0.00209418050954374,-0.00805919339884115,0.000149994198570319,0.0590009909033945
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,-0.0105784290867972,0.00560275639832296,-0.0215598316275102,0.000402973453915781,0.0590416909880531
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,-0.00703507261683725,0.0037343062569806,-0.0143543128805192,0.000284167646844719,0.0596044151369033
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,39586,0.00971734922716722,0.00516387293303625,-0.000403841721583831,0.0198385401759183,0.0598902964213625
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,-0.0216710515512645,0.0115473453359946,-0.0443038484098139,0.000961745307284843,0.0605843384837768
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,-0.0110638134416697,0.00590244622916076,-0.0226326080508248,0.000504981167485381,0.0608954181885169
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,39757,-0.0140120752292346,0.00749733559941258,-0.0287068530040832,0.000682702545614059,0.0616572536186196
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,-0.00803448545164384,0.00430770781271688,-0.0164775927645689,0.000408621861281235,0.0621828915072576
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,0.0106504304924307,0.00571620040522977,-0.000553322301819679,0.021854183286681,0.0624602765254671
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,-0.0102422056445806,0.00550111478352284,-0.0210243906202853,0.000539979331124204,0.0626516609564448
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.00503230103820369,0.00270566462870957,-0.000270801634067059,0.0103354037104744,0.0629245950133291
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,-0.0132943388502035,0.0071824822330695,-0.0273720040270198,0.000783326326612689,0.0642042812264098
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,41839,0.0146171920946951,0.00789911129673789,-0.000865066046911171,0.0300994502363013,0.0642658475650744
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,0.00713221106912621,0.00387876350206631,-0.00047016539492375,0.0147345875331762,0.0659738582077147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,39560,-0.0139138139368807,0.0075800413736473,-0.0287706950292294,0.000943067155468002,0.0664460633379917
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,39560,0.00913320045593931,0.00498057576016843,-0.000628728033990807,0.0188951289458694,0.0667161362094927
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,39919,-0.00518460191620631,0.00282820820702692,-0.0107278900019791,0.00035868616956646,0.066802727879868
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,42119,-0.0131233233787169,0.00717182997352421,-0.0271801101268244,0.000933463369390517,0.0672954170868102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,0.0085184625700877,0.0046628713983043,-0.000620765370588722,0.0176576905107641,0.0677455261693695
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCN,Decorin,41900,-0.00443796499306414,0.002430560452307,-0.00920186347958586,0.000325933493457581,0.0678874470559838
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,39929,-0.0190200298457756,0.0104300094597738,-0.0394628483869323,0.00142278869538103,0.0682408659115997
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,42070,0.00579174195492496,0.00318227847544969,-0.000445523856956436,0.0120290077668064,0.0687814213879524
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0172719169501179,0.00949959630663842,-0.0358911257111292,0.00134729181089342,0.0690639953289404
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,39575,0.0135252063587774,0.00743945607839958,-0.00105612755488577,0.0281065402724406,0.0690857281348027
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,0.01617417834335,0.00891737197028827,-0.001303870718415,0.033652227405115,0.0697384273509978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,39539,0.00793786969360453,0.00438668301040141,-0.000660029006782229,0.0165357683939913,0.0703948947863515
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,39649,-0.00604497627192702,0.00334877805984851,-0.0126085812692301,0.000518628725376055,0.0710817150422657
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.00659615073810903,0.00365483072091855,-0.0137596189511094,0.000567317474891332,0.071132351981684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,39915,0.00472148532856369,0.00261706176954107,-0.000407955739736822,0.00985092639686419,0.071239567824283
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00576832761411649,0.00320037850352389,-0.000504414252790328,0.0120410694810233,0.0715069232323177
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,0.00745577312064176,0.00413689654196439,-0.000652544101608447,0.015564090342892,0.0715315565975224
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,-0.0133292670162462,0.0074045954168812,-0.0278422740333334,0.00118374000084092,0.0718613908370743
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,39979,-0.00634211675111154,0.00352516562670955,-0.0132514413794623,0.000567207877239178,0.0720297411823749
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,39757,0.00640012595996191,0.00356291018702642,-0.000583178006609873,0.0133834299265337,0.0724707198960638
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,41843,-0.00717891607783109,0.00400847206933125,-0.0150355213337203,0.000677689178058152,0.0733264301315384
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.0125043992028801,0.00701080772776303,-0.0262455823492956,0.00123678394353549,0.0745176556202923
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,39652,-0.0134377994067024,0.00756299643990382,-0.0282612724289139,0.00138567361550904,0.0756315387496503
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,0.0055572663490448,0.00313561257506904,-0.00058853429809051,0.0117030669961801,0.0763714122834512
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,-0.0144137289925458,0.00814350289759739,-0.0303749946718367,0.00154753668674507,0.0767602883092996
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,-0.00904344201687009,0.0051323774461174,-0.0191029018112602,0.00101601777752001,0.0780907525295754
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,-0.00861682323379307,0.0048906282124318,-0.0182024545301594,0.000968808062573264,0.078108088799791
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,0.00639280913023667,0.00363634322899627,-0.000734423598596022,0.0135200418590694,0.0787689136284154
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,41900,0.00965622954276513,0.00549582469299403,-0.00111558685550317,0.0204280459410334,0.0789387832832565
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.00899835224487473,0.00515156627363901,-0.00109871765145773,0.0190954221412072,0.0807136477709355
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,0.0081090027792017,0.00464870108460166,-0.00100245134661756,0.017220456905021,0.0811236559701884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,-0.0118659841230467,0.00680430891232215,-0.0252024295911981,0.00147046134510468,0.0812054079790457
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,-0.00789671926435052,0.00453049178492899,-0.0167764831628113,0.000983044634110303,0.0813586331531624
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,-0.00962018843254719,0.0055254698036289,-0.0204501092476598,0.00120973238256546,0.0817006787625418
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,41883,-0.016273420956104,0.00937333208672544,-0.0346451518460859,0.00209830993387785,0.0825621912067151
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,0.00598487159940658,0.00345636213683389,-0.000789598188787849,0.012759341387601,0.0833813886205559
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,39649,-0.00411451508551574,0.00237976806322168,-0.00877886048943023,0.00054983031839875,0.0838448422221147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,42286,0.00802855993706323,0.00464617119387134,-0.0010779356029246,0.0171350554770511,0.0840117032764987
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPHS2,Podocin,39657,0.0186829090794596,0.0108526979634014,-0.00258837892880711,0.0399541970877263,0.0851882778521982
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,41843,-0.0133441250569835,0.00776445080912686,-0.0285624486428722,0.00187419852890513,0.0857073206206492
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,-0.012282537085962,0.00715121608861973,-0.0262989206196567,0.00173384644773264,0.0859022841048793
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,42310,0.00534368168122386,0.00311492389650835,-0.000761569155932508,0.0114489325183802,0.0862744410104508
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,42137,0.00425273456696194,0.00248245679946656,-0.00061288075999252,0.00911834989391641,0.086714238901714
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.00477321799913683,0.00279798851744733,-0.000710839495059942,0.0102572754933336,0.0880463826518101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,39934,-0.00950981965797514,0.00559092281899996,-0.0204680283832151,0.00144838906726478,0.0889818400194993
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,0.00886347935741345,0.00525721869322155,-0.0014406692813008,0.0191676279961277,0.0918258862890578
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,39586,0.0166501601655817,0.00987691952281637,-0.00270860209913837,0.0360089224303018,0.0918695681381858
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,-0.0205085645442443,0.0122385064537419,-0.0444960371935785,0.00347890810508977,0.093812457777394
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,-0.0107092605121092,0.00639677483092538,-0.0232469391807229,0.00182841815650455,0.0941256817731322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,39560,0.00541993186102315,0.00324168866240689,-0.00093377791729436,0.0117736416393407,0.0945633050229114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.00583257089063064,0.00349118526105018,-0.012675294002289,0.00101015222102771,0.094818084821426
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,-0.0162999927162795,0.0097569901574457,-0.0354236934248731,0.00282370799231408,0.094829724432209
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,-0.00651859904321379,0.00391495233574404,-0.0141919056212721,0.00115470753484452,0.095930521037798
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,-0.0110994122412683,0.00666860692443741,-0.0241698818131657,0.001971057330629,0.0960553780635183
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,39510,0.00604766277549006,0.0036575234797284,-0.0011210832447776,0.0132164087957577,0.0982608241305945
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.00439703128598368,0.00266851949343125,-0.000833266921141573,0.00962732949310894,0.0994288477984925
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,-0.0190411319406742,0.011582356015571,-0.0417425497311934,0.0036602858498449,0.100209476894557
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,39586,-0.00682379232792534,0.00416225452133607,-0.014981811189744,0.00133422653389335,0.101149000258436
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,39919,-0.00925285905094198,0.00564657139728499,-0.0203201389896206,0.0018144208877366,0.101310096984302
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,-0.00531987548879379,0.00324649740914078,-0.0116830104107097,0.00104325943312213,0.101314208188296
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0291394963308582,0.0178363047041908,-0.00581966088935579,0.0640986535510722,0.102341631740175
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,-0.0130699580816958,0.00800044841642235,-0.0287508369778836,0.00261092081449199,0.102355470638115
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,39649,-0.00703364015578595,0.00430712279601336,-0.0154756008359721,0.00140832052440023,0.10249218597832
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,-0.0142880103471582,0.00877226666705292,-0.0314816530145819,0.00290563232026556,0.103390255790462
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,0.0114037008979254,0.00702184709563795,-0.00235911940952501,0.0251665212053757,0.104397802474332
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,39575,0.00879886612984482,0.00542011072960596,-0.00182455090018286,0.0194222831598725,0.104538226611565
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,0.0118905673152564,0.00732483754986607,-0.00246611428248115,0.0262472489129939,0.104549192962272
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,39806,-0.00614604237301704,0.00379437618820842,-0.0135830197019055,0.00129093495587147,0.105308378768905
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.00832869216628495,0.00514856404243646,-0.0184198776894604,0.00176249335689052,0.105761861789162
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,39979,-0.00443124944982227,0.00274331894201042,-0.00980815457616269,0.000945655676518158,0.106276121720241
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,0.00671559240864009,0.00415898719813732,-0.00143602249970906,0.0148672073169892,0.106400515419627
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,-0.0141242700595445,0.00877634008372453,-0.0313258966236446,0.00307735650455554,0.107566975865674
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,39930,-0.0206462388392782,0.0128487988262248,-0.0458298845386787,0.0045374068601223,0.108112642093334
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0150028273584475,0.00935964260620836,-0.0333477268666159,0.00334207214972087,0.108979301574367
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MB,Myoglobin,42310,-0.00947921526118814,0.00592715262344767,-0.0210964344031456,0.00213800388076928,0.109779997315457
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,39638,-0.00309604458193613,0.00194062059259795,-0.00689966094342811,0.000707571779555845,0.110653922009161
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,-0.0123521836549093,0.00776093671811151,-0.0275636196224078,0.00285925231258926,0.111506951406164
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,39624,-0.0113718959801306,0.00715404232993809,-0.0253938189468093,0.00265002698654804,0.111959023418607
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,39586,0.00888845371556369,0.00560150260164278,-0.00209049138365615,0.0198673988147835,0.112587157523947
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,39657,-0.00791863907548501,0.00499620214602938,-0.0177111952817026,0.00187391713073257,0.113010454533977
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,42187,-0.00456949975463596,0.00288583689357748,-0.0102257400660478,0.0010867405567759,0.113348418079342
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,42181,0.00642892705032771,0.00406275370084943,-0.00153407020333717,0.0143919243039926,0.113580133149227
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,42132,-0.032094926933481,0.0203019127733283,-0.0718866759692045,0.00769682210224253,0.113928409597472
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,39757,0.00565855070659857,0.00358046631582069,-0.00135916327240998,0.0126762646856071,0.114044805970133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,0.00630207556641674,0.00399236912068058,-0.00152296791011719,0.0141271190429507,0.114472627034114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,39657,-0.0078119702540628,0.00495320405361732,-0.0175202501991528,0.00189630969102715,0.114788485156573
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,-0.00738081944087069,0.00468539107844211,-0.0165641859546172,0.00180254707287586,0.1152147731514
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,-0.00686732679515908,0.00438178246460179,-0.0154556204257786,0.00172096683546043,0.117085788051139
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,-0.00560099234739944,0.0035748336538296,-0.0126076663089055,0.00140568161410658,0.117188646214569
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,42262,-0.00489068159975308,0.00312546920032961,-0.0110166012323991,0.00123523803289295,0.117656920445642
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,39859,-0.0050893067624793,0.00325945211291406,-0.0114778329037908,0.00129921937883225,0.118457635222373
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,-0.00491096060175842,0.00314720973100975,-0.0110794916745375,0.00125757047102069,0.118689911709539
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.00764180997526601,0.0048997031809595,-0.00196160825941461,0.0172452282099466,0.11887111744531
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,-0.00664870348479733,0.00427855131086557,-0.0150346640540938,0.00173725708449918,0.120222299462323
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,-0.00406244478916529,0.00262062906956844,-0.00919887776551942,0.00107398818718885,0.121126430695448
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,-0.00946831451937347,0.00611403661158847,-0.0214518262780869,0.00251519723933993,0.121502159359985
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,41967,-0.0172623086117995,0.0111708541358465,-0.0391571827180587,0.0046325654944597,0.122297654352677
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,42249,0.00489737682470612,0.00317800533066155,-0.00133151362339051,0.0111262672728028,0.123334560724845
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,0.0109980681797874,0.0071454785425303,-0.00300706976357196,0.0250032061231468,0.123792966915035
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,-0.00552790524270027,0.00360647481127307,-0.0125965958727955,0.00154078538739496,0.125360540076706
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,-0.00494171553716988,0.00323071662563062,-0.0112739201234059,0.00139048904906613,0.126138781008879
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00483083701961063,0.00316249057469657,-0.00136764450679466,0.0110293185460159,0.126650855750327
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,0.00383020671405344,0.00251178005506613,-0.00109288219387618,0.00875329562198305,0.127313356225642
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,39657,-0.00418040588831979,0.00274873883555541,-0.00956793400600838,0.0012071222293688,0.128327317391819
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,42070,-0.0306948841246996,0.0201956596519231,-0.0702783770424688,0.00888860879306966,0.128565792141942
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,39586,-0.00791255404261582,0.00522044447963788,-0.0181446252227061,0.00231951713747443,0.129627567448494
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,-0.0114925915490107,0.00759339339478658,-0.0263756426027924,0.00339045950477101,0.130181644733889
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.00954235777859751,0.00634474194625778,-0.00289333643606774,0.0219780519932628,0.132615391203782
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,-0.0104215170180761,0.00693404687219602,-0.0240122488875804,0.00316921485142806,0.132875982006649
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,39649,-0.011772725757715,0.00784854561709649,-0.0271558751672241,0.00361042365179411,0.133646033097197
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,41913,-0.00538336104299546,0.00360262713749398,-0.0124445102324836,0.00167778814649274,0.135124166338222
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,-0.00707683543231588,0.00474308149572964,-0.016373275163946,0.00221960429931422,0.135719135465423
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,0.00526681380411706,0.00354482495762081,-0.00168104311281973,0.0122146707210538,0.137367227159803
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,0.0100296690031597,0.00675248567231287,-0.00320520291457348,0.023264540920893,0.137480127544662
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,-0.00942676371032477,0.00636335401471701,-0.0218989375791701,0.00304541015852056,0.138519893168147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,41913,-0.00617160194847971,0.00416836667901857,-0.0143416006393561,0.00199839674239668,0.138742089513864
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,-0.00627588478506044,0.00424613422288686,-0.0145983078619187,0.0020465382917978,0.139429399622381
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,-0.00973834207385845,0.00659353221437248,-0.0226616652140285,0.00318498106631161,0.139716701353046
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,0.00796794419797145,0.00540530834932088,-0.00262646016669747,0.0185623485626404,0.140478893183779
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00961419366008647,0.0065441596421663,-0.00321235923855948,0.0224407465587324,0.141826466668436
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,39649,-0.00431678717568273,0.0029418170211374,-0.010082748537112,0.00144917418574657,0.142298983354125
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,-0.00809148347400935,0.00554824426875122,-0.0189660422407617,0.00278307529274304,0.144757814751219
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,39875,0.0113113981370524,0.00775826102969799,-0.00389479348115564,0.0265175897552605,0.14487359843997
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,39575,0.0100196826973922,0.0068764806674724,-0.00345821941085371,0.0234975848056381,0.145118884525502
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00544468074553384,0.00373791687477957,-0.00188163632903411,0.0127709978201018,0.145248243377953
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,39657,-0.00511958729509042,0.00351524223093308,-0.0120094620677192,0.00177028747753841,0.145311372929852
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.00473069586250181,0.00325708085820553,-0.00165318261958102,0.0111145743445847,0.146408587144295
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,39919,-0.0119667176103554,0.0082675005981752,-0.0281710187827788,0.00423758356206797,0.147801202569851
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.00796699159725113,0.00552013599450711,-0.0187864581464851,0.0028524749519828,0.148976413203753
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,0.00626284487499762,0.00434270137331693,-0.00224884981670356,0.0147745395666988,0.149287231334787
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.00954106582289588,0.00664511394720511,-0.0225654891594179,0.00348335751362614,0.151087318308435
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,-0.0101429074149042,0.00706871129471601,-0.0239975815525476,0.00371176672273919,0.151338670291526
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,0.00807788253879585,0.00564149568972193,-0.00297944901305913,0.0191352140906508,0.152209388983629
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,-0.00696502107159476,0.0049010860549523,-0.0165711497393013,0.00264110759611174,0.155306035992078
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00624781547810331,0.00440855876952404,-0.0023929597101638,0.0148885906663704,0.156452422658527
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,42075,-0.0088227974273243,0.00623077303760251,-0.0210351125810252,0.00338951772637662,0.156797546402859
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.00630379614972898,0.00445343205685294,-0.0150325229811607,0.00242493068170279,0.15695234275872
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,-0.00720037136239153,0.0050973220515877,-0.0171911225835034,0.00279037985872036,0.157807829259518
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,-0.0125157742593713,0.00886059921245622,-0.0298825487157855,0.00485100019704291,0.157819987325387
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00678996763174148,0.00483049911945561,-0.0162577459058745,0.00267781064239152,0.15985780285557
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,-0.00548600539653556,0.00390698438954332,-0.0131436948000405,0.00217168400696936,0.160301283815705
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENG,Endoglin,42310,-0.00256323637098741,0.00182579948104469,-0.006141803353835,0.00101533061186019,0.16037185460691
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,-0.0109428186343529,0.00781360089075519,-0.0262574763802331,0.00437183911152723,0.161396408954533
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,0.00636278291924509,0.00454364233321509,-0.00254275605385649,0.0152683218923467,0.161430653378969
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,0.00515141992439498,0.00368002707187629,-0.00206143313648255,0.0123642729852725,0.161591848270614
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,39649,0.00998625723783695,0.00715094077465847,-0.00402958668049365,0.0240021011561675,0.162593360082851
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,39657,0.00850370463594743,0.00611873821664186,-0.00348902226867062,0.0204964315405655,0.164623443071605
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,-0.00881554502384366,0.0063440567795939,-0.0212498963118477,0.00361880626416038,0.164686019710505
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.00528883806770623,0.00380620415263736,-0.00217132207146299,0.0127489982068754,0.164699575796327
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,42207,-0.0229564278411417,0.0165330985173228,-0.0553613009350944,0.00944844525281091,0.165003514169031
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,-0.00591793149351045,0.00427689556420976,-0.0143006467993616,0.00246478381234068,0.166479111612832
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,-0.00691393538541022,0.00502066574142826,-0.0167544402386096,0.00292656946778917,0.168510006438201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,0.00616614640841453,0.00447920738907452,-0.00261310007417154,0.0149453928910006,0.16865877393725
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,-0.00663596221933936,0.00483848679028479,-0.0161193963282976,0.00284747188961883,0.170247837636923
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,-0.00956440659177901,0.0069843231485427,-0.0232536799629227,0.00412486677936469,0.170893396365598
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,-0.00651702473328039,0.00476032521240628,-0.0158472621495967,0.00281321268303592,0.171017673243235
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,42070,-0.00805012983045242,0.00588806253915364,-0.0195907324071936,0.00349047274628872,0.171586997317138
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,39649,0.00497696623601057,0.00364810978495143,-0.00217332894249423,0.0121272614145154,0.17251388368033
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00608481429322484,0.00446523265329774,-0.00266704170723873,0.0148366702936884,0.173001882162286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,0.00440420165457674,0.00324275137379242,-0.00195159103805641,0.0107599943472099,0.174438288960611
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,39560,-0.0105661548012945,0.00778369686359007,-0.0258222006539311,0.004689891051342,0.174659060915503
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,39560,0.00615700198961453,0.00453772764870798,-0.00273694420185311,0.0150509481810822,0.174857785274952
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.0109505014911677,0.00807342744237258,-0.026774419278218,0.00487341629588252,0.175011446079888
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,-0.00476153489954475,0.00351608737604429,-0.0116530661565916,0.00212999635750206,0.175690497896162
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,42262,-0.00623444763678176,0.0046549737544805,-0.0153581961955635,0.00288930092200001,0.180492422647523
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,41913,0.00659569536612991,0.00493024736293089,-0.00306758946521464,0.0162589801974745,0.1809838027286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,39870,-0.004625441426651,0.00345939818863126,-0.0114058618763683,0.00215497902306626,0.181228295125923
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,42088,-0.010131489592624,0.00766496911088903,-0.0251548290499665,0.0048918498647185,0.186260068737385
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,39575,-0.00668747536930746,0.00506622378204765,-0.0166172739821208,0.00324232324350592,0.186858595953702
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,0.00443238685155337,0.00336088292290013,-0.0021549436773309,0.0110197173804376,0.187258056130576
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,42196,-0.00488520298344502,0.00371317175765237,-0.0121630196284437,0.00239261366155363,0.188316570697248
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,-0.00709833004854249,0.00541074140981892,-0.0177033832117876,0.0035067231147026,0.189582664758365
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,39649,-0.00832819093644028,0.00635009499830651,-0.020774377133121,0.00411799526024048,0.189713946881665
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00894348883854454,0.00683600312242309,-0.0223420549584938,0.00445507728140473,0.190801691589186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,41839,0.0044599241045438,0.00341219871718994,-0.00222798538114847,0.0111478335902361,0.191217459535997
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,39657,-0.00395149043640278,0.00302377252052825,-0.00987808457663815,0.00197510370383258,0.191305070093044
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,41538,-0.00391617416302899,0.00300052124152554,-0.00979719579641905,0.00196484747036107,0.191860009689797
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.00388996027381717,0.00298113246679564,-0.00973297990873663,0.00195305936110228,0.191967706557002
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.00527603313329417,0.00405046200073057,-0.0132149386547261,0.00266287238813775,0.192746144772717
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,-0.00362094517317652,0.00278698373604638,-0.00908343329582742,0.00184154294947438,0.193889932508651
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEB,Nebulin,39575,-0.00549218529606638,0.0042366806631495,-0.0137960793958394,0.00281170880370665,0.194885087458367
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.0060287876134547,0.00465856584630747,-0.0151595766722173,0.00310200144530793,0.195647887502946
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,-0.00654134848429732,0.00505554462661251,-0.0164502159524578,0.00336751898386321,0.195728607345349
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00622405798028651,0.00483639585519555,-0.0157033938564698,0.00325527789589678,0.19814888668267
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,41839,-0.00800130384080848,0.00622571149191845,-0.0202036983649686,0.00420109068335168,0.198743795913228
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,0.0108989870608213,0.00849848637172814,-0.00575804622776581,0.0275560203494085,0.199707699117762
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,39757,0.00526810479800851,0.00411546526024783,-0.00279820711207724,0.0133344167080943,0.200545322616695
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,-0.00710049697908891,0.00555010078586918,-0.0179786945193925,0.00377770056121467,0.200802467306718
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,41976,0.00880226192093961,0.00688243663580269,-0.00468731388523366,0.0222918377271129,0.200938407341171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,-0.00552541305464878,0.00432162749300613,-0.0139958029409408,0.00294497683164324,0.201082066011127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,41913,-0.0184866538645342,0.014598272854923,-0.0470992686601832,0.0101259609311149,0.205406747974596
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,39586,0.00629925291338905,0.0049839996552854,-0.00346938641097034,0.0160678922377484,0.206294485300074
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,0.00457137198818087,0.00361821492979652,-0.00252032927422031,0.0116630732505821,0.206460284016432
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,39919,-0.00571704069960383,0.00454729770341794,-0.014629744198303,0.00319566279909534,0.208692991022495
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCIN,Adseverin,39586,-0.00987036003027796,0.00786644470564438,-0.0252885916533409,0.00554787159278503,0.209599058171761
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,39398,-0.00941590619344792,0.00750689498522252,-0.0241294203644841,0.00529760797758821,0.209759756519457
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,0.00376220410092939,0.00300301571163577,-0.00212370669387672,0.0096481148957355,0.210301861327762
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,0.00451822070988662,0.00361376996571365,-0.00256476842291214,0.0116012098426854,0.211219245001234
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,-0.00377612349292238,0.00302081437894839,-0.00969691967566122,0.00214467268981646,0.211308326656998
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,0.0108986676839434,0.00873722307042436,-0.00622628953408836,0.0280236249019751,0.212283104496608
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,0.00619298037546255,0.00496654491814244,-0.00354144766409662,0.0159274084150217,0.212446314018974
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,-0.00366345128322657,0.00293836231986838,-0.00942264143016859,0.00209573886371546,0.212504681917865
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,42070,-0.00366685751649905,0.00294599765661485,-0.00944101292346415,0.00210729789046605,0.21326691741463
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.00997142150045028,0.00805275265911725,-0.00581197371141953,0.0257548167123201,0.215644430933973
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,41843,-0.0128439706245186,0.0104771536687265,-0.0333791918152225,0.00769125056618522,0.22025710407781
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,0.00317645113192572,0.00259744225621688,-0.00191453569025937,0.0082674379541108,0.221383086471469
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,39657,0.00390420473279488,0.00319636217291584,-0.00236066512612016,0.0101690745917099,0.221940762232948
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,-0.00651522641622682,0.00533762753119286,-0.0169769763773648,0.00394652354491119,0.222255311980043
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALLD,Palladin,39657,0.00493866921900195,0.00406131927456745,-0.00302151655915024,0.0128988549971541,0.224001035169961
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,-0.00625736080241854,0.00517086406816034,-0.0163922543760128,0.00387753277117573,0.226255130673718
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,0.00508540386894653,0.00420336903278505,-0.00315319943531218,0.0133240071732052,0.226366363228411
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,39657,-0.00396649831303109,0.00327969647580264,-0.0103947034056043,0.00246170677954208,0.226531156778627
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.0052511227187202,0.00434481478181611,-0.0137669596910798,0.00326471425363938,0.226844208975953
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,0.00559938835151685,0.00464800374121384,-0.00351069898126227,0.014709475684296,0.228349432512577
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,-0.00527048520103813,0.0043877702849139,-0.0138705149594694,0.00332954455739311,0.229708636162175
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,-0.00618018187870381,0.00514842002899911,-0.0162710851355421,0.00391072137813444,0.230008625413977
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,39930,-0.0147334838582351,0.0123271349101576,-0.0388946682821439,0.00942770056567383,0.232030993039088
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,42119,-0.00641489255885681,0.0053842473727197,-0.0169680174093874,0.00413823229167379,0.233510203859114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,41843,-0.00685217242014838,0.00575130321438865,-0.0181247267203501,0.00442038188005337,0.233513184580806
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00826191342951278,0.00696992275895654,-0.0219229620370676,0.00539913517804202,0.235897789714479
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00478058508092267,0.0040675739502618,-0.0127530300234358,0.00319185986159046,0.239903611202505
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,-0.0215384780678733,0.018333037010165,-0.0574712306077967,0.0143942744720502,0.240081397036559
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.0083248430897575,0.00714362228456179,-0.0223263427674986,0.00567665658798362,0.243901379512952
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,-0.00402729468701158,0.00347405642551453,-0.0108364452810201,0.0027818559069969,0.24638012955283
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,42145,0.0140357484207941,0.0121329231030905,-0.00974478086126328,0.0378162777028514,0.247361584132566
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,39657,-0.0122646939751227,0.0106748705838816,-0.0331874403195307,0.00865805236928526,0.250609122865306
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.0075834097438227,0.00660810044441825,-0.0205352866148825,0.00536846712723707,0.251157643310975
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.00291785329351242,0.00254377509563927,-0.00206794589394055,0.00790365248096539,0.251378618851044
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,-0.00595786538139543,0.00519834766113787,-0.0161466267972257,0.0042308960344348,0.251775651833257
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,39929,0.00266509493280815,0.00232570482631441,-0.00189328652676809,0.00722347639238439,0.251848321114236
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,39657,-0.00751095366545562,0.00657090159298659,-0.0203899207877093,0.0053680134567981,0.253037235471683
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,0.00441414068054011,0.00386549581287312,-0.00316223111269121,0.0119905124737714,0.253501697476838
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,42145,0.00420550545428096,0.00374017861836332,-0.00312524463771116,0.0115362555462731,0.260857786004086
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00750340224491593,0.00669089000840183,-0.0206175466613835,0.00561074217155165,0.262127025985627
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,-0.00634493798611649,0.00565920889472917,-0.0174369874197857,0.00474711144755269,0.262239430901381
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00471069251177214,0.00420493573161933,-0.012952366545746,0.00353098152220175,0.262619882193171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,39657,-0.00645744024685266,0.00576706532408441,-0.0177608882820581,0.00484600778835278,0.262861718565595
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,0.00886223395956604,0.00795398881553075,-0.00672758411887423,0.0244520520380063,0.265223207473247
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,0.00937394372107151,0.00842868711776109,-0.00714628302974021,0.0258941704718832,0.266098678374988
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,-0.0122687349090163,0.0110431422087629,-0.0339132936381916,0.00937582382015893,0.266600167594362
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,0.00660482939334463,0.00595050397927368,-0.00505815840603178,0.018267817192721,0.267039978823281
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,-0.00619411903403094,0.00558444028557674,-0.0171396219937614,0.00475138392569946,0.267378842200939
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,0.00722013232665775,0.00651786937616977,-0.00555489165063501,0.0199951563039505,0.267995804842218
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,-0.00878279463266263,0.00796676033380228,-0.0243976448869151,0.00683205562158984,0.270298977399983
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,-0.00699187004342717,0.00634732579661075,-0.0194326286047842,0.0054488885179299,0.270682576398791
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F2,Prothrombin,39979,0.00173424562257824,0.00157971522314364,-0.00136199621478329,0.00483048745993977,0.272305591482815
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,-0.00807140171585057,0.00735814328770366,-0.0224933625597497,0.00635055912804862,0.272693903085185
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,0.00590480060968381,0.00538564217794787,-0.00465105805909402,0.0164606592784616,0.272925126173391
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,-0.00740479805343372,0.0067571994093579,-0.0206489088957752,0.00583931278890777,0.273173188818387
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00560856152486134,0.00512045864482525,-0.0156446604687188,0.00442753741899616,0.273398336440779
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,39919,0.00454790808183249,0.00415584414508518,-0.00359754644253446,0.0126933626061994,0.273829006084715
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00606074050837999,0.00557037326368367,-0.0169786721052,0.00485719108844001,0.276605154963659
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,39929,-0.00805324302188583,0.00744041925612617,-0.0226364647638931,0.00652997872012147,0.279113790860744
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,0.00670395947684607,0.00619481450903186,-0.00543787696085637,0.0188457959145485,0.279192353915263
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.00618910034586011,0.00572205144171871,-0.0174043211716288,0.00502612047990856,0.279443286361249
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,-0.00650304967681293,0.00602814500680174,-0.0183182138901443,0.00531211453651847,0.280710069211691
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.0041631575045292,0.00386242451147584,-0.00340719453796345,0.0117335095470218,0.281118644052425
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.0039324176277596,0.00365825496804821,-0.00323776210961489,0.0111025973651341,0.28242345281221
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,39586,-0.00763769617041686,0.00711283886722039,-0.0215788603501688,0.00630346800933511,0.282940338966943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,39518,-0.00501986338508149,0.00468888424434692,-0.0142100765040015,0.00417034973383848,0.284378370289193
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,0.00458270110340593,0.00429763173570223,-0.00384065709857043,0.0130060593053823,0.28629716541163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,0.00320967185856129,0.0030166416667124,-0.00270294580819501,0.0091222895253176,0.287352915243216
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.00633620178930382,0.00595585076559018,-0.00533726571125293,0.0180096692898606,0.287414717786977
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,-0.00453686627778898,0.0042833637321692,-0.0129322591928406,0.00385852663726265,0.289535524374949
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,39934,-0.00420318875083753,0.00398903559301356,-0.0120216985131441,0.00361532101146904,0.292049415858919
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,39900,-0.00589807772665291,0.00560109170892272,-0.0168762174761415,0.00508006202283562,0.292353021596259
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,39586,-0.00689202586737444,0.00655545179157968,-0.0197407113788706,0.00595665964412173,0.29312438340343
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,-0.00568088171576978,0.00540862748448515,-0.0162817915853607,0.00492002815382112,0.293586158915193
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,39586,0.00465451409181788,0.00443442220816049,-0.00403695343617668,0.0133459816198124,0.293910153903394
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,39657,0.00620373831181938,0.005922008943082,-0.00540339921662134,0.0178108758402601,0.294858153295632
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00860402161783177,0.00821661579153853,-0.0247085885692473,0.00750054533358374,0.295053920656777
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,-0.00332259243329304,0.00319352106206159,-0.00958189371493375,0.00293670884834768,0.298165376758303
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,0.0140896155250501,0.0135769382731349,-0.0125211834902943,0.0407004145403944,0.299399773673139
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,0.00546199761755738,0.00526768577577149,-0.00486266650295475,0.0157866617380695,0.29981040369602
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,-0.013809115728613,0.0133684745961351,-0.0400113259370377,0.0123930944798117,0.301640913791716
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.00423314725533589,0.00410474160387573,-0.00381214628826055,0.0122784407989323,0.302427307551133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,39934,-0.00510772340296459,0.00499582724448261,-0.0148995448021505,0.00468409799622132,0.306614424009041
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,39657,-0.00491323848163207,0.00482912954286788,-0.0143783323856531,0.00455185542238899,0.308977360442956
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,39959,0.00242911034401459,0.0023879770648441,-0.00225132470307984,0.00710954539110903,0.309067996529064
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,0.00666265723677871,0.00655968249505191,-0.00619432045352303,0.0195196349270804,0.309795527138748
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,-0.00921484552187255,0.00908174563869691,-0.0270150669737185,0.00858537592997339,0.310288492176245
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,0.00278073689006419,0.00274572190173077,-0.00260087803732811,0.00816235181745649,0.31119655565397
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,41839,-0.00486049141837941,0.0048031902768631,-0.0142747443610311,0.00455376152427226,0.311590108941707
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,39575,-0.00700958823814158,0.00695380704621641,-0.0206390500487257,0.00661987357244258,0.313466279092784
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,41913,0.00498047630369486,0.00501302073475483,-0.00484504433642459,0.0148059969438143,0.32048050092892
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,39560,-0.00551841141742444,0.00556068971602719,-0.0164173632608377,0.00538054042598885,0.321025843321441
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,42246,-0.00458310898187,0.00463095648398426,-0.0136597836904792,0.00449356572673916,0.322354016948696
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,39757,0.0174971964031261,0.0177110382342926,-0.0172164385360875,0.0522108313423396,0.323210280400157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,-0.00325607356985136,0.00332243322926098,-0.00976804269920288,0.00325589555950016,0.32709452708107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,-0.00459526158705466,0.00469820754373843,-0.013803748372782,0.00461322519867267,0.328051583049959
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_DRA,,42060,-0.00376258027704324,0.00384955836726761,-0.0113077146768878,0.00378255412280127,0.328385910043898
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.00709648478057599,0.00726777322673067,-0.00714835074381612,0.0213413203049681,0.328872087875921
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.00583737359651015,0.00598071249626073,-0.0175595700891812,0.00588482289616087,0.329069410352611
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,0.00660108522829797,0.00677048618418679,-0.00666906769270814,0.0198712381493041,0.32958814422839
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,-0.00584114737452637,0.00600564839204258,-0.0176122182229298,0.00592992347387709,0.330768456417596
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,0.00555835226441166,0.00572520226574989,-0.00566304417645813,0.0167797487052814,0.331640996893261
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,0.00278987915112604,0.0028827604492337,-0.00286033132937201,0.00844008963162409,0.333174756633995
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00663377278619479,0.00685832218790085,-0.0200760842744804,0.00680853870209087,0.333435823710858
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,0.00729158012920975,0.00754188427270783,-0.00749051304529758,0.0220736733037171,0.333659577823975
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOC,Myocilin,42137,0.00452849375847651,0.00472421743014537,-0.00473097240460841,0.0137879599215614,0.3377924611244
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,39757,0.00422819336543943,0.00442187223808681,-0.00443867622121072,0.0128950629520896,0.338992017008167
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,41300,-0.00505935058650999,0.00529128281927888,-0.0154302649122966,0.00531156373927661,0.339006015281771
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,42144,-0.0033338137316668,0.00351930060231595,-0.0102316429122061,0.00356401544887246,0.34350568717825
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,-0.00519777563042489,0.00548900937499783,-0.0159562340054206,0.00556068274457085,0.343685416179577
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,-0.00703474970735786,0.00743807624596456,-0.0216133791494484,0.00754387973473269,0.344283825574621
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.0030875675940763,0.00326617512748829,-0.00331413565580074,0.00948927084395335,0.344514730417163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,39657,-0.0060196955181134,0.00641333996825955,-0.0185898418559021,0.00655045081967532,0.347945873891692
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,0.00356501534821284,0.00381565315498631,-0.00391366483556033,0.011043695531986,0.350162742720225
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,39560,0.00523690263877386,0.00562045672037307,-0.00577919253315736,0.0162529978107051,0.351482392805992
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.00401005444096291,0.00431496174344389,-0.0124673794581129,0.00444727057618712,0.352734804410438
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,0.00547916442976359,0.00589709984019871,-0.00607915125702588,0.0170374801165531,0.352842851344078
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,0.00270966666179176,0.00291833384231365,-0.00301026766914298,0.00842960099272651,0.353169475526855
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00530706859922537,0.00571841179102999,-0.00590101851119341,0.0165151557096441,0.35338979691128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,41654,0.00308880806368667,0.00333578419141402,-0.00344932895148482,0.00962694507885815,0.354483054792992
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,0.00412586794624085,0.00447305056583715,-0.00464131116279996,0.0128930470552817,0.356348724258091
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,39560,0.00762408824384444,0.00827653058730443,-0.00859791170727224,0.0238460881949611,0.356982170619319
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,-0.0120559758612596,0.013103229107837,-0.0377383049126201,0.013626353190101,0.357549435634426
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0082190106803105,0.00899111195273344,-0.00940356874704705,0.025841590107668,0.360667203555147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,0.00454897333336932,0.00499736288786928,-0.00524585792685446,0.0143438045935931,0.362694005756423
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.00394187114336325,0.00433866057977599,-0.0124456458797242,0.00456190359299769,0.363609276702742
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLPS,Colipase,42115,-0.00702025691326592,0.00778902373766843,-0.022286743439096,0.0082462296125642,0.367444224615677
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,39560,0.00446940846856977,0.00498613920570135,-0.00530342437460487,0.0142422413117444,0.370076705935962
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESPL1,Separin,39560,0.00509116734514801,0.00568346601920075,-0.00604842605248545,0.0162307607427815,0.370386924730725
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,-0.00222654366478863,0.00248636827534064,-0.00709982548445628,0.00264673815487902,0.370535617109197
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,39966,-0.00455658486740637,0.00508880539325819,-0.0145306434381924,0.00541747370337968,0.370585067645358
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,-0.00439841530922758,0.00493257379441164,-0.0140662599462744,0.00526942932781923,0.372565205786246
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,39649,0.00460140374688569,0.00517904873646244,-0.00554953177658069,0.0147523392703521,0.374309993713665
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.00508112853935003,0.0057709513531706,-0.0163921931915644,0.00622993611286434,0.378625856906062
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,39736,-0.00342207608538517,0.00389592484713837,-0.0110580887857764,0.00421393661500603,0.379760159012827
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,0.00267958651252017,0.0030515948713098,-0.00330153943524704,0.00866071246028737,0.379912024728018
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,-0.00940505392175751,0.010720984328454,-0.0304181832055273,0.0116080753620123,0.380366197528622
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,42079,-0.00265031461569246,0.0030335086448597,-0.00859599155961746,0.00329536232823255,0.382308329064681
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,-0.00521815347153859,0.00598010886309749,-0.0169391668432097,0.00650285990013249,0.382908418769423
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,39575,0.00415096608744078,0.00475963197633418,-0.00517791258617422,0.0134798447610558,0.383162470611081
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,-0.00682858901462227,0.00786868504822954,-0.0222512117091522,0.00859403367990762,0.385512756434794
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,-0.00724445333773115,0.00834856073287875,-0.0236076323741735,0.00911872569871119,0.38555025066975
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.00559913541228808,0.00648337646434571,-0.0071082824578295,0.0183065532824057,0.387815230176263
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,-0.00334657578584614,0.00389438470181661,-0.0109795698014067,0.00428641822971442,0.390171509174474
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,-0.00350666253122131,0.00408661927227519,-0.0115164363048807,0.00450311124243806,0.390864245514699
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,39586,-0.00885323140189418,0.0104008817958457,-0.0292389597217518,0.0115324969179635,0.394676771777552
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.00309729589074709,0.00367171969406987,-0.00409927470962985,0.010293866491124,0.398933082682289
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,-0.0028467469856287,0.00340997871750551,-0.0095303052719395,0.00383681130068211,0.40382940762725
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,42310,-0.00366658877927735,0.0044136687427781,-0.0123173795151224,0.00498420195656771,0.406137857304896
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,-0.00516212464072687,0.00626337484143332,-0.0174383393299362,0.00711409004848244,0.409857325691989
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BSND,Barttin,39560,-0.00293487102436245,0.00357328890231519,-0.00993851727290022,0.00406877522417532,0.411472738822508
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,0.00654093978622651,0.00797000286955174,-0.0090802658380949,0.0221621454105479,0.411837949479442
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,-0.00440555529777902,0.00538560311971184,-0.0149613374124142,0.00615022681685619,0.413357920201849
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,-0.00314273569956853,0.00384992393559281,-0.0106885866133304,0.00440311521419338,0.414339835021255
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,0.00339913502141245,0.00417304437565709,-0.00478003195487545,0.0115783019977004,0.415347018328612
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,41900,-0.0052254044125973,0.00643453473854278,-0.0178370925001411,0.00738628367494655,0.416756032302875
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,-0.00267027951274143,0.00329812936542782,-0.00913461306897995,0.0037940540434971,0.418167662454528
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,-0.00157296398957158,0.00194951784355808,-0.00539401896294542,0.00224809098380227,0.419771096615848
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,-0.00228268441045739,0.00284013222726184,-0.00784934357589059,0.0032839747549758,0.421573419221161
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.00456991657549315,0.00569135410676836,-0.00658513747377282,0.0157249706247591,0.422013521404709
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00405859277167442,0.00505760851014087,-0.0139715054515505,0.00585431990820168,0.422296832188431
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,-0.00243514682951619,0.00307055717651686,-0.00845343889548923,0.00358314523645685,0.427755037761275
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,39638,-0.00742976152154102,0.00938153149598726,-0.0258175632536761,0.010958040210594,0.42840326639157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,39657,-0.00480326992477606,0.00608814661978621,-0.016736037299557,0.00712949745000491,0.430155587985012
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,-0.0046527258558414,0.00591621396206352,-0.0162485052214859,0.00694305350980309,0.431628583753013
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,39919,-0.00293955196779722,0.00375208365047674,-0.0102936359227316,0.00441453198713719,0.433382107709958
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,42310,-0.00611371082661359,0.00782414413914913,-0.0214490333393459,0.0092216116861187,0.434586430311353
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,-0.00737162509785422,0.00944462427190717,-0.0258830886707923,0.0111398384750838,0.435107364557119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00488458756794302,0.00626685777030179,-0.0171676287977345,0.00739845366184849,0.435742141911561
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,39575,-0.00327999052973922,0.0042125753488212,-0.0115366382134288,0.00497665715395034,0.436221064378978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.00694514231341155,0.00893065091344807,-0.0244492181037698,0.0105589334769467,0.436774784854815
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.00416716906641428,0.00537737595735494,-0.01470682594283,0.00637248781000141,0.438389025181466
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,41900,-0.00876946544456394,0.0113633588400889,-0.0310416487711382,0.0135027178820103,0.440286999706278
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,0.0135971821211849,0.0176903454974799,-0.0210758950538757,0.0482702592962455,0.442133984062428
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00449846494299281,0.00586115946051284,-0.015986337485598,0.00698940759961236,0.44279828606871
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,-0.00314098600203445,0.00410484560438681,-0.0111864833866326,0.0049045113825637,0.444174484081239
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,-0.00444135462579108,0.00581662060917569,-0.0158419310197754,0.00695922176819326,0.445144178791365
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,-0.00697708336829113,0.00919526359325764,-0.0249998000110761,0.0110456332744938,0.448006624950512
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,-0.00671837026341689,0.00890190353359273,-0.0241661011892586,0.0107293606624249,0.450437977276863
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,39657,0.00267615255910811,0.00354741450235971,-0.00427677986551693,0.00962908498373314,0.450628004348876
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,-0.00388546176709558,0.00515143269088224,-0.0139822698412248,0.00621134630703362,0.450712937446751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,39560,0.003967215301354,0.00532191501736339,-0.00646373813267824,0.0143981687353862,0.45601642234869
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,-0.00373268593478969,0.00500857066118658,-0.0135494844307154,0.006084112561136,0.456127960762916
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,0.00362312800727105,0.00488655014194149,-0.00595451027093426,0.0132007662854764,0.458436954712766
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,-0.00297415026464201,0.00402336901116932,-0.0108599535265339,0.00491165299724985,0.459789424108236
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.0027155135873301,0.0036759671227889,-0.00448938197333614,0.00992040914799634,0.460092300149824
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,0.0037275170908931,0.00509791143912065,-0.00626438932978336,0.0137194235115696,0.464679012067183
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,0.00562763815702205,0.00771449586980262,-0.00949277374779109,0.0207480500618352,0.465718282864907
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,-0.0147354052312907,0.0203294542725351,-0.0545811356054595,0.0251103251428781,0.468568697156506
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00268795810959548,0.00371066063016873,-0.00458493672553524,0.00996085294472619,0.468842741733081
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,0.00410910751701982,0.00567929143928646,-0.00702230370398165,0.0152405187380213,0.469372548923791
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,39638,-0.00603189795317392,0.00835979964085319,-0.0224171052492462,0.0103533093428983,0.470594967902295
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,39560,0.00469054572630767,0.00652187909513511,-0.00809233730015714,0.0174734287527725,0.472032062073457
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.00699229284434088,0.00974707749413536,-0.0260965647328462,0.0121119790441644,0.473159097377937
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,42016,0.00969946642161123,0.0135271513970356,-0.0168137503165786,0.036212683159801,0.473363824240785
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.00240364619685313,0.00336665392765672,-0.00419499550135404,0.0090022878950603,0.475266341108716
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,0.00465242608697582,0.00655153279881973,-0.00818857819871086,0.0174934303726625,0.477639927679595
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,39966,0.00327278784278775,0.00461168953625688,-0.00576612364827573,0.0123116993338512,0.477921995545584
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,0.00298868078065652,0.00424701801997553,-0.00533547453849552,0.0113128360998086,0.481626620635292
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00292711145723233,0.00416140912604508,-0.00522925042981602,0.0110834733442807,0.4818248980958
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPGN,Epigen,39919,0.00344284391613553,0.00493326935218787,-0.00622636401415271,0.0131120518464238,0.485264816113627
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00158952942382707,0.00230011232245938,-0.00291869072819332,0.00609774957584747,0.48953599892122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,-0.00413931320501314,0.00602275868100125,-0.0159439202197756,0.00766529380974931,0.49191921180639
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,0.00353168640133853,0.0051489427630945,-0.00656024141432669,0.0136236142170037,0.492787405748879
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,-0.00504398176816533,0.00735922380412842,-0.019468060424257,0.00938009688792639,0.493108375124364
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,39657,0.00343700352394904,0.00502620789559156,-0.00641436395141042,0.0132883709993085,0.494105422266538
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,41913,0.00297985352330928,0.00436500220289781,-0.00557555079437042,0.011535257840989,0.494827635317529
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00336319447933949,0.00493428069829282,-0.00630799568931443,0.0130343846479934,0.495507738590547
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSPN,Claspin,41820,-0.00255103446620237,0.00375652938313401,-0.00991383205714502,0.00481176312474029,0.497090546497318
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,39759,0.00176244052633398,0.00260245568631732,-0.00333837261884798,0.00686325367151593,0.498279081574184
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,41814,-0.00435147758810115,0.00643740449140551,-0.0169687903912559,0.00826583521505365,0.499072974790082
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,-0.00210669080637658,0.00313547691124501,-0.0082522255524168,0.00403884393966365,0.501668734627166
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,0.00346935150682705,0.00520596832079024,-0.00673434640192182,0.0136730494155759,0.505157924994806
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,-0.00441823199275288,0.00663597543919563,-0.0174247438535763,0.00858827986807056,0.5055528777782
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,39720,0.00256644237942811,0.00387504044418233,-0.00502863689116925,0.0101615216500255,0.507792190803871
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,39929,0.00654829548410227,0.0101064316524345,-0.0132603105546694,0.026356901522874,0.517041102391119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,0.00249191969789035,0.00385390591941862,-0.00506173590417015,0.0100455752999508,0.51790695448694
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,41900,0.00221845841092359,0.00343354081208923,-0.00451128158077129,0.00894819840261847,0.518216748366799
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,42181,-0.00187865321838144,0.00291025483112947,-0.0075827526873952,0.00382544625063231,0.518595486731956
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,39735,-0.00212743447693437,0.00330400079402267,-0.00860327603321881,0.00434840707935007,0.519655827183893
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.00433031060889941,0.00676234673076549,-0.0175845102011998,0.00892388898340096,0.521954442750929
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,0.00251201532298381,0.00392748602405138,-0.0051858572841569,0.0102098879301245,0.522446330580705
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,39657,-0.00288388911863973,0.00454429151438199,-0.0117907004868284,0.00602292224954897,0.525690726427294
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,41843,-0.00893694530844987,0.0141234110216021,-0.0366188309107899,0.0187449402938902,0.526891329917768
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,-0.00369873430973843,0.00587529310651017,-0.0152143087984984,0.00781684017902151,0.529006198825212
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,-0.00213162044197311,0.00340646920734289,-0.00880830008836518,0.00454505920441897,0.531485118288224
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,-0.0024690823885339,0.00397498760291198,-0.0102600580902414,0.00532189331317358,0.534510529525696
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,0.00699046505787188,0.0112783554886753,-0.0151151116999317,0.0290960418156755,0.535394143821322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,42123,-0.00832236694081858,0.0135994531252148,-0.0349772950662396,0.0183325611846025,0.540572292328028
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,-0.00425987668856788,0.00696437965161633,-0.0179100608057359,0.00939030742860014,0.540771198881925
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,0.00260160586927471,0.00426569626660974,-0.00575915881328038,0.0109623705518298,0.541947263326563
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,42249,-0.00205935486471382,0.00339773061214829,-0.00871890686452447,0.00460019713509682,0.5444603178889
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,39757,-0.00229021633342628,0.00378628820884164,-0.00971134122275589,0.00513090855590333,0.54527694477896
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,0.00261464602117965,0.00432693942231092,-0.00586615524654975,0.011095447288909,0.545675581963999
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,-0.00286527553667806,0.0047452733489136,-0.0121660113005487,0.0064354602271926,0.545975826903942
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,39649,0.00416669036114246,0.00690398084463395,-0.00936511209434007,0.017698492816625,0.546175218971434
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,-0.00189543624736603,0.0031538997438559,-0.00807707974532358,0.00428620725059153,0.547864557355049
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,-0.00324060687135012,0.00540035070023828,-0.0138252942438171,0.0073440805011169,0.548469617488767
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,0.00307102444315458,0.00512274364917299,-0.00696955310922448,0.0131116019955336,0.54885741417464
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,39575,0.00355197334882053,0.00593307397888971,-0.0080768516498033,0.0151807983474444,0.549403079273306
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,0.00138965882371807,0.00233708413622804,-0.0031910260832889,0.00597034373072503,0.552114865873253
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00479910402207841,0.00821926940541973,-0.0113106640125443,0.0209088720567011,0.559309940186365
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,-0.00152247578001331,0.0026155833387399,-0.00664901912394351,0.00360406756391689,0.560525428434508
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,-0.00216880337090937,0.00373536046119939,-0.00949010987486017,0.00515250313304144,0.56151037423984
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00291585173951202,0.00504331427414841,-0.0128007477168429,0.00696904423781886,0.563166738174717
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,0.00265163730608505,0.00458723002138959,-0.00633933353583853,0.0116426081480086,0.563243754537521
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,0.00698233632315233,0.0121435059971197,-0.0168189354312023,0.030783608077507,0.565312669971802
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,-0.00342064444886319,0.00596021550534242,-0.0151026668393343,0.00826137794160795,0.566036304158898
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,-0.00145486371509847,0.00253781385376547,-0.00642897886847879,0.00351925143828185,0.566468581978728
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,0.00181699627245442,0.00318571397503227,-0.00442700311860883,0.00806099566351767,0.568446667980996
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,0.00505451201150557,0.0088750208893805,-0.0123405289316802,0.0224495529546914,0.569014173123592
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,-0.00583954751258489,0.0102738815255705,-0.025976355302703,0.0142972602775332,0.569783382834327
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,0.00214145418350363,0.00379329727971342,-0.00529340848473467,0.00957631685174194,0.572398470918112
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,0.00239204166806485,0.0042561015997038,-0.0059499174673546,0.0107340008034843,0.57410949218028
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,41839,0.0031228931569461,0.00558754633794561,-0.0078286976654273,0.0140744839793195,0.576237772619645
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,39959,0.000854495796417402,0.0015370792467418,-0.00215817952719653,0.00386717112003133,0.578275293167157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,0.00183446152992879,0.00333370993250841,-0.0046996099377877,0.00836853299764529,0.582141008728099
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,39757,-0.00302621599354366,0.00551116772829493,-0.0138281047410017,0.0077756727539144,0.582943606389235
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,-0.00283471860382033,0.00517390046958437,-0.0129755635242057,0.00730612631656504,0.583779493023506
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,42208,-0.00644822285729214,0.0118192982421408,-0.0296140474118881,0.0167176016973038,0.585372336337799
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,39649,0.00277922678997077,0.00510743859195183,-0.00723135285025482,0.0127898064301964,0.586347339045457
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00354971402272799,0.00655146565764135,-0.016390586711705,0.00929115866624906,0.587953447734348
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,-0.00259775145180164,0.0048108392013961,-0.012026996286538,0.00683149338293471,0.589222488413945
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,39649,-0.00348439506332104,0.006462075230916,-0.0161500625159164,0.00918127238927431,0.589755016646908
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.00276225012156405,0.0051337965830026,-0.00729999118112105,0.0128244914242492,0.590551993910321
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,41900,0.00154519274829698,0.00288445346369391,-0.00410833604054309,0.00719872153713705,0.592177011426149
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,39757,0.0030155484504198,0.00567797847242031,-0.00811328935552401,0.0141443862563636,0.595363219061875
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00142290689774365,0.00269767501566127,-0.00671034992843973,0.00386453613295243,0.597886771849036
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,39575,0.00265831570025631,0.00506527485258244,-0.00726962301080528,0.0125862544113179,0.599724671001094
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,-0.00422982626768769,0.00809305638569033,-0.0200922167836407,0.0116325642482654,0.601229208355426
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.00219696712817018,0.00420571832503367,-0.00604624078889581,0.0104401750452362,0.601416985288836
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.00561309586581445,0.0107726454980536,-0.0267274810419995,0.0155012893103706,0.602341875901419
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,41843,-0.00430382988467557,0.00829054070064695,-0.0205532896579436,0.0119456298885925,0.603682003143748
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,41843,-0.00889853509770225,0.0171610048171329,-0.0425341045392827,0.0247370343438782,0.604095601848269
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,39757,-0.00322028964282199,0.00622586461757345,-0.015422984293266,0.00898240500762197,0.604996259766779
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,0.00183475468956439,0.00355952481044053,-0.00514191393889904,0.00881142331802783,0.606249462915715
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,39560,0.00361701548845062,0.0070657281730764,-0.0102318117307791,0.0174658427076804,0.608724453941027
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,0.00239260711732412,0.00469492468712871,-0.00680944526944817,0.0115946595040964,0.610330689749769
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCLN,Nicalin,41913,-0.00272394089943167,0.00541193733271019,-0.0133313380715436,0.00788345627268031,0.614747036772543
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,42016,-0.00180572632053432,0.00359841559119976,-0.00885862087928585,0.00524716823821721,0.615808358688713
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00166236686553501,0.00334034406465526,-0.00820944123225933,0.0048847075011893,0.618731238062158
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.00298124440745059,0.00601775244323139,-0.0147760391961841,0.00881355038128293,0.620320001091134
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,39934,-0.00232466295640361,0.00472435243461161,-0.0115843937282424,0.00693506781543516,0.622686743127083
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,41913,-0.00163572217640044,0.00333384455958136,-0.0081700575131799,0.00489861316037903,0.623688183249062
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00417023704828511,0.00854397666876388,-0.0209164313190623,0.0125759572224921,0.625495065929651
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,39757,-0.00119903044058926,0.00247001730432765,-0.00604026435707144,0.00364220347589293,0.627378033863324
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,39979,-0.00108408304914204,0.00224159457775185,-0.00547760842153567,0.00330944232325159,0.628663909052551
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00311938763640837,0.00645899924538259,-0.0095402508845415,0.0157790261573582,0.629139328562596
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.00354613903560729,0.00739689810058465,-0.0180440593127532,0.0109517812415386,0.631657291228631
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,-0.00466172690306008,0.00980019474067542,-0.0238701085947839,0.0145466547886637,0.634313991181504
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,39958,0.00152038496521592,0.00319959677028348,-0.0047508247045397,0.00779159463497153,0.634667691021978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,-0.00156300607511936,0.00329333566031925,-0.00801794396934509,0.00489193181910636,0.635083618226314
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.00151988940238103,0.00321483394204466,-0.00782096392878856,0.00478118512402651,0.636383614398745
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,39757,0.00289483834945464,0.00617215457782152,-0.00920258462307555,0.0149922613219848,0.639067468223951
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,39736,0.00172147303936878,0.00368620250492252,-0.00550348387027936,0.00894642994901693,0.640505818169529
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,-0.00328420361320508,0.00703799048471319,-0.0170786649632429,0.0105102577368328,0.640767091256333
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,0.00168843415384437,0.00362154997385279,-0.0054098037949071,0.00878667210259584,0.641068251320821
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,42296,0.00197203830164235,0.00423515565043625,-0.00632886677321271,0.0102729433764974,0.641483919446205
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,41900,0.00345613238063096,0.00742705395618426,-0.0111008933734902,0.0180131581347521,0.641693001362611
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00290612755369945,0.00626014316573908,-0.00936375305114915,0.0151760081585481,0.642494331063926
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,-0.00309837938690171,0.0066767873811502,-0.0161848826539561,0.00998812388015267,0.642619336112223
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,-0.00261416030009139,0.00573853370726186,-0.0138616863663246,0.00863336576614185,0.64872607112072
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,39657,0.00142878795299028,0.00315526534425755,-0.00475553212175453,0.00761310802773508,0.650682521260993
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,41843,0.00422825518880353,0.00936694428349063,-0.0141309556068381,0.0225874659844452,0.651707402703751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00340296979660448,0.00755909142873317,-0.0182187889969215,0.0114128494037125,0.652587820619956
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,39657,-0.00187085282079313,0.00416213660213859,-0.0100286405609848,0.00628693491939851,0.653084598123663
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,39560,-0.00312179941885909,0.0069600978638347,-0.0167635912319751,0.0105199923942569,0.653780983371452
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,0.00226873129483516,0.00511900105924958,-0.00776451078129402,0.0123019733709643,0.657631223919614
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRN1,Neuritin,39934,0.00163955752966976,0.00370726130301521,-0.00562667462424005,0.00890578968357958,0.658312605584698
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,-0.00207640218481841,0.00472628168187321,-0.0113399142812899,0.00718710991165307,0.660430345141317
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,-0.00197870378314238,0.00451726823457569,-0.0108325495229107,0.00687514195662597,0.661372390243474
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,42119,0.00362147040011907,0.0083058972902729,-0.0126580882888158,0.019901029089054,0.662835027847044
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,39586,-0.00271922467562452,0.00624067885710711,-0.0149509552355544,0.00951250588430542,0.663044258316056
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,0.00133268702692745,0.00309742874576596,-0.00473827331477383,0.00740364736862872,0.667017880255138
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,39586,-0.00344380546188656,0.00800466768594908,-0.0191329541263468,0.0122453432025736,0.667040661702391
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.00156835776302972,0.00366114279042335,-0.00560748210620004,0.00874419763225949,0.668383403974655
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,-0.00226482646496811,0.005288615114601,-0.0126305120895861,0.00810085915964985,0.668480681025447
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,39934,-0.00712528752300761,0.0166497586478204,-0.0397588144727356,0.0255082394267204,0.668694635249848
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00271514625537407,0.00638558344873835,-0.0098005973041531,0.0152308898149012,0.670698231845446
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.00209941529655428,0.00496228811849448,-0.0118255000088035,0.0076266694156949,0.672249529529207
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,39575,-0.00192814628029331,0.00455898791464204,-0.0108637625929917,0.00700747003240508,0.672352456379985
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,0.00241253682782872,0.00571993496390148,-0.00879853570141818,0.0136236093570756,0.673196070982107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,-0.00375657305930528,0.00891895525492169,-0.0212377253589518,0.0137245792403412,0.67362332097123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00164016894027346,0.00390802732687191,-0.0092999025009424,0.00601956462039549,0.674718417845241
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,-0.00185167052857014,0.00443968738427976,-0.0105534578017585,0.00685011674461818,0.676633440794905
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,-0.00131492846958101,0.00320711808397038,-0.00760087991416295,0.00497102297500093,0.681811596708571
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,-0.00184286649717199,0.00450122109855887,-0.0106652598503474,0.0069795268560034,0.682243146064096
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,0.00159064151967683,0.00389272669928976,-0.0060391028109311,0.00922038585028477,0.682827311814695
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,41839,-0.0023626074239317,0.00583529042255757,-0.0137997766521445,0.00907456180428113,0.685570367402018
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,0.00284898691183419,0.00705860905335425,-0.0109858868327401,0.0166838606564085,0.686500836036358
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,41913,0.00136324485653939,0.00337965133188097,-0.00526087175394732,0.0079873614670261,0.686683641148547
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,0.00216383439298212,0.00536508750870159,-0.00835173712407299,0.0126794059100372,0.686722439450297
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,0.00296202411577554,0.00736689015204799,-0.0114770805822385,0.0174011288137896,0.687638424913458
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,0.00317915908229016,0.00792849009513451,-0.0123606815041735,0.0187189996687538,0.688443046161545
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,42016,-0.00441823995068246,0.0110569696636099,-0.0260899004913578,0.0172534205899929,0.68946585395318
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,-0.00288912034278285,0.00723469180736923,-0.0170691162852265,0.0112908755996608,0.689648582378403
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,0.00488053687568287,0.0125281292373575,-0.0196745964295379,0.0294356701809036,0.696864831739039
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,0.00315114225807114,0.00813798484498601,-0.0127993080381014,0.0191015925542437,0.698605118197316
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00201100649120123,0.00520855038674953,-0.00819775226682785,0.0122197652492303,0.69943219270978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,0.00293600422842585,0.00771394351432706,-0.0121833250596552,0.0180553335165069,0.703499887992863
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-0.00134109699832398,0.00357309656865808,-0.00834436627289381,0.00566217227624586,0.707420933940835
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,39657,-0.00129680342405277,0.00353565066008978,-0.00822667871782873,0.0056330718697232,0.713790678468326
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,-0.0027896654988442,0.00761443100412052,-0.0177139502669204,0.012134619269232,0.714099303292439
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,-0.0010321569075048,0.00283777868751415,-0.00659420313503253,0.00452988932002293,0.716074049628064
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLC,Galectin-10,42119,-0.00257191701787823,0.00710972653832301,-0.0165069810329913,0.0113631469972349,0.717547304519089
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,0.00219576257439559,0.00609252995023714,-0.00974559612806921,0.0141371212768604,0.718553141419201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,39930,-0.00996967417203846,0.0276787548478032,-0.0642200336737327,0.0442806853296558,0.718710051919484
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,-0.00299505017309562,0.00833505950235868,-0.0193317667977186,0.0133416664515274,0.719353968274183
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,42310,-0.000918969092067325,0.00256347674041184,-0.00594338350327453,0.00410544531913988,0.719985580268606
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,0.00171625501364303,0.00488322779110423,-0.00785487145692126,0.0112873814842073,0.725249363108448
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,-0.00319345795290729,0.00912504881424644,-0.0210785536288303,0.0146916377230157,0.726370846747756
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,0.00287652287019093,0.00822276139399118,-0.0132400894620318,0.0189931352024136,0.726477193403103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,39560,-0.00341570331176305,0.00986697362119074,-0.0227549716092969,0.0159235649857708,0.729217563419835
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,0.00152300597688472,0.00440657356793484,-0.00711387821626755,0.010159890170037,0.729633861679156
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,41774,-0.00230912428960342,0.00671615393101656,-0.0154727859943959,0.010854537415189,0.730989805540123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAG,S-arrestin,39586,0.00190463136352111,0.00557449169669023,-0.00902137236199174,0.012830635089034,0.732606490361456
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,-0.00223012873802957,0.00657749447134366,-0.0151220179018631,0.010661760425804,0.734574063096497
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00130241384434331,0.00384574382112533,-0.00884007173374895,0.00623524404506234,0.734868427965301
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,39560,-0.00141592867500852,0.00426454267958822,-0.00977443232700144,0.0069425749769844,0.739877812179468
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00105299320234183,0.00317308124199056,-0.00727223243664331,0.00516624603195966,0.74000612611462
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,0.00230350075960415,0.00695349588567388,-0.0113253511763166,0.0159323526955249,0.740444035732996
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,41913,0.00106204701695326,0.00324693022534939,-0.00530193622473155,0.00742603025863806,0.743602952163798
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,-0.00180552442304468,0.00556246239855082,-0.0127079507242043,0.00909690187811494,0.745495876668349
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,39560,0.00124605900626677,0.00389288182460023,-0.00638398936994967,0.00887610738248321,0.74890884363438
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,39575,0.00169762510595791,0.00535338773348885,-0.00879501485168024,0.0121902650635961,0.751164422849653
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,0.000914429554266779,0.0029078711101476,-0.00478499782162251,0.00661385693015607,0.753171148402035
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,-0.00148702043134704,0.00473870699765306,-0.010774886146747,0.00780084528405297,0.753676538899823
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,-0.00354068508222588,0.0114229235063262,-0.0259296151546253,0.0188482449901735,0.756594683886577
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,39657,-0.000864033084221528,0.00279106499151833,-0.00633452046759745,0.0046064542991544,0.756892963032439
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,0.000628979653609163,0.00203416699565201,-0.00335798765786878,0.00461594696508711,0.757168429530224
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00110978149854218,0.0036219359031108,-0.00598921287155499,0.00820877586863936,0.759301461787426
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.000864631908142884,0.00292132973426255,-0.00486117437101172,0.00659043818729749,0.767255962720752
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00173481542961378,0.00586789419140007,-0.00976625718553036,0.0132358880447579,0.767506550480208
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.00193939444331697,0.00661506814933814,-0.0149049280160197,0.0110261391293858,0.769391334617195
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,0.000933184939916368,0.00323122663834499,-0.00540001927123981,0.00726638915107255,0.77273829737601
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,41913,-0.00145367197057244,0.00509606264904474,-0.0114419547627001,0.00853461082155525,0.775454032257554
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,-0.000989751514720633,0.00349772196989102,-0.00784528657570704,0.00586578354626577,0.777203990463364
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,-0.00273972716441485,0.00968322724829058,-0.0217188525710644,0.0162393982422347,0.777230737788302
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.000957723283791911,0.00341208782650333,-0.00764541542373843,0.00572996885615461,0.778955984130264
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,39586,-0.0014190129759545,0.00511205114952793,-0.0114386332290292,0.00860060727712024,0.781338535390782
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,0.000761051218847281,0.00276674885812575,-0.00466177654307919,0.00618387898077375,0.783267012054
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,0.00121542484786668,0.00449252143575073,-0.00758991716620475,0.0100207668619381,0.786746682124098
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,42299,0.00126772190398266,0.00470683881169689,-0.00795768216694326,0.0104931259749086,0.78767506261111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,-0.00150870979982078,0.00576903073425998,-0.0128160100389704,0.00979859043932878,0.793697393718444
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00164122472063409,0.00631734162842241,-0.0107407648710738,0.014023214312342,0.795025295702705
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,-0.00114424953112294,0.00440801135402118,-0.00978395178500445,0.00749545272275857,0.795188661269541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,39929,0.000734885942010319,0.00284714896258923,-0.00484552602466456,0.0063152979086852,0.796324446562057
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.00203317852287353,0.00802981369631219,-0.0137052563218984,0.0177716133676454,0.80011472240075
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00143844384878083,0.00573890064122735,-0.0126866891055864,0.00980980140802478,0.802090970688842
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,39966,0.000677666059224032,0.00271206732220086,-0.00463798589228966,0.00599331801073772,0.80269188715732
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00155417599840439,0.00626374150144996,-0.0107227573444375,0.0138311093412463,0.804044170932732
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,39586,0.00239948479905953,0.00972263964668586,-0.0166568889084448,0.0214558585065638,0.805072610145686
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTTG1,Securin,39757,-0.00106093825450852,0.00444107819622392,-0.0097654515191074,0.00764357501009037,0.811193681518744
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,39586,-0.00117835789982295,0.00495978459821,-0.0108995357123145,0.00854281991266865,0.81220937473784
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,-0.00100673978080167,0.00429131135123698,-0.00941771002922614,0.00740423046762281,0.814523922763287
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,41839,0.00114873271255517,0.00490600153923441,-0.00846703030434428,0.0107644957294546,0.814873345252097
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,41913,-0.00180925178300403,0.00775591184736654,-0.0170108390038424,0.0133923354378344,0.815552312958978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.00105880665791234,0.00454762150062023,-0.00785453148330331,0.00997214479912799,0.815900467598025
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,39539,0.000880786552450394,0.00384379036796712,-0.00665304256876517,0.00841461567366596,0.818760258295904
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,42070,0.000445514158462596,0.00202296532270207,-0.00351949787403347,0.00441052619095866,0.825696716262018
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,39934,-0.00080609363519118,0.00369848973248241,-0.0080551335108567,0.00644294624047434,0.827470349953556
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,39560,0.000960686294705185,0.00446009556897494,-0.0077811010204857,0.00970247360989606,0.829462675052674
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,-0.000782136597643169,0.00364661679801712,-0.00792950552175673,0.00636523232647039,0.830174425442042
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.000830997906929545,0.00390597513218927,-0.00682471335216143,0.00848670916602052,0.831525550856857
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.000577831716986187,0.00272505387933073,-0.00591893732047442,0.00476327388650205,0.832076510553002
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,39575,0.000721436266508817,0.00340588270724791,-0.00595409383969708,0.00739696637271471,0.832250896108166
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,41913,0.00128008699189253,0.00611560337288907,-0.01070649561897,0.0132666696027551,0.834205612873522
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.000898906234338392,0.00429459214179064,-0.00751849436357127,0.00931630683224806,0.834209190087979
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00151329474954552,0.0072633675545359,-0.0157494951564359,0.0127229056573448,0.834962556905252
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,-0.00151779104073403,0.00730310500083333,-0.0158318768423674,0.0127962947608993,0.835366919692402
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,39560,-0.000944332154556287,0.00456755613807002,-0.00989674218517352,0.00800807787606095,0.836210670272436
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,-0.00105221168619777,0.00512708975978475,-0.0111013076153759,0.00899688424298034,0.837398713084862
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,0.000285247823176231,0.00142302154989547,-0.0025038744146189,0.00307437006097136,0.841130569693439
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00105446102885705,0.00526792640110555,-0.00927067471730982,0.0113795967750239,0.841354276842473
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSC1,Hamartin,39657,0.00152812140863698,0.00788254279198916,-0.0139216624636618,0.0169779052809357,0.846287907426354
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.00057503300749483,0.00303683177552363,-0.00652722328752115,0.00537715727253148,0.849819584054413
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,0.00122817922592823,0.00652729219735593,-0.0115653134808894,0.0140216719327458,0.850754178246346
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,42016,-0.0011105653818803,0.00594682707883668,-0.0127663464564002,0.0105452156926396,0.851860078305768
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,41913,0.000954571422400003,0.00513577526968818,-0.00911154810618884,0.0110206909509888,0.852551850323976
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,0.000698356247578052,0.00376602182811761,-0.00668304653553246,0.00807975903068856,0.85289045423334
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,0.00516460588392671,0.0283599437091627,-0.0504208837860322,0.0607500955538856,0.85550039454378
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,39575,0.00109122675485881,0.00620537473696913,-0.0110713077296007,0.0132537612393183,0.8604135621101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,-0.00163462137396067,0.00950348370000539,-0.0202614494259712,0.0169922066780499,0.863438260019313
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,39586,-0.000610543593248609,0.00360551495907857,-0.00767735291304261,0.00645626572654539,0.865535454188072
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,0.00144892259157055,0.0086907244673534,-0.0155848973644421,0.0184827425475832,0.867592990158982
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,0.000543269922182482,0.00344722981083512,-0.00621330050705435,0.00729984035141932,0.874777492169794
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.000441594516173193,0.00289238628616121,-0.00522748260470278,0.00611067163704917,0.878657447139201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,41913,0.000982057762347315,0.00643823538248248,-0.0116368835873183,0.013600999112013,0.878767111757817
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,39560,0.000964563063823512,0.00639119542704594,-0.0115621799731865,0.0134913061008335,0.880041125742348
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.000651568268648718,0.00444953092057805,-0.0093726488729817,0.00806951233568427,0.883580456235949
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.000590347771697037,0.00408064163296969,-0.00740770982892356,0.00858840537231763,0.884973747306995
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.000614494181691496,0.00431268439594395,-0.00783836723435864,0.00906735559774163,0.886698826380708
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,41843,-0.00133818466957513,0.00941079253015762,-0.0197833380286841,0.0171069686895338,0.886926715221092
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,0.000989857722865098,0.00716992336956435,-0.013063192081481,0.0150429075272112,0.890197927818566
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,0.000504755165763507,0.0038533344853773,-0.00704778042557601,0.00805729075710302,0.895784133298709
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,39560,-0.00157109476853091,0.0124588883693302,-0.0259905159724181,0.0228483264353562,0.899653241520107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.000258423112641095,0.00205724563039264,-0.00429062454821068,0.00377377832292849,0.900038060278307
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,39575,-0.00109922854181149,0.00878437009115601,-0.0183165939204773,0.0161181368368543,0.9004192922635
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,0.000837418419997125,0.00686625023661741,-0.012620432043773,0.0142952688837673,0.90293171724321
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,-0.000783804022580014,0.00645432513861333,-0.0134342812942621,0.0118666732491021,0.903345486292558
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,0.000724096808929332,0.00603651360062105,-0.0111074698482879,0.0125556634661466,0.904522707982233
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,41913,-0.000521865570066081,0.00452001035232118,-0.0093810858606156,0.00833735472048344,0.908084864671936
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.000520342196111077,0.00468536497488323,-0.00866297315466005,0.00970365754688221,0.911573244959837
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,0.000607661302845807,0.00550194334992381,-0.0101761476630049,0.0113914702686965,0.912058605699609
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,0.000682786125988068,0.00620028984818054,-0.0114697819764458,0.0128353542284219,0.912314524062341
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,-0.000523470559021913,0.00521588080302036,-0.0107465969329418,0.00969965581489798,0.920059633184837
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,-0.000724818700069872,0.00741149656179099,-0.0152513519611802,0.0138017145610405,0.922095293030758
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,39929,0.00040042925359043,0.00426195682960443,-0.00795300613243425,0.00875386463961511,0.925147105424009
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,39657,0.000418617367101987,0.00459745577696024,-0.00859239595574009,0.00942963068994407,0.927451224139178
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,-0.000627700769702655,0.00693005601533645,-0.0142106105597621,0.0129552090203568,0.92783069353247
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,39966,-0.000491659720289183,0.0054480154549445,-0.0111697700119804,0.010186450571402,0.928093595478525
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.00064587823047505,0.00735263183554744,-0.0137652801671979,0.015057036628148,0.93000266459473
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.000470345940987344,0.00543113169508366,-0.0101746721813766,0.0111153640633513,0.930989320926221
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.000320359869083365,0.0038556942601833,-0.0072368008808759,0.00787752061904263,0.933783496518082
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,-0.000327926416808277,0.00430699712152546,-0.00876964077499817,0.00811378794138162,0.939310636867632
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,39757,-0.00044118907057466,0.00599221610490268,-0.0121859326361839,0.0113035544950346,0.941308483138119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,39979,0.000131328314113645,0.00199763292324852,-0.00378403221545345,0.00404668884368074,0.947584416177341
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.000594560531270739,0.00913578186785498,-0.017311571929725,0.0185006929922665,0.948110933613219
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,0.000267077567736324,0.00416882490406805,-0.00790381924423705,0.0084379743797097,0.948919293436897
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,39649,0.000380804963977628,0.00627087135843001,-0.0119101028985452,0.0126717128265005,0.951578519399028
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,-0.000174986765615905,0.00297134458109768,-0.00599882214456735,0.00564884861333554,0.953039639146308
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,0.000143353223157051,0.0026634897585676,-0.00507708670363544,0.00536379314994954,0.957078105715862
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.000387030557018135,0.0073900889662849,-0.0148716049309365,0.0140975438169003,0.958233579560438
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,-0.000168990936376264,0.00369640863708058,-0.0074139518650542,0.00707596999230167,0.963536140085805
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.000263663238559074,0.00616365445191118,-0.0118170994871868,0.012344425964305,0.965879864114726
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,0.000216998700817951,0.0052991553579617,-0.010169345800787,0.0106033432024229,0.967336758912425
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.000152852160703317,0.00374745312075787,-0.00749786027738875,0.00719215595598212,0.967465285686101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,0.000233239736460518,0.00574259445271853,-0.0110222453908678,0.0114887248637888,0.967602973770795
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,0.000142566096097454,0.00447820339713459,-0.00863471256228633,0.00891984475448124,0.974603770911942
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,39638,-0.000122880213163268,0.00436425244419384,-0.0086768150037832,0.00843105457745667,0.97753818049851
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.000161326895152551,0.00575919654642682,-0.0114493521261491,0.011126698335844,0.977653047207205
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,0.000167184671666159,0.00728313836297461,-0.0141077665197641,0.0144421358630964,0.981686553534808
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,39919,0.000220170422504282,0.0111592862799111,-0.0216520306861215,0.0220923715311301,0.984259270767516
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-9.02743920052747e-05,0.00532924101281306,-0.0105355867771189,0.0103550379931083,0.986485231278926
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,6.43983041784586e-05,0.00453588801637168,-0.00882594220791003,0.00895473881626695,0.988672666569293
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,-8.41382540081731e-05,0.00668484936939668,-0.0131864430180257,0.0130181665100093,0.989957992130257
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,39990,2.92682380427071e-05,0.00242899146309537,-0.00473155502962422,0.00479009150570964,0.990386299037951
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,39919,-5.37439362703925e-05,0.00609559771896661,-0.012001115465445,0.0118936275929042,0.992965422546859
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,39657,-3.17450197568224e-05,0.00391729884648421,-0.00770965075886588,0.00764616071935224,0.993534317342203
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,-2.4542580695125e-05,0.00389571961540948,-0.00766015302689771,0.00761106786550746,0.994973547664665
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,41913,-5.49533072789645e-05,0.00997466923930632,-0.0196053050163193,0.0194953984017614,0.995604330408788
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,41839,-2.45467940989471e-05,0.00535930481936855,-0.0105287842400613,0.0104796906518634,0.996345595116355
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,39757,5.66520635319295e-07,0.00294167906592362,-0.00576512444857498,0.00576625748984561,0.99984634355859
